PID,core,grade,tumor_size,gender,PTNM_M,age,Patientstatus,treatment,PTNM_T,DiseaseStage,PTNM_N,AllSamplesSVSp4.Array,TMALocation,TMAxlocation,yLocation,diseasestatus,TMABlocklabel,UBTMAlocation,%tumorcells,%normalepithelialcells,%stroma,%inflammatorycells,Yearofsamplecollection,PrimarySite,histology,PTNM_Radicality,Lymphaticinvasion,Venousinvasion,ERStatus,PRStatus,HER2Status,Pre-surgeryTx,Post-surgeryTx,Tag,Ptdiagnosis,DFSmonth,OSmonth,Comment,ER+DuctalCa,TripleNegDuctal,hormonesensitive,Post_surgeryTx,hormoneresistantaftersenstive,Fulvestran,microinvasion,I_plus_neg,SN,MIC,Count_Cells,FileName_FullStack,Height_FullStack,Width_FullStack,area,sum_area_cells,Subtype,HR,clinical_type,response
257,BaselTMA_SP41_257_X3Y1,3,35,FEMALE,0,63,alive,,2,1. Primary Dx,1a,Sp4.1,X3Y1,3,1,tumor,Sp4.1,27,90,0,10,0,2000,breast,invasive ductal breast carcinoma-,0,,,positive,negative,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,98,154,"",1,0,,,1,,FALSE,"","","",3683,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_27_257_X3Y1_28_a0_full.tiff,743,749,556507,395873,PR-ER+,positive,HR+HER2-,Resistant
7,BaselTMA_SP41_7_X5Y1,3,20,FEMALE,0,90,death,,4,1. Primary Dx,0,Sp4.1,X5Y1,5,1,tumor,Sp4.1,45,75,0,10,15,2000,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,37,37,"",1,0,,1,,,FALSE,"","","",3892,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_45_7_X5Y1_56_a0_full.tiff,775,859,665725,353725,PR+ER+,positive,HR+HER2-,Refractory
166,BaselTMA_SP41_166_X15Y4,3,28,FEMALE,0,68,death by primary disease,,2,1. Primary Dx,0,Sp4.1,X15Y4,15,4,tumor,Sp4.1,122,70,0,10,20,2000,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,negative,negative,negative,none,none,Sp4.1,breast cancer,35,37,"",,1,,,,,FALSE,i-,"","",3068,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_122_166_X15Y4_231_a0_full.tiff,723,749,541527,356411,PR-ER-,negative,TripleNeg,""
238,BaselTMA_SP41_238_X7Y1,1,15,FEMALE,0,55,alive,,1c,1. Primary Dx,2a,Sp4.1,X7Y1,7,1,tumor,Sp4.1,62,75,0,20,50,2000,breast,invasive tubular breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,140,233,"",,0,1,,,,FALSE,"","","",3173,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_62_238_X7Y1_4_a0_full.tiff,840,712,598080,286198,PR+ER+,positive,HR+HER2-,Sensitive
238,BaselTMA_SP41_238_X8Y1,1,15,FEMALE,0,55,alive,,1c,1. Primary Dx,2a,Sp4.1,X8Y1,8,1,non-tumor,Sp4.1,70,0,70,30,0,2000,breast,invasive tubular breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,140,233,"",,0,1,,,,FALSE,"","","",2121,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_70_238_X8Y1_16_a0_full.tiff,765,689,527085,193119,PR+ER+,positive,HR+HER2-,Sensitive
68,BaselTMA_SP41_68_X10Y1,1,17,FEMALE,0,58,alive,,1c,1. Primary Dx,2a,Sp4.1,X10Y1,10,1,non-tumor,Sp4.1,86,0,40,60,0,2000,breast,invasive ductal breast carcinoma-,0,,,positive,positive,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,169,169,"",1,0,1,,,,FALSE,"","","",299,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_86_68_X10Y1_44_a0_full.tiff,334,450,150300,24940,PR+ER+,positive,HR+HER2-,Sensitive
68,BaselTMA_SP41_68_X9Y1,1,17,FEMALE,0,58,alive,,1c,1. Primary Dx,2a,Sp4.1,X9Y1,9,1,tumor,Sp4.1,78,60,0,35,5,2000,breast,invasive ductal breast carcinoma-,0,,,positive,positive,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,169,169,"",1,0,1,,,,FALSE,"","","",2262,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_78_68_X9Y1_30_a0_full.tiff,689,688,474032,218846,PR+ER+,positive,HR+HER2-,Sensitive
72,BaselTMA_SP41_72_X11Y1,3,9,FEMALE,1,43,alive,,1,1. Primary Dx,0,Sp4.1,X11Y1,11,1,tumor,Sp4.1,94,80,0,20,0,2000,breast,invasive ductal breast carcinoma-mucinous breast carcinoma,0,,,positive,negative,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,186,186,"",1,0,1,,,,FALSE,"","","",2740,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_94_72_X11Y1_6_a0_full.tiff,716,737,527692,289717,PR-ER+,positive,HR+HER2-,Sensitive
72,BaselTMA_SP41_72_X12Y1,3,9,FEMALE,1,43,alive,,1,1. Primary Dx,0,Sp4.1,X12Y1,12,1,non-tumor,Sp4.1,102,0,50,50,0,2000,breast,invasive ductal breast carcinoma-mucinous breast carcinoma,0,,,positive,negative,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,186,186,"",1,0,1,,,,FALSE,"","","",480,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_102_72_X12Y1_18_a0_full.tiff,765,658,503370,57607,PR-ER+,positive,HR+HER2-,Sensitive
274,BaselTMA_SP41_274_X13Y1,2,20,FEMALE,0,61,alive,,1c,1. Primary Dx,1a,Sp4.1,X13Y1,13,1,tumor,Sp4.1,110,100,0,0,0,2000,breast,invasive ductal breast carcinoma-invasive lobular breast carcinoma,0,,,positive,positive,negative,none,Hormone therapy,Sp4.1,breast cancer,171,171,"",1,0,1,,,,FALSE,"","","",539,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_110_274_X13Y1_32_a0_full.tiff,658,729,479682,55599,PR+ER+,positive,HR+HER2-,Sensitive
274,BaselTMA_SP41_274_X14Y1,2,20,FEMALE,0,61,alive,,1c,1. Primary Dx,1a,Sp4.1,X14Y1,14,1,non-tumor,Sp4.1,118,0,50,45,5,2000,breast,invasive ductal breast carcinoma-invasive lobular breast carcinoma,0,,,positive,positive,negative,none,Hormone therapy,Sp4.1,breast cancer,171,171,"",1,0,1,,,,FALSE,"","","",617,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_118_274_X14Y1_46_a0_full.tiff,657,638,419166,59880,PR+ER+,positive,HR+HER2-,Sensitive
153,BaselTMA_SP41_153_X7Y5,1,11,FEMALE,0,68,alive,,1c,1. Primary Dx,0,Sp4.1,X7Y5,7,5,tumor,Sp4.1,58,70,0,30,0,2000,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,144,144,"",1,0,1,,,,FALSE,i-,"","",1381,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_58_153_X7Y5_209_a0_full.tiff,685,760,520600,135415,PR+ER+,positive,HR+HER2-,Sensitive
58,BaselTMA_SP41_58_X15Y1,2,35,FEMALE,0,57,alive,,2,1. Primary Dx,0,Sp4.1,X15Y1,15,1,tumor,Sp4.1,125,80,0,10,10,2000,breast,invasive ductal breast carcinoma-,0,,,positive,negative,negative,none,Tamoxifen,Sp4.1,breast cancer,181,181,"",1,0,1,,,,FALSE,"","","",4352,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_125_58_X15Y1_60_a0_full.tiff,688,811,557968,395821,PR-ER+,positive,HR+HER2-,Sensitive
58,BaselTMA_SP41_58_X16Y1,2,35,FEMALE,0,57,alive,,2,1. Primary Dx,0,Sp4.1,X16Y1,16,1,non-tumor,Sp4.1,132,0,0,100,0,2000,breast,invasive ductal breast carcinoma-,0,,,positive,negative,negative,none,Tamoxifen,Sp4.1,breast cancer,181,181,"",1,0,1,,,,FALSE,"","","",527,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_132_58_X16Y1_74_a0_full.tiff,637,548,349076,54751,PR-ER+,positive,HR+HER2-,Sensitive
206,BaselTMA_SP41_206_X1Y2,1,16,FEMALE,0,41,alive,,1c,1. Primary Dx,0,Sp4.1,X1Y2,1,2,tumor,Sp4.1,8,80,0,20,0,2000,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,121,121,"",1,0,1,,,,FALSE,"","","",3473,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_8_206_X1Y2_70_a0_full.tiff,730,768,560640,286618,PR+ER+,positive,HR+HER2-,Sensitive
206,BaselTMA_SP41_206_X2Y2,1,16,FEMALE,0,41,alive,,1c,1. Primary Dx,0,Sp4.1,X2Y2,2,2,non-tumor,Sp4.1,17,0,60,35,5,2000,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,121,121,"",1,0,1,,,,FALSE,"","","",1868,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_17_206_X2Y2_85_a0_full.tiff,733,730,535090,181535,PR+ER+,positive,HR+HER2-,Sensitive
135,BaselTMA_SP41_135_X8Y5,2,40,FEMALE,0,75,death by primary disease,,2,1. Primary Dx,1a,Sp4.1,X8Y5,8,5,tumor,Sp4.1,66,70,0,25,5,2000,breast,invasive ductal breast carcinoma-,0,1,0,negative,negative,negative,none,none,Sp4.1,breast cancer,35,37,"",,1,,,,,FALSE,"","","",3426,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_66_135_X8Y5_217_a0_full.tiff,662,770,509740,352073,PR-ER-,negative,TripleNeg,""
280,BaselTMA_SP41_280_X9Y5,3,25,FEMALE,0,56,alive,,2,1. Primary Dx,0,Sp4.1,X9Y5,9,5,tumor,Sp4.1,74,80,0,15,5,2000,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,positive,none,Tamoxifen,Sp4.1,breast cancer,166,166,"",1,0,1,,,,FALSE,"","","",3083,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_74_280_X9Y5_223_a0_full.tiff,721,777,560217,268130,PR+ER+,positive,HR+HER2+,Sensitive
220,BaselTMA_SP41_220_X10Y5,3,35,FEMALE,0,92,death,,2,1. Primary Dx,X,Sp4.1,X10Y5,10,5,tumor,Sp4.1,82,75,0,10,15,2000,breast,invasive ductal breast carcinoma-,0,,,negative,negative,positive,none,none,Sp4.1,breast cancer,16,16,"",,0,,,,,FALSE,"","","",3572,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_82_220_X10Y5_229_a0_full.tiff,708,779,551532,374722,PR-ER-,negative,HR-HER2+,""
187,BaselTMA_SP41_187_X3Y2,1,11,FEMALE,0,65,alive,,1c,1. Primary Dx,0,Sp4.1,X3Y2,3,2,non-tumor,Sp4.1,26,0,0,100,0,2000,breast,invasive tubular breast carcinoma-,0,,,negative,negative,negative,none,none,Sp4.1,breast cancer,166,166,"",,1,,,,,FALSE,"","","",263,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_26_187_X3Y2_99_a0_full.tiff,621,730,453330,15804,PR-ER-,negative,TripleNeg,""
187,BaselTMA_SP41_187_X4Y2,1,11,FEMALE,0,65,alive,,1c,1. Primary Dx,0,Sp4.1,X4Y2,4,2,non-tumor,Sp4.1,35,0,0,100,0,2000,breast,invasive tubular breast carcinoma-,0,,,negative,negative,negative,none,none,Sp4.1,breast cancer,166,166,"",,1,,,,,FALSE,"","","",62,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_35_187_X4Y2_112_a0_full.tiff,836,871,728156,5400,PR-ER-,negative,TripleNeg,""
88,BaselTMA_SP41_88_X11Y5_235,1,18,FEMALE,0,63,alive,,1,1. Primary Dx,0,Sp4.1,X11Y5,11,5,tumor,Sp4.1,90,50,0,40,10,2000,breast,invasive tubular breast carcinoma-in situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Hormone therapy,Sp4.1,breast cancer,121,121,"",1,0,1,,,,FALSE,"","","",4727,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_90_88_X11Y5_235_a0_full.tiff,733,790,579070,512959,PR+ER+,positive,HR+HER2-,Sensitive
88,BaselTMA_SP41_88_X11Y5_242,1,18,FEMALE,0,63,alive,,1,1. Primary Dx,0,Sp4.1,X11Y5,11,5,tumor,Sp4.1,90,50,0,40,10,2000,breast,invasive tubular breast carcinoma-in situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Hormone therapy,Sp4.1,breast cancer,121,121,"",1,0,1,,,,FALSE,"","","",1246,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_90_88_X11Y5_242_a0_full.tiff,523,625,326875,111189,PR+ER+,positive,HR+HER2-,Sensitive
24,BaselTMA_SP41_24_X5Y2,3,22,FEMALE,0,40,death by primary disease,,2,1. Primary Dx,0,Sp4.1,X5Y2,5,2,tumor,Sp4.1,44,80,0,20,0,2000,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,0,0,positive,negative,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,90,105,"",1,0,,,1,,FALSE,"","","",2174,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_44_24_X5Y2_124_a0_full.tiff,777,739,574203,228772,PR-ER+,positive,HR+HER2-,Resistant
24,BaselTMA_SP41_24_X6Y2,3,22,FEMALE,0,40,death by primary disease,,2,1. Primary Dx,0,Sp4.1,X6Y2,6,2,non-tumor,Sp4.1,53,0,70,30,0,2000,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,0,0,positive,negative,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,90,105,"",1,0,,,1,,FALSE,"","","",1200,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_53_24_X6Y2_58_a0_full.tiff,671,732,491172,103935,PR-ER+,positive,HR+HER2-,Resistant
284,BaselTMA_SP41_284_X7Y2,2,13,FEMALE,0,65,alive,,1c,1. Primary Dx,0,Sp4.1,X7Y2,7,2,tumor,Sp4.1,61,80,0,15,5,2001,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,negative,negative,none,Hormone therapy,Sp4.1,breast cancer,169,169,"",1,0,1,,,,FALSE,"","","",1266,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_61_284_X7Y2_72_a0_full.tiff,746,681,508026,119365,PR-ER+,positive,HR+HER2-,Sensitive
284,BaselTMA_SP41_284_X8Y2,2,13,FEMALE,0,65,alive,,1c,1. Primary Dx,0,Sp4.1,X8Y2,8,2,non-tumor,Sp4.1,69,0,70,30,0,2001,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,negative,negative,none,Hormone therapy,Sp4.1,breast cancer,169,169,"",1,0,1,,,,FALSE,"","","",109,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_69_284_X8Y2_87_a0_full.tiff,647,670,433490,10284,PR-ER+,positive,HR+HER2-,Sensitive
20,BaselTMA_SP41_20_X12Y5,1,12,FEMALE,0,67,alive,,1c,1. Primary Dx,0,Sp4.1,X12Y5,12,5,tumor,Sp4.1,98,80,0,10,10,2001,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Hormone therapy,Sp4.1,breast cancer,107,118,"",1,0,,,1,,FALSE,"","","",405,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_98_20_X12Y5_246_a0_full.tiff,699,309,215991,44612,PR+ER+,positive,HR+HER2-,Resistant
18,BaselTMA_SP41_18_X13Y5,1,25,FEMALE,0,84,alive,,2,1. Primary Dx,1a,Sp4.1,X13Y5,13,5,tumor,Sp4.1,106,60,0,40,0,2001,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,1,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,4,118,"",1,0,,1,,,FALSE,"","","",1913,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_106_18_X13Y5_248_a0_full.tiff,774,709,548766,177887,PR+ER+,positive,HR+HER2-,Refractory
42,BaselTMA_SP41_42_X14Y5,2,33,FEMALE,0,58,alive,,2,1. Primary Dx,2,Sp4.1,X14Y5,14,5,tumor,Sp4.1,114,70,0,30,0,2001,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,189,189,"",1,0,,,,,FALSE,"","","",1748,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_114_42_X14Y5_250_a0_full.tiff,717,814,583638,223164,PR+ER+,positive,HR+HER2-,""
52,BaselTMA_SP41_52_X10Y2_101,3,55,FEMALE,0,68,death by primary disease,,3,1. Primary Dx,1a,Sp4.1,X10Y2,10,2,non-tumor,Sp4.1,85,0,80,20,0,2001,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, lymphangiosis carcinomatosa",0,1,,negative,negative,negative,none,Chemotherapy,Sp4.1,breast cancer,14,42,"",,1,,,,,FALSE,"","","",9,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_85_52_X10Y2_101_a0_full.tiff,246,454,111684,1069,PR-ER-,negative,TripleNeg,""
52,BaselTMA_SP41_52_X10Y2_102,3,55,FEMALE,0,68,death by primary disease,,3,1. Primary Dx,1a,Sp4.1,X10Y2,10,2,non-tumor,Sp4.1,85,0,80,20,0,2001,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, lymphangiosis carcinomatosa",0,1,,negative,negative,negative,none,Chemotherapy,Sp4.1,breast cancer,14,42,"",,1,,,,,FALSE,"","","",20,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_85_52_X10Y2_102_a0_full.tiff,246,448,110208,2222,PR-ER-,negative,TripleNeg,""
52,BaselTMA_SP41_52_X9Y3,3,55,FEMALE,0,68,death by primary disease,,3,1. Primary Dx,1a,Sp4.1,X9Y2,9,2,tumor,Sp4.1,77,80,0,20,0,2001,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, lymphangiosis carcinomatosa",0,1,,negative,negative,negative,none,Chemotherapy,Sp4.1,breast cancer,14,42,"",,1,,,,,FALSE,"","","",2924,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_77_52_X9Y3_126_a0_full.tiff,768,755,579840,245952,PR-ER-,negative,TripleNeg,""
141,BaselTMA_SP41_141_X11Y2,3,52,FEMALE,0,38,alive,,3,1. Primary Dx,0,Sp4.1,X11Y2,11,2,tumor,Sp4.1,93,95,0,3,2,2001,breast,invasive ductal breast carcinoma-lymphangiosis carcinomatosa,0,1,,positive,positive,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,180,180,"",1,0,,,,,FALSE,"","","",5669,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_93_141_X11Y2_89_a0_full.tiff,727,780,567060,474942,PR+ER+,positive,HR+HER2-,""
141,BaselTMA_SP41_141_X12Y2,3,52,FEMALE,0,38,alive,,3,1. Primary Dx,0,Sp4.1,X12Y2,12,2,non-tumor,Sp4.1,101,0,60,40,0,2001,breast,invasive ductal breast carcinoma-lymphangiosis carcinomatosa,0,1,,positive,positive,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,180,180,"",1,0,,,,,FALSE,"","","",702,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_101_141_X12Y2_104_a0_full.tiff,586,617,361562,61719,PR+ER+,positive,HR+HER2-,""
83,BaselTMA_SP41_83_X13Y2,2,16,FEMALE,0,54,alive,,1c,1. Primary Dx,2,Sp4.1,X13Y2,13,2,tumor,Sp4.1,109,50,0,20,30,2001,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,115,115,"",1,0,,,,,FALSE,"","","",4360,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_109_83_X13Y2_116_a0_full.tiff,672,774,520128,385486,PR+ER+,positive,HR+HER2-,""
83,BaselTMA_SP41_83_X14Y2,2,16,FEMALE,0,54,alive,,1c,1. Primary Dx,2,Sp4.1,X14Y2,14,2,non-tumor,Sp4.1,117,0,50,50,0,2001,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,115,115,"",1,0,,,,,FALSE,"","","",2110,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_117_83_X14Y2_128_a0_full.tiff,711,742,527562,175176,PR+ER+,positive,HR+HER2-,""
100,BaselTMA_SP41_100_X15Y5,3,31,FEMALE,0,51,alive,,2,1. Primary Dx,0,Sp4.1,X15Y5,15,5,tumor,Sp4.1,121,90,0,10,0,2001,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,171,171,"",1,0,,,,,FALSE,i-,"","",3563,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_121_100_X15Y5_252_a0_full.tiff,728,742,540176,352513,PR+ER+,positive,HR+HER2-,""
204,BaselTMA_SP41_204_X16Y4_237,2,18,FEMALE,0,50,alive,,1c,1. Primary Dx,0,Sp4.1,X16Y4,16,4,tumor,Sp4.1,129,50,0,20,30,2000,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, lymphangiosis carcinomatosa",0,1,,positive,positive,negative,none,Anastrazol,Sp4.1,breast cancer,174,174,"",1,0,1,,,,FALSE,i-,"","",593,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_128_204_X16Y4_237_a0_full.tiff,333,377,125541,58471,PR+ER+,positive,HR+HER2-,Sensitive
204,BaselTMA_SP41_204_X16Y4_238,2,18,FEMALE,0,50,alive,,1c,1. Primary Dx,0,Sp4.1,X16Y4,16,4,tumor,Sp4.1,129,50,0,20,30,2000,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, lymphangiosis carcinomatosa",0,1,,positive,positive,negative,none,Anastrazol,Sp4.1,breast cancer,174,174,"",1,0,1,,,,FALSE,i-,"","",677,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_128_204_X16Y4_238_a0_full.tiff,254,736,186944,73787,PR+ER+,positive,HR+HER2-,Sensitive
177,BaselTMA_SP41_177_X16Y5,2,15,FEMALE,0,49,alive,,1c,1. Primary Dx,0,Sp4.1,X16Y5,16,5,tumor,Sp4.1,128,70,0,10,20,2001,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,179,179,"",1,0,1,,,,FALSE,i-,sn,"",2727,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_128_177_X16Y5_254_a0_full.tiff,626,642,401892,238316,PR+ER+,positive,HR+HER2-,Sensitive
31,BaselTMA_SP41_31_X15Y2,3,22,FEMALE,0,44,alive,,2,1. Primary Dx,3a,Sp4.1,X15Y2,15,2,tumor,Sp4.1,124,70,0,25,5,2001,breast,mixed ductal lobular breast carcinoma-lymphangiosis carcinomatosa,0,1,1,positive,positive,negative,none,Chemotherapy,Sp4.1,breast cancer,24,24,"",,0,,,,,TRUE,"","","",4314,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_124_31_X15Y2_140_a0_full.tiff,796,815,648740,411187,PR+ER+,positive,HR+HER2-,""
31,BaselTMA_SP41_31_X16Y2,3,22,FEMALE,0,44,alive,,2,1. Primary Dx,3a,Sp4.1,X16Y2,16,2,non-tumor,Sp4.1,131,0,50,50,0,2001,breast,mixed ductal lobular breast carcinoma-lymphangiosis carcinomatosa,0,1,1,positive,positive,negative,none,Chemotherapy,Sp4.1,breast cancer,24,24,"",,0,,,,,TRUE,"","","",217,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_131_31_X16Y2_153_a0_full.tiff,759,719,545721,22901,PR+ER+,positive,HR+HER2-,""
216,BaselTMA_SP41_216_X1Y6,1,13,FEMALE,0,67,alive w metastases,,1c,1. Primary Dx,1a,Sp4.1,X1Y6,1,6,tumor,Sp4.1,4,70,0,30,0,2001,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,negative,negative,none,Tamoxifen,Sp4.1,breast cancer,72,110,"",1,0,,,1,1,TRUE,"","","",2525,BaselTMA_SP41_33.475kx17.665ky_8500x5000_13_20170905_4_216_X1Y6_12_a0_full.tiff,831,636,528516,199274,PR-ER+,positive,HR+HER2-,Resistant
283,BaselTMA_SP41_283_X2Y6,2,11,FEMALE,0,66,alive,,1c,1. Primary Dx,0,Sp4.1,X2Y6,2,6,tumor,Sp4.1,13,80,0,15,5,2001,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,141,141,"",1,0,1,,,,FALSE,"","","",2560,BaselTMA_SP41_33.475kx17.665ky_8500x5000_13_20170905_13_283_X2Y6_24_a0_full.tiff,628,714,448392,209448,PR+ER+,positive,HR+HER2-,Sensitive
282,BaselTMA_SP41_282_X1Y3,1,18,FEMALE,0,57,alive,,1c,1. Primary Dx,0,Sp4.1,X1Y3,1,3,tumor,Sp4.1,7,65,0,15,20,2001,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, cribriform breast carcinoma",0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,144,144,"",1,0,1,,,,TRUE,"","","",2432,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170912_7_282_X1Y3_258_a0_full.tiff,611,829,506519,253852,PR+ER+,positive,HR+HER2-,Sensitive
282,BaselTMA_SP41_282_X2Y3_148,1,18,FEMALE,0,57,alive,,1c,1. Primary Dx,0,Sp4.1,X2Y3,2,3,non-tumor,Sp4.1,16,0,70,30,0,2001,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, cribriform breast carcinoma",0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,144,144,"",1,0,1,,,,TRUE,"","","",89,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_16_282_X2Y3_148_a0_full.tiff,531,348,184788,8890,PR+ER+,positive,HR+HER2-,Sensitive
282,BaselTMA_SP41_282_X2Y3_149,1,18,FEMALE,0,57,alive,,1c,1. Primary Dx,0,Sp4.1,X2Y3,2,3,non-tumor,Sp4.1,16,0,70,30,0,2001,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, cribriform breast carcinoma",0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,144,144,"",1,0,1,,,,TRUE,"","","",68,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_16_282_X2Y3_149_a0_full.tiff,454,178,80812,6458,PR+ER+,positive,HR+HER2-,Sensitive
45,BaselTMA_SP41_45_X3Y3,2,55,FEMALE,0,91,death,,3,1. Primary Dx,0,Sp4.1,X3Y3,3,3,tumor,Sp4.1,25,80,0,20,0,2001,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, mucinous breast carcinoma",0,,,positive,negative,positive,none,Tamoxifen,Sp4.1,breast cancer,63,63,"",1,0,,,,,FALSE,"","","",3045,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_25_45_X3Y3_161_a0_full.tiff,758,736,557888,324674,PR-ER+,positive,HR+HER2+,""
45,BaselTMA_SP41_45_X4Y3,2,55,FEMALE,0,91,death,,3,1. Primary Dx,0,Sp4.1,X4Y3,4,3,non-tumor,Sp4.1,34,0,80,20,0,2001,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, mucinous breast carcinoma",0,,,positive,negative,positive,none,Tamoxifen,Sp4.1,breast cancer,63,63,"",1,0,,,,,FALSE,"","","",89,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_34_45_X4Y3_173_a0_full.tiff,774,671,519354,7335,PR-ER+,positive,HR+HER2+,""
133,BaselTMA_SP41_133_X3Y6,3,22,FEMALE,0,32,death by primary disease,,2,1. Primary Dx,0,Sp4.1,X3Y6,3,6,tumor,Sp4.1,22,60,0,20,20,2001,breast,invasive ductal breast carcinoma-lymphangiosis carcinomatosa,0,1,,negative,negative,positive,none,Chemotherapy,Sp4.1,breast cancer,10,21,"",,0,,,,,FALSE,i-,sn,"",4219,BaselTMA_SP41_33.475kx17.665ky_8500x5000_13_20170905_22_133_X3Y6_38_a0_full.tiff,796,744,592224,379050,PR-ER-,negative,HR-HER2+,""
69,BaselTMA_SP41_69_X5Y3,3,24,FEMALE,0,74,alive,,2,1. Primary Dx,1mi,Sp4.1,X5Y3,5,3,tumor,Sp4.1,43,60,0,20,20,2001,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,"","",negative,none,Tamoxifen,Sp4.1,breast cancer,110,110,"",,0,1,,,,FALSE,"","","",2204,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_43_69_X5Y3_183_a0_full.tiff,752,734,551968,216923,"","","",Sensitive
211,BaselTMA_SP41_211_X4Y6,2,25,FEMALE,0,67,alive,,2,1. Primary Dx,1mi,Sp4.1,X4Y6,4,6,tumor,Sp4.1,31,70,0,30,0,2001,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,134,134,"",1,0,1,,,,FALSE,"","","",2352,BaselTMA_SP41_33.475kx17.665ky_8500x5000_13_20170905_31_211_X4Y6_52_a0_full.tiff,793,719,570167,215581,PR+ER+,positive,HR+HER2-,Sensitive
228,BaselTMA_SP41_228_X7Y3,1,33,FEMALE,0,59,death by primary disease,,2,1. Primary Dx,0,Sp4.1,X7Y3,7,3,tumor,Sp4.1,60,80,0,15,5,2001,breast,invasive ductal breast carcinoma-partially mucinous,0,,,positive,positive,positive,none,Tamoxifen,Sp4.1,breast cancer,21,90,"",1,0,,1,,,FALSE,"","","",270,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_60_228_X7Y3_114_a0_full.tiff,692,728,503776,27269,PR+ER+,positive,HR+HER2+,Refractory
259,BaselTMA_SP41_259_X10Y3,2,37,FEMALE,0,47,alive w metastases,,2,1. Primary Dx,1a,Sp4.1,X10Y3,10,3,non-tumor,Sp4.1,84,0,0,100,0,2001,breast,invasive ductal breast carcinoma-,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,99,125,"",1,0,,,1,1,FALSE,"","","",3681,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_84_259_X10Y3_138_a0_full.tiff,807,701,565707,358007,PR+ER+,positive,HR+HER2-,Resistant
239,BaselTMA_SP41_239_X11Y3_151,3,14,FEMALE,0,42,alive,,1c,1. Primary Dx,0,Sp4.1,X11Y3,11,3,tumor,Sp4.1,92,70,0,30,0,2001,breast,invasive ductal breast carcinoma-tubular and lobular breast carcinoma,0,,,positive,positive,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,128,128,"",1,0,,,,,FALSE,"","","",69,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_92_239_X11Y3_151_a0_full.tiff,293,736,215648,6174,PR+ER+,positive,HR+HER2-,""
239,BaselTMA_SP41_239_X11Y3_165,3,14,FEMALE,0,42,alive,,1c,1. Primary Dx,0,Sp4.1,X11Y3,11,3,tumor,Sp4.1,92,70,0,30,0,2001,breast,invasive ductal breast carcinoma-tubular and lobular breast carcinoma,0,,,positive,positive,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,128,128,"",1,0,,,,,FALSE,"","","",2757,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_92_239_X11Y3_165_a0_full.tiff,746,769,573674,273536,PR+ER+,positive,HR+HER2-,""
239,BaselTMA_SP41_239_X12Y3,3,14,FEMALE,0,42,alive,,1c,1. Primary Dx,0,Sp4.1,X12Y3,12,3,non-tumor,Sp4.1,100,0,80,20,0,2001,breast,invasive ductal breast carcinoma-tubular and lobular breast carcinoma,0,,,positive,positive,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,128,128,"",1,0,,,,,FALSE,"","","",80,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_100_239_X12Y3_177_a0_full.tiff,726,689,500214,7470,PR+ER+,positive,HR+HER2-,""
117,BaselTMA_SP41_117_X13Y3,1,15,FEMALE,0,75,death,,1c,1. Primary Dx,0,Sp4.1,X13Y3,13,3,tumor,Sp4.1,108,70,0,10,20,2001,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,100,100,"",1,0,,,,,TRUE,i-,"","",4580,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_108_117_X13Y3_187_a0_full.tiff,825,799,659175,492383,PR+ER+,positive,HR+HER2-,""
117,BaselTMA_SP41_117_X14Y3,1,15,FEMALE,0,75,death,,1c,1. Primary Dx,0,Sp4.1,X14Y3,14,3,non-tumor,Sp4.1,116,0,60,40,0,2001,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,100,100,"",1,0,,,,,TRUE,i-,"","",233,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_116_117_X14Y3_195_a0_full.tiff,696,648,451008,20936,PR+ER+,positive,HR+HER2-,""
165,BaselTMA_SP41_165_X5Y6,3,30,FEMALE,0,82,death,,2,1. Primary Dx,1a,Sp4.1,X5Y6,5,6,tumor,Sp4.1,40,80,0,20,0,2002,breast,invasive ductal breast carcinoma-,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,60,60,"",1,0,,,,,FALSE,"","","",1731,BaselTMA_SP41_33.475kx17.665ky_8500x5000_13_20170905_40_165_X5Y6_66_a0_full.tiff,805,723,582015,172668,PR+ER+,positive,HR+HER2-,""
231,BaselTMA_SP41_231_X6Y6_10,2,70,FEMALE,0,52,alive,,3,1. Primary Dx,2a,Sp4.1,X6Y6,6,6,tumor,Sp4.1,49,70,0,25,5,2002,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,1,,negative,negative,positive,none,Chemotherapy,Sp4.1,breast cancer,102,102,"",,0,,,,,FALSE,"","","",852,BaselTMA_SP41_23.475kx17.66ky_10000x5000_12_20170905_49_231_X6Y6_10_a0_full.tiff,270,711,191970,81606,PR-ER-,negative,HR-HER2+,""
231,BaselTMA_SP41_231_X6Y6_256,2,70,FEMALE,0,52,alive,,3,1. Primary Dx,2a,Sp4.1,X6Y6,6,6,tumor,Sp4.1,49,70,0,25,5,2002,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,1,,negative,negative,positive,none,Chemotherapy,Sp4.1,breast cancer,102,102,"",,0,,,,,FALSE,"","","",1604,BaselTMA_SP41_23.475kx17.66ky_10000x5000_12_20170912_49_231_X6Y6_256_a0_full.tiff,436,705,307380,177553,PR-ER-,negative,HR-HER2+,""
37,BaselTMA_SP41_37_X7Y6,3,22,FEMALE,0,78,alive,,2,1. Primary Dx,0,Sp4.1,X7Y6,7,6,tumor,Sp4.1,57,70,0,20,10,2002,breast,invasive ductal breast carcinoma-,0,,,positive,negative,positive,none,Tamoxifen,Sp4.1,breast cancer,127,127,"",1,0,1,,,,FALSE,i-,"","",2883,BaselTMA_SP41_23.475kx17.66ky_10000x5000_12_20170905_57_37_X7Y6_22_a0_full.tiff,727,773,561971,325693,PR-ER+,positive,HR+HER2+,Sensitive
57,BaselTMA_SP41_57_X8Y6,2,36,FEMALE,0,42,alive,,2,1. Primary Dx,2a,Sp4.1,X8Y6,8,6,tumor,Sp4.1,65,70,0,30,0,2002,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, lymphangiosis carcinomatosa",0,1,,positive,negative,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,130,130,"",1,0,,,,,FALSE,"","","",1265,BaselTMA_SP41_23.475kx17.66ky_10000x5000_12_20170905_65_57_X8Y6_36_a0_full.tiff,752,747,561744,114593,PR-ER+,positive,HR+HER2-,""
227,BaselTMA_SP41_227_X9Y6,2,24,FEMALE,0,77,death,,2,1. Primary Dx,1a,Sp4.1,X9Y6,9,6,tumor,Sp4.1,73,100,0,0,0,2002,breast,invasive ductal breast carcinoma-lymphangiosis carcinomatosa,0,1,,negative,negative,positive,none,none,Sp4.1,breast cancer,24,24,"",,0,,,,,FALSE,"","","",1647,BaselTMA_SP41_23.475kx17.66ky_10000x5000_12_20170905_73_227_X9Y6_50_a0_full.tiff,649,815,528935,263397,PR-ER-,negative,HR-HER2+,""
234,BaselTMA_SP41_234_X10Y6,2,22,FEMALE,0,68,death by primary disease,,2,1. Primary Dx,1mi,Sp4.1,X10Y6,10,6,tumor,Sp4.1,81,80,0,20,0,2002,breast,invasive ductal breast carcinoma-,0,,,positive,negative,negative,none,Tamoxifen,Sp4.1,breast cancer,94,97,"",1,0,,,1,,FALSE,"","","",2374,BaselTMA_SP41_23.475kx17.66ky_10000x5000_12_20170905_81_234_X10Y6_64_a0_full.tiff,758,803,608674,336092,PR-ER+,positive,HR+HER2-,Resistant
254,BaselTMA_SP41_254_X11Y6,3,17,FEMALE,0,51,death by primary disease,,1c,1. Primary Dx,3a,Sp4.1,X11Y6,11,6,tumor,Sp4.1,89,40,0,20,40,2003,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, lymphangiosis carcinomatosa",0,1,,negative,negative,negative,none,Chemotherapy,Sp4.1,breast cancer,13,21,"",,1,,,,,TRUE,"","","",2990,BaselTMA_SP41_23.475kx17.66ky_10000x5000_12_20170905_89_254_X11Y6_78_a0_full.tiff,728,747,543816,312738,PR-ER-,negative,TripleNeg,""
277,BaselTMA_SP41_277_X12Y6,2,17,FEMALE,0,47,death by primary disease,,1c,1. Primary Dx,1a,Sp4.1,X12Y6,12,6,tumor,Sp4.1,97,60,0,40,0,2003,breast,invasive ductal breast carcinoma-lymphangiosis carcinomatosa,0,1,,positive,positive,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,23,49,"",1,0,,1,1,1,FALSE,"","","",678,BaselTMA_SP41_15.475kx17.66ky_8000x5000_11_20170905_97_277_X12Y6_8_a0_full.tiff,223,754,168142,61112,PR+ER+,positive,HR+HER2-,Resistant
86,BaselTMA_SP41_86_X15Y3,2,45,FEMALE,0,63,death by primary disease,,2,1. Primary Dx,1mi,Sp4.1,X15Y3,15,3,tumor,Sp4.1,123,70,0,30,0,2003,breast,invasive ductal breast carcinoma-,0,,,positive,positive,negative,none,Chemotherapy - Letrozol,Sp4.1,breast cancer,42,44,"",1,0,,,1,,FALSE,"","","",1923,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_123_86_X15Y3_203_a0_full.tiff,732,773,565836,259258,PR+ER+,positive,HR+HER2-,Resistant
247,BaselTMA_SP41_247_X13Y6,2,15,FEMALE,0,63,alive,,1c,1. Primary Dx,1a,Sp4.1,X13Y6,13,6,tumor,Sp4.1,105,70,0,30,0,2003,breast,invasive ductal breast carcinoma-lymphangiosis carcinomatosa,0,1,,positive,positive,negative,none,Chemotherapy - Letrozol,Sp4.1,breast cancer,122,122,"",1,0,,,,,FALSE,"","","",3720,BaselTMA_SP41_15.475kx17.66ky_8000x5000_11_20170905_105_247_X13Y6_20_a0_full.tiff,677,804,544308,339426,PR+ER+,positive,HR+HER2-,""
33,BaselTMA_SP41_33_X14Y6,3,15,FEMALE,0,69,alive,,1c,1. Primary Dx,0,Sp4.1,X14Y6,14,6,tumor,Sp4.1,113,70,0,20,10,2003,breast,invasive ductal breast carcinoma-,0,,,negative,negative,negative,none,Chemotherapy,Sp4.1,breast cancer,95,95,"",,1,,,,,FALSE,i-,sn,"",3564,BaselTMA_SP41_15.475kx17.66ky_8000x5000_11_20170905_113_33_X14Y6_34_a0_full.tiff,712,737,524744,354487,PR-ER-,negative,TripleNeg,""
214,BaselTMA_SP41_214_X15Y6,3,25,FEMALE,0,78,alive,,2,1. Primary Dx,1a,Sp4.1,X15Y6,15,6,tumor,Sp4.1,120,50,0,25,25,2003,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,negative,negative,negative,none,none,Sp4.1,breast cancer,104,104,"",,1,,,,,TRUE,"","","",2197,BaselTMA_SP41_15.475kx17.66ky_8000x5000_11_20170905_120_214_X15Y6_48_a0_full.tiff,778,675,525150,221392,PR-ER-,negative,TripleNeg,""
237,BaselTMA_SP41_237_X16Y6,2,38,FEMALE,0,68,alive,,2,1. Primary Dx,2a,Sp4.1,X16Y6,16,6,tumor,Sp4.1,127,50,0,50,0,2003,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,negative,negative,none,Tamoxifen,Sp4.1,breast cancer,13,85,"",1,0,,1,,,FALSE,"","","",2795,BaselTMA_SP41_15.475kx17.66ky_8000x5000_11_20170905_127_237_X16Y6_62_a0_full.tiff,639,800,511200,278636,PR-ER+,positive,HR+HER2-,Refractory
263,BaselTMA_SP41_263_X1Y4,3,43,FEMALE,0,48,death by primary disease,,2,1. Primary Dx,1a,Sp4.1,X1Y4,1,4,tumor,Sp4.1,6,70,0,25,5,2003,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, lymphangiosis carcinomatosa",0,1,,positive,negative,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,30,44,"",1,0,,1,,,FALSE,"","","",335,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_6_263_X1Y4_191_a0_full.tiff,683,697,476051,32560,PR-ER+,positive,HR+HER2-,Refractory
263,BaselTMA_SP41_263_X2Y4,3,43,FEMALE,0,48,death by primary disease,,2,1. Primary Dx,1a,Sp4.1,X2Y4,2,4,non-tumor,Sp4.1,15,0,90,10,0,2003,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, lymphangiosis carcinomatosa",0,1,,positive,negative,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,30,44,"",1,0,,1,,,FALSE,"","","",694,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_15_263_X2Y4_199_a0_full.tiff,676,752,508352,64710,PR-ER+,positive,HR+HER2-,Refractory
39,BaselTMA_SP41_39_X1Y7,3,35,FEMALE,0,79,alive,,2,1. Primary Dx,2a,Sp4.1,X1Y7,1,7,tumor,Sp4.1,3,60,0,20,20,2003,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,negative,negative,positive,none,Chemotherapy,Sp4.1,breast cancer,115,115,"",,0,,,,,FALSE,"","","",2546,BaselTMA_SP41_33.475kx17.665ky_8500x5000_13_20170905_3_39_X1Y7_81_a0_full.tiff,760,694,527440,256535,PR-ER-,negative,HR-HER2+,""
61,BaselTMA_SP41_61_X3Y4,3,30,FEMALE,0,26,death by primary disease,,2,1. Primary Dx,0,Sp4.1,X3Y4,3,4,tumor,Sp4.1,24,50,0,20,30,2003,breast,invasive ductal breast carcinoma-,0,,,negative,negative,negative,none,Chemotherapy,Sp4.1,breast cancer,19,39,"",,1,,,,,TRUE,i-,"","",1976,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_24_61_X3Y4_207_a0_full.tiff,757,700,529900,189983,PR-ER-,negative,TripleNeg,""
61,BaselTMA_SP41_61_X4Y4,3,30,FEMALE,0,26,death by primary disease,,2,1. Primary Dx,0,Sp4.1,X4Y4,4,4,non-tumor,Sp4.1,33,0,50,50,0,2003,breast,invasive ductal breast carcinoma-,0,,,negative,negative,negative,none,Chemotherapy,Sp4.1,breast cancer,19,39,"",,1,,,,,TRUE,i-,"","",71,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_33_61_X4Y4_215_a0_full.tiff,698,776,541648,6979,PR-ER-,negative,TripleNeg,""
44,BaselTMA_SP41_44_X2Y7,2,11,FEMALE,0,59,alive,,1c,1. Primary Dx,0,Sp4.1,X2Y7,2,7,tumor,Sp4.1,12,60,0,40,0,2003,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Anastrazol,Sp4.1,breast cancer,108,108,"",1,0,1,,,,FALSE,i-,sn,"",3307,BaselTMA_SP41_33.475kx17.665ky_8500x5000_13_20170905_12_44_X2Y7_95_a0_full.tiff,776,741,575016,300263,PR+ER+,positive,HR+HER2-,Sensitive
186,BaselTMA_SP41_186_X5Y4,2,15,FEMALE,0,65,alive,,1c,1. Primary Dx,1a,Sp4.1,X5Y4,5,4,tumor,Sp4.1,42,90,0,0,10,2003,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,116,116,"",1,0,1,,,,FALSE,"","","",4947,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_42_186_X5Y4_221_a0_full.tiff,727,848,616496,480873,PR+ER+,positive,HR+HER2-,Sensitive
186,BaselTMA_SP41_186_X6Y4,2,15,FEMALE,0,65,alive,,1c,1. Primary Dx,1a,Sp4.1,X6Y4,6,4,non-tumor,Sp4.1,51,0,60,40,0,2003,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,116,116,"",1,0,1,,,,FALSE,"","","",2003,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_51_186_X6Y4_227_a0_full.tiff,681,826,562506,198998,PR+ER+,positive,HR+HER2-,Sensitive
224,BaselTMA_SP41_224_X3Y7,2,75,FEMALE,0,55,death by primary disease,,3,1. Primary Dx,2a,Sp4.1,X3Y7,3,7,tumor,Sp4.1,21,70,0,25,5,2003,breast,invasive ductal breast carcinoma-,0,,,positive,negative,positive,none,Chemotherapy - Anastrazol,Sp4.1,breast cancer,68,107,"",1,0,,,1,,FALSE,"","","",1613,BaselTMA_SP41_33.475kx17.665ky_8500x5000_13_20170905_21_224_X3Y7_110_a0_full.tiff,736,769,565984,168666,PR-ER+,positive,HR+HER2+,Resistant
104,BaselTMA_SP41_104_X7Y4,2,21,FEMALE,0,56,alive,,2,1. Primary Dx,0,Sp4.1,X7Y4,7,4,tumor,Sp4.1,59,70,0,30,0,2003,breast,invasive ductal breast carcinoma-,0,,,positive,positive,negative,none,none,Sp4.1,breast cancer,107,107,"",1,0,,,,,FALSE,i-,"","",498,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_59_104_X7Y4_163_a0_full.tiff,738,668,492984,47737,PR+ER+,positive,HR+HER2-,""
104,BaselTMA_SP41_104_X8Y4_175,2,21,FEMALE,0,56,alive,,2,1. Primary Dx,0,Sp4.1,X8Y4,8,4,non-tumor,Sp4.1,67,0,60,40,0,2003,breast,invasive ductal breast carcinoma-,0,,,positive,positive,negative,none,none,Sp4.1,breast cancer,107,107,"",1,0,,,,,FALSE,i-,"","",1904,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_67_104_X8Y4_175_a0_full.tiff,675,540,364500,163306,PR+ER+,positive,HR+HER2-,""
104,BaselTMA_SP41_104_X8Y4_233,2,21,FEMALE,0,56,alive,,2,1. Primary Dx,0,Sp4.1,X8Y4,8,4,non-tumor,Sp4.1,67,0,60,40,0,2003,breast,invasive ductal breast carcinoma-,0,,,positive,positive,negative,none,none,Sp4.1,breast cancer,107,107,"",1,0,,,,,FALSE,i-,"","",2104,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_67_104_X8Y4_233_a0_full.tiff,741,736,545376,275514,PR+ER+,positive,HR+HER2-,""
218,BaselTMA_SP41_218_X10Y4_193,2,45,FEMALE,0,78,death by primary disease,,2,1. Primary Dx,1a,Sp4.1,X10Y4,10,4,non-tumor,Sp4.1,83,0,50,50,0,2003,breast,mixed ductal lobular breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,67,67,"",,0,,,1,,TRUE,"","","",2642,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_83_218_X10Y4_193_a0_full.tiff,713,771,549723,258559,PR+ER+,positive,HR+HER2-,Resistant
218,BaselTMA_SP41_218_X10Y4_244,2,45,FEMALE,0,78,death by primary disease,,2,1. Primary Dx,1a,Sp4.1,X10Y4,10,4,non-tumor,Sp4.1,83,0,50,50,0,2003,breast,mixed ductal lobular breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,67,67,"",,0,,,1,,TRUE,"","","",2511,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_83_218_X10Y4_244_a0_full.tiff,720,852,613440,215399,PR+ER+,positive,HR+HER2-,Resistant
218,BaselTMA_SP41_218_X9Y4_185,2,45,FEMALE,0,78,death by primary disease,,2,1. Primary Dx,1a,Sp4.1,X9Y4,9,4,tumor,Sp4.1,75,60,0,30,10,2003,breast,mixed ductal lobular breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,67,67,"",,0,,,1,,TRUE,"","","",88,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_75_218_X9Y4_185_a0_full.tiff,574,595,341530,7049,PR+ER+,positive,HR+HER2-,Resistant
218,BaselTMA_SP41_218_X9Y4_240,2,45,FEMALE,0,78,death by primary disease,,2,1. Primary Dx,1a,Sp4.1,X9Y4,9,4,tumor,Sp4.1,75,60,0,30,10,2003,breast,mixed ductal lobular breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,67,67,"",,0,,,1,,TRUE,"","","",2651,BaselTMA_SP41_33.475kx12.66ky_8500x8500_2_20170905_75_218_X9Y4_240_a0_full.tiff,711,778,553158,280311,PR+ER+,positive,HR+HER2-,Resistant
159,BaselTMA_SP41_159_X11Y4,3,27,FEMALE,0,71,death by primary disease,,2,1. Primary Dx,1mi,Sp4.1,X11Y4,11,4,tumor,Sp4.1,91,50,0,30,20,2003,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,none,Sp4.1,breast cancer,28,58,"",1,0,,,,,TRUE,"","","",321,BaselTMA_SP41_25.475kx12.665ky_8000x8500_3_20170905_91_159_X11Y4_201_a0_full.tiff,711,767,545337,26764,PR+ER+,positive,HR+HER2-,""
159,BaselTMA_SP41_159_X12Y4,3,27,FEMALE,0,71,death by primary disease,,2,1. Primary Dx,1mi,Sp4.1,X12Y4,12,4,tumor,Sp4.1,99,60,0,20,20,2003,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,none,Sp4.1,breast cancer,28,58,"",1,0,,,,,TRUE,"","","",2551,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_99_159_X12Y4_211_a0_full.tiff,767,723,554541,230744,PR+ER+,positive,HR+HER2-,""
38,BaselTMA_SP41_38_X4Y7,2,24,FEMALE,0,53,alive,,2,1. Primary Dx,0,Sp4.1,X4Y7,4,7,tumor,Sp4.1,30,70,0,30,0,2004,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, lymphangiosis carcinomatosa",0,1,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,87,87,"",1,0,1,,,,TRUE,i-,"","",2457,BaselTMA_SP41_33.475kx17.665ky_8500x5000_13_20170905_30_38_X4Y7_122_a0_full.tiff,776,747,579672,312537,PR+ER+,positive,HR+HER2-,Sensitive
114,BaselTMA_SP41_114_X13Y4,3,30,FEMALE,0,46,alive,,2,1. Primary Dx,1a,Sp4.1,X13Y4,13,4,tumor,Sp4.1,107,80,0,15,5,2004,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,negative,negative,negative,none,Chemotherapy,Sp4.1,breast cancer,99,104,"",,1,,,,,FALSE,"","","",2718,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_107_114_X13Y4_219_a0_full.tiff,421,833,350693,295852,PR-ER-,negative,TripleNeg,""
114,BaselTMA_SP41_114_X14Y4,3,30,FEMALE,0,46,alive,,2,1. Primary Dx,1a,Sp4.1,X14Y4,14,4,non-tumor,Sp4.1,115,0,70,20,10,2004,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,negative,negative,negative,none,Chemotherapy,Sp4.1,breast cancer,99,104,"",,1,,,,,FALSE,"","","",332,BaselTMA_SP41_15.475kx12.665ky_10000x8500_5_20170905_115_114_X14Y4_225_a0_full.tiff,701,763,534863,36098,PR-ER-,negative,TripleNeg,""
196,BaselTMA_SP41_196_X5Y7,2,21,FEMALE,0,66,alive,,2,1. Primary Dx,0,Sp4.1,X5Y7,5,7,tumor,Sp4.1,39,80,0,15,5,2004,breast,"invasive ductal breast carcinoma-invasive lobular breast carcinoma, in situ ductal breast carcinoma",0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,106,106,"",1,0,1,,,,TRUE,i+,sn,"",1408,BaselTMA_SP41_33.475kx17.665ky_8500x5000_13_20170905_39_196_X5Y7_134_a0_full.tiff,730,753,549690,128440,PR+ER+,positive,HR+HER2-,Sensitive
268,BaselTMA_SP41_268_X6Y7,3,19,FEMALE,0,70,death by primary disease,,1c,1. Primary Dx,1a,Sp4.1,X6Y7,6,7,tumor,Sp4.1,48,75,0,20,5,2004,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, lymphangiosis carcinomatosa",0,1,1,positive,positive,negative,none,Letrozol,Sp4.1,breast cancer,16,39,"",1,0,,1,,,FALSE,"","","",2395,BaselTMA_SP41_23.475kx17.66ky_10000x5000_12_20170905_48_268_X6Y7_93_a0_full.tiff,709,710,503390,262840,PR+ER+,positive,HR+HER2-,Refractory
62,BaselTMA_SP41_62_X7Y7,2,22,FEMALE,0,73,alive,,2,1. Primary Dx,0,Sp4.1,X7Y7,7,7,tumor,Sp4.1,56,60,0,20,20,2004,breast,mixed ductal lobular breast carcinoma-,0,,,positive,positive,negative,none,Anastrazol,Sp4.1,breast cancer,101,101,"",,0,1,,,,FALSE,i-,sn,"",3027,BaselTMA_SP41_23.475kx17.66ky_10000x5000_12_20170905_56_62_X7Y7_108_a0_full.tiff,786,711,558846,286916,PR+ER+,positive,HR+HER2-,Sensitive
219,BaselTMA_SP41_219_X8Y7,2,32,FEMALE,0,53,alive,,2,1. Primary Dx,0,Sp4.1,X8Y7,8,7,tumor,Sp4.1,64,70,0,20,10,2003,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,negative,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,117,117,"",1,0,,,,,FALSE,i-,"","",2839,BaselTMA_SP41_23.475kx17.66ky_10000x5000_12_20170905_64_219_X8Y7_120_a0_full.tiff,770,665,512050,244988,PR-ER+,positive,HR+HER2-,""
256,BaselTMA_SP41_256_X9Y7,1,18,FEMALE,0,58,alive,,1c,1. Primary Dx,1a,Sp4.1,X9Y7,9,7,tumor,Sp4.1,72,90,0,10,0,2003,breast,invasive ductal breast carcinoma-,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,86,86,"",1,0,1,,,,FALSE,"","","",3168,BaselTMA_SP41_23.475kx17.66ky_10000x5000_12_20170905_72_256_X9Y7_132_a0_full.tiff,757,742,561694,288487,PR+ER+,positive,HR+HER2-,Sensitive
55,BaselTMA_SP41_55_X10Y7,2,45,FEMALE,0,70,alive w metastases,,4b,1. Primary Dx,1a,Sp4.1,X10Y7,10,7,tumor,Sp4.1,80,50,0,50,0,2003,breast,"mixed ductal lobular breast carcinoma-in situ ductal breast carcinoma, lymphangiosis carcinomatosa",0,1,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,88,114,"",,0,,,1,,FALSE,"","","",1647,BaselTMA_SP41_23.475kx17.66ky_10000x5000_12_20170905_80_55_X10Y7_144_a0_full.tiff,752,737,554224,171127,PR+ER+,positive,HR+HER2-,Resistant
60,BaselTMA_SP41_60_X11Y7,3,24,FEMALE,0,62,death by primary disease,,4b,1. Primary Dx,0,Sp4.1,X11Y7,11,7,tumor,Sp4.1,88,80,0,20,0,2003,breast,mixed ductal lobular breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,positive,none,Letrozol,Sp4.1,breast cancer,73,75,"",,0,,,1,,FALSE,i-,"","",2339,BaselTMA_SP41_23.475kx17.66ky_10000x5000_12_20170905_88_60_X11Y7_157_a0_full.tiff,750,735,551250,287683,PR+ER+,positive,HR+HER2+,Resistant
92,BaselTMA_SP41_92_X12Y7,2,18,FEMALE,0,69,alive w metastases,,1c,1. Primary Dx,3a,Sp4.1,X12Y7,12,7,tumor,Sp4.1,96,30,0,20,50,2003,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,negative,negative,none,Tamoxifen,Sp4.1,breast cancer,13,99,"",1,0,,1,,,FALSE,"","","",4549,BaselTMA_SP41_15.475kx17.66ky_8000x5000_11_20170905_96_92_X12Y7_76_a0_full.tiff,690,654,451260,333495,PR-ER+,positive,HR+HER2-,Refractory
11,BaselTMA_SP41_11_X13Y7,2,11,FEMALE,0,49,alive,,2,1. Primary Dx,1a,Sp4.1,X13Y7,13,7,tumor,Sp4.1,104,75,0,20,5,2004,breast,invasive ductal breast carcinoma-,0,,,positive,negative,negative,none,Chemotherapy - Anastrazol,Sp4.1,breast cancer,111,111,"",1,0,,,,,TRUE,"","","",4571,BaselTMA_SP41_15.475kx17.66ky_8000x5000_11_20170905_104_11_X13Y7_91_a0_full.tiff,758,756,573048,421457,PR-ER+,positive,HR+HER2-,""
126,BaselTMA_SP41_126_X14Y7,3,25,FEMALE,0,53,alive,,2,1. Primary Dx,0,Sp4.1,X14Y7,14,7,tumor,Sp4.1,112,70,0,20,10,2004,breast,invasive ductal breast carcinoma-,0,,,positive,negative,negative,none,Tamoxifen,Sp4.1,breast cancer,95,95,"",1,0,1,,,,FALSE,i+,sn,"",2894,BaselTMA_SP41_15.475kx17.66ky_8000x5000_11_20170905_112_126_X14Y7_106_a0_full.tiff,787,710,558770,351520,PR-ER+,positive,HR+HER2-,Sensitive
191,BaselTMA_SP41_191_X15Y7,3,35,FEMALE,0,66,death,,2,1. Primary Dx,1a,Sp4.1,X15Y7,15,7,tumor,Sp4.1,119,60,0,10,30,2004,breast,invasive ductal breast carcinoma-,0,,,negative,negative,negative,none,none,Sp4.1,breast cancer,4,4,"",,1,,,,,FALSE,"","","",4555,BaselTMA_SP41_15.475kx17.66ky_8000x5000_11_20170905_119_191_X15Y7_118_a0_full.tiff,730,774,565020,497139,PR-ER-,negative,TripleNeg,""
40,BaselTMA_SP41_40_X16Y7,2,44,FEMALE,0,51,alive,,2,1. Primary Dx,2a,Sp4.1,X16Y7,16,7,tumor,Sp4.1,126,70,0,20,10,2004,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, lymphangiosis carcinomatosa",0,1,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,110,110,"",1,0,1,,,,TRUE,"","","",2762,BaselTMA_SP41_15.475kx17.66ky_8000x5000_11_20170905_126_40_X16Y7_130_a0_full.tiff,755,663,500565,243667,PR+ER+,positive,HR+HER2-,Sensitive
14,BaselTMA_SP41_14_X1Y8,3,15,FEMALE,0,70,death,,1c,1. Primary Dx,1a,Sp4.1,X1Y8,1,8,tumor,Sp4.1,2,30,0,20,50,2004,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,negative,negative,positive,none,Chemotherapy,Sp4.1,breast cancer,1,1,"",,0,,,,,FALSE,"","","",3439,BaselTMA_SP41_33.475kx17.665ky_8500x5000_13_20170905_2_14_X1Y8_146_a0_full.tiff,796,731,581876,366873,PR-ER-,negative,HR-HER2+,""
2,BaselTMA_SP41_2_X2Y8,2,15,FEMALE,0,40,alive,,1c,1. Primary Dx,1a,Sp4.1,X2Y8,2,8,tumor,Sp4.1,11,50,0,30,20,2004,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, mucinous breast carcinoma",0,,,positive,positive,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,101,101,"",1,0,,,,,FALSE,"","","",2756,BaselTMA_SP41_33.475kx17.665ky_8500x5000_13_20170905_11_2_X2Y8_159_a0_full.tiff,770,737,567490,273574,PR+ER+,positive,HR+HER2-,""
134,BaselTMA_SP41_134_X3Y8,3,17,FEMALE,0,52,death by primary disease,,1c,1. Primary Dx,1mi,Sp4.1,X3Y8,3,8,tumor,Sp4.1,20,45,0,5,50,2004,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, lymphangiosis carcinomatosa",0,1,,positive,negative,positive,none,Chemotherapy - Anastrazol,Sp4.1,breast cancer,35,61,"",1,0,,1,,,TRUE,"","","",2261,BaselTMA_SP41_33.475kx17.665ky_8500x5000_13_20170905_20_134_X3Y8_171_a0_full.tiff,689,668,460252,182898,PR-ER+,positive,HR+HER2+,Refractory
112,BaselTMA_SP41_112_X5Y8,2,19,FEMALE,0,73,alive,,1c,1. Primary Dx,0,Sp4.1,X5Y8,5,8,tumor,Sp4.1,38,50,0,50,0,1998,breast,invasive ductal breast carcinoma-,0,,,positive,negative,negative,none,Letrozol,Sp4.1,breast cancer,143,143,"",1,0,1,,,,FALSE,"",sn,"",3278,BaselTMA_SP41_33.475kx17.665ky_8500x5000_13_20170905_38_112_X5Y8_181_a0_full.tiff,720,740,532800,234189,PR-ER+,positive,HR+HER2-,Sensitive
53,BaselTMA_SP41_53_X6Y8,1,18,FEMALE,0,54,alive,,1c,1. Primary Dx,0,Sp4.1,X6Y8,6,8,tumor,Sp4.1,47,60,0,40,0,1998,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Letrozol,Sp4.1,breast cancer,175,175,"",1,0,1,,,,FALSE,"",sn,"",2187,BaselTMA_SP41_23.475kx17.66ky_10000x5000_12_20170905_47_53_X6Y8_169_a0_full.tiff,665,717,476805,175992,PR+ER+,positive,HR+HER2-,Sensitive
129,BaselTMA_SP41_129_X7Y8,2,14,FEMALE,0,69,death by primary disease,,1c,1. Primary Dx,3a,Sp4.1,X7Y8,7,8,tumor,Sp4.1,55,50,0,50,0,1998,breast,mixed ductal lobular breast carcinoma-mucinous breast carcinoma,0,,,negative,negative,negative,none,Tamoxifen,Sp4.1,breast cancer,6,44,"",,1,,1,,,FALSE,"","","",1800,BaselTMA_SP41_23.475kx17.66ky_10000x5000_12_20170905_55_129_X7Y8_179_a0_full.tiff,772,689,531908,181406,PR-ER-,negative,TripleNeg,Refractory
203,BaselTMA_SP41_203_X8Y8,1,11,FEMALE,0,66,alive,,1c,1. Primary Dx,0,Sp4.1,X8Y8,8,8,tumor,Sp4.1,63,50,0,50,0,1998,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,none,Sp4.1,breast cancer,54,180,"",1,0,,,,,FALSE,"","","",2840,BaselTMA_SP41_23.475kx17.66ky_10000x5000_12_20170905_63_203_X8Y8_189_a0_full.tiff,697,695,484415,279545,PR+ER+,positive,HR+HER2-,""
276,BaselTMA_SP41_276_X9Y8,2,52,FEMALE,0,80,death by primary disease,,3,1. Primary Dx,2a,Sp4.1,X9Y8,9,8,tumor,Sp4.1,71,80,0,20,0,1998,breast,invasive ductal breast carcinoma-lymphangiosis carcinomatosa,0,1,,positive,positive,negative,chemotherapy,Tamoxifen,Sp4.1,breast cancer,33,55,"",1,0,,1,,,FALSE,"","","",4125,BaselTMA_SP41_23.475kx17.66ky_10000x5000_12_20170905_71_276_X9Y8_197_a0_full.tiff,737,773,569701,388309,PR+ER+,positive,HR+HER2-,Refractory
101,BaselTMA_SP41_101_X10Y8,2,30,FEMALE,0,76,death by primary disease,,2,1. Primary Dx,3a,Sp4.1,X10Y8,10,8,tumor,Sp4.1,79,90,0,10,0,1999,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, lymphangiosis carcinomatosa",0,1,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,33,135,"",1,0,,1,,,FALSE,"","","",3436,BaselTMA_SP41_23.475kx17.66ky_10000x5000_12_20170905_79_101_X10Y8_205_a0_full.tiff,716,722,516952,350959,PR+ER+,positive,HR+HER2-,Refractory
41,BaselTMA_SP41_41_X11Y8,3,40,FEMALE,0,85,death,,2,1. Primary Dx,X,Sp4.1,X11Y8,11,8,tumor,Sp4.1,87,60,0,40,0,1998,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,negative,negative,none,none,Sp4.1,breast cancer,14,14,"",1,0,,,,,FALSE,"","","",3228,BaselTMA_SP41_23.475kx17.66ky_10000x5000_12_20170905_87_41_X11Y8_213_a0_full.tiff,732,749,548268,354675,PR-ER+,positive,HR+HER2-,""
255,BaselTMA_SP41_255_X12Y8,2,6,FEMALE,1,51,death,,1b,1. Primary Dx,2a,Sp4.1,X12Y8,12,8,tumor,Sp4.1,95,50,0,50,0,1998,breast,invasive ductal breast carcinoma-,0,,,positive,positive,negative,none,none,Sp4.1,breast cancer,88,88,"",1,0,,,,,TRUE,"","","",1870,BaselTMA_SP41_15.475kx17.66ky_8000x5000_11_20170905_95_255_X12Y8_142_a0_full.tiff,688,762,524256,163309,PR+ER+,positive,HR+HER2-,""
267,BaselTMA_SP41_267_X13Y8,3,90,FEMALE,0,65,death by primary disease,,4b,1. Primary Dx,2a,Sp4.1,X13Y8,13,8,tumor,Sp4.1,103,70,0,30,0,1999,breast,"invasive ductal breast carcinoma-in situ ductal breast carcinoma, lymphangiosis carcinomatosa",1,1,1,positive,negative,negative,none,Chemotherapy,Sp4.1,breast cancer,0,13,"",1,0,,1,,,FALSE,"","","",1891,BaselTMA_SP41_15.475kx17.66ky_8000x5000_11_20170905_103_267_X13Y8_155_a0_full.tiff,751,676,507676,188261,PR-ER+,positive,HR+HER2-,Refractory
48,BaselTMA_SP41_48_X14Y8,3,30,FEMALE,0,76,death by primary disease,,2,1. Primary Dx,1a,Sp4.1,X14Y8,14,8,tumor,Sp4.1,111,80,0,20,0,1999,breast,invasive ductal breast carcinoma-,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,2,2,"",1,0,,1,,,FALSE,"","","",3725,BaselTMA_SP41_15.475kx17.66ky_8000x5000_11_20170905_111_48_X14Y8_167_a0_full.tiff,698,749,522802,342230,PR+ER+,positive,HR+HER2-,Refractory
212,BaselTMA_SP41_212_X1Y9,2,20,FEMALE,0,80,alive,,1c,1. Primary Dx,1a,Sp4.1,X1Y9,1,9,tumor,Sp4.1,1,50,0,25,25,1999,breast,invasive ductal breast carcinoma-,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,137,137,"",1,0,1,,,,FALSE,"",sn,"",2255,BaselTMA_SP41_331.8kx19.665ky_10000x2000_15_20170905_1_212_X1Y9_26_a0_full.tiff,707,745,526715,187306,PR+ER+,positive,HR+HER2-,Sensitive
106,BaselTMA_SP41_106_X2Y9,2,45,FEMALE,0,91,death,,2,1. Primary Dx,X,Sp4.1,X2Y9,2,9,tumor,Sp4.1,10,50,0,30,20,1999,breast,invasive ductal breast carcinoma-,0,,,positive,negative,negative,none,none,Sp4.1,breast cancer,97,97,"",1,0,,,,,FALSE,"","","",2478,BaselTMA_SP41_331.8kx19.665ky_10000x2000_15_20170905_10_106_X2Y9_40_a0_full.tiff,834,738,615492,217549,PR-ER+,positive,HR+HER2-,""
249,BaselTMA_SP41_249_X3Y9,3,29,FEMALE,0,55,death by primary disease,,2,1. Primary Dx,3a,Sp4.1,X3Y9,3,9,tumor,Sp4.1,19,70,0,20,10,1999,breast,mixed ductal lobular breast carcinoma-lymphangiosis carcinomatosa,0,1,,positive,"",negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,100,109,"",,0,,,1,,TRUE,"","","",2187,BaselTMA_SP41_331.8kx19.665ky_10000x2000_15_20170905_19_249_X3Y9_54_a0_full.tiff,756,732,553392,204733,"","","",Resistant
63,BaselTMA_SP41_63_X4Y9,2,30,FEMALE,0,85,death,,2,1. Primary Dx,1a,Sp4.1,X4Y9,4,9,tumor,Sp4.1,28,90,0,10,0,2000,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Tamoxifen,Sp4.1,breast cancer,89,89,"",1,0,1,,,,FALSE,"","","",3339,BaselTMA_SP41_331.8kx19.665ky_10000x2000_15_20170905_28_63_X4Y9_68_a0_full.tiff,748,758,566984,410356,PR+ER+,positive,HR+HER2-,Sensitive
8,BaselTMA_SP41_8_X5Y9,3,22,FEMALE,0,80,death by primary disease,,2,1. Primary Dx,3a,Sp4.1,X5Y9,5,9,tumor,Sp4.1,37,60,0,30,10,2001,breast,invasive ductal breast carcinoma-lymphangiosis carcinomatosa,0,1,,negative,negative,negative,none,none,Sp4.1,breast cancer,5,16,"",,1,,,,,FALSE,"","","",2014,BaselTMA_SP41_331.8kx19.665ky_10000x2000_15_20170905_37_8_X5Y9_83_a0_full.tiff,730,717,523410,192247,PR-ER-,negative,TripleNeg,""
9,BaselTMA_SP41_9_X6Y9,3,25,FEMALE,0,59,death,,2,1. Primary Dx,1a,Sp4.1,X6Y9,6,9,tumor,Sp4.1,46,70,0,30,0,2004,breast,invasive ductal breast carcinoma-in situ ductal breast carcinoma,0,,,positive,positive,negative,none,Chemotherapy - Tamoxifen,Sp4.1,breast cancer,7,32,"",1,0,,1,,,FALSE,"","","",2758,BaselTMA_SP41_331.8kx19.665ky_10000x2000_15_20170905_46_9_X6Y9_97_a0_full.tiff,793,727,576511,306665,PR+ER+,positive,HR+HER2-,Refractory
13,BaselTMA_SP42_13_X5Y8,1,22,FEMALE,0,59,alive,,2,1. Primary Dx,0,Sp4.2,X5Y8,5,8,tumor,Sp4.2,38,,,,,2008,breast,invasive ductal breast carcinoma-,0,0,0,positive,negative,negative,none,Tamoxifen,Sp4.2,breast cancer,63,63,"",1,0,1,,,,FALSE,i-,sn,"",2933,BaselTMA_SP42_32.435kx20.41ky_7000x7000_11_20179015_38_13_X5Y8_83_a0_full.tiff,825,859,708675,287041,PR-ER+,positive,HR+HER2-,Sensitive
215,BaselTMA_SP42_215_X3Y1,2,23,FEMALE,0,72,alive,,2,1. Primary Dx,0,Sp4.2,X3Y1,3,1,tumor,Sp4.2,27,,,,,2001,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,positive,none,Letrozol,Sp4.2,breast cancer,152,152,"",1,0,1,,,,FALSE,"","","",2269,BaselTMA_SP42_39.8kx13.885ky_7000x7000_2_20179015_27_215_X3Y1_166_a0_full.tiff,713,794,566122,234314,PR+ER+,positive,HR+HER2+,Sensitive
215,BaselTMA_SP42_215_X4Y1,2,23,FEMALE,0,72,alive,,2,1. Primary Dx,0,Sp4.2,X4Y1,4,1,non-tumor,Sp4.2,36,,,,,2001,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,positive,none,Letrozol,Sp4.2,breast cancer,152,152,"",1,0,1,,,,FALSE,"","","",165,BaselTMA_SP42_39.8kx13.885ky_7000x7000_2_20179015_36_215_X4Y1_263_a0_full.tiff,636,939,597204,13401,PR+ER+,positive,HR+HER2+,Sensitive
36,BaselTMA_SP42_36_X5Y1,2,17,FEMALE,0,70,alive,,1c,1. Primary Dx,0,Sp4.2,X5Y1,5,1,tumor,Sp4.2,45,,,,,2001,breast,invasive ductal breast carcinoma-,0,0,0,negative,negative,negative,none,Chemotherapy,Sp4.2,breast cancer,144,144,"",,1,,,,,FALSE,"","","",2351,BaselTMA_SP42_32.8kx13.885ky_7000x8000_5_20179015_45_36_X5Y1_6_a0_full.tiff,725,751,544475,271574,PR-ER-,negative,TripleNeg,""
36,BaselTMA_SP42_36_X6Y1,2,17,FEMALE,0,70,alive,,1c,1. Primary Dx,0,Sp4.2,X6Y1,6,1,non-tumor,Sp4.2,54,,,,,2001,breast,invasive ductal breast carcinoma-,0,0,0,negative,negative,negative,none,Chemotherapy,Sp4.2,breast cancer,144,144,"",,1,,,,,FALSE,"","","",587,BaselTMA_SP42_32.8kx13.885ky_7000x8000_5_20179015_54_36_X6Y1_95_a0_full.tiff,538,528,284064,53072,PR-ER-,negative,TripleNeg,""
113,BaselTMA_SP42_113_X2Y5,2,17,FEMALE,0,79,alive,,1c,1. Primary Dx,0,Sp4.2,X2Y5,2,5,tumor,Sp4.2,14,,,,,2001,breast,invasive ductal breast carcinoma-mucinous breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,121,121,"",1,0,1,,,,FALSE,"","","",3246,BaselTMA_SP42_39.025kx22410ky_7000x8500_8_20179015_14_113_X2Y5_129_a0_full.tiff,626,801,501426,286657,PR+ER+,positive,HR+HER2-,Sensitive
84,BaselTMA_SP42_84_X7Y1,3,17,FEMALE,0,37,alive,,1c,1. Primary Dx,1a,Sp4.2,X7Y1,7,1,tumor,Sp4.2,62,,,,,2004,breast,invasive ductal breast carcinoma-Lymphangiosis carcinomatosa,0,1,0,negative,negative,negative,none,Chemotherapy,Sp4.2,breast cancer,84,84,"",,1,,,,,FALSE,"","","",1242,BaselTMA_SP42_32.8kx13.885ky_7000x8000_5_20179015_62_84_X7Y1_193_a0_full.tiff,596,626,373096,117412,PR-ER-,negative,TripleNeg,""
84,BaselTMA_SP42_84_X8Y1,3,17,FEMALE,0,37,alive,,1c,1. Primary Dx,1a,Sp4.2,X8Y1,8,1,non-tumor,Sp4.2,70,,,,,2004,breast,invasive ductal breast carcinoma-Lymphangiosis carcinomatosa,0,1,0,negative,negative,negative,none,Chemotherapy,Sp4.2,breast cancer,84,84,"",,1,,,,,FALSE,"","","",206,BaselTMA_SP42_32.8kx13.885ky_7000x8000_5_20179015_70_84_X8Y1_266_a0_full.tiff,698,711,496278,21403,PR-ER-,negative,TripleNeg,""
105,BaselTMA_SP42_105_X10Y1,2,26,FEMALE,0,28,alive,,2,1. Primary Dx,1mi,Sp4.2,X10Y1,10,1,non-tumor,Sp4.2,86,,,,,2003,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,positive,none,none,Sp4.2,breast cancer,50,119,"",1,0,,,,,FALSE,"",sn,"",1318,BaselTMA_SP42_26.8kx12.885ky_7000x7000_6_20179015_86_105_X10Y1_98_a0_full.tiff,780,778,606840,120013,PR+ER+,positive,HR+HER2+,""
105,BaselTMA_SP42_105_X9Y1,2,26,FEMALE,0,28,alive,,2,1. Primary Dx,1mi,Sp4.2,X9Y1,9,1,tumor,Sp4.2,78,,,,,2003,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,positive,none,none,Sp4.2,breast cancer,50,119,"",1,0,,,,,FALSE,"",sn,"",407,BaselTMA_SP42_26.8kx12.885ky_7000x7000_6_20179015_78_105_X9Y1_9_a0_full.tiff,673,721,485233,44634,PR+ER+,positive,HR+HER2+,""
6,BaselTMA_SP42_6_X11Y1,3,25,FEMALE,0,46,alive,,2,1. Primary Dx,0,Sp4.2,X11Y1,11,1,tumor,Sp4.2,94,,,,,2004,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,79,79,"",1,0,1,,,,FALSE,i+,sn,"",1948,BaselTMA_SP42_26.8kx12.885ky_7000x7000_6_20179015_94_6_X11Y1_196_a0_full.tiff,656,699,458544,215152,PR+ER+,positive,HR+HER2-,Sensitive
6,BaselTMA_SP42_6_X12Y1,3,25,FEMALE,0,46,alive,,2,1. Primary Dx,0,Sp4.2,X12Y1,12,1,non-tumor,Sp4.2,102,,,,,2004,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,79,79,"",1,0,1,,,,FALSE,i+,sn,"",68,BaselTMA_SP42_26.8kx12.885ky_7000x7000_6_20179015_102_6_X12Y1_293_a0_full.tiff,705,756,532980,7054,PR+ER+,positive,HR+HER2-,Sensitive
265,BaselTMA_SP42_265_X14Y1,3,35,FEMALE,0,50,death by primary disease,,2,1. Primary Dx,3a,Sp4.2,X14Y1,14,1,non-tumor,Sp4.2,118,,,,,2004,breast,invasive ductal breast carcinoma-,0,0,0,negative,negative,positive,none,Chemotherapy - Immune therapy,Sp4.2,breast cancer,38,41,"",,0,,,,,FALSE,"","","",148,BaselTMA_SP42_20.8kx6.8ky_6500x1500_15_20179015_118_265_X14Y1_101_a0_full.tiff,501,814,407814,14325,PR-ER-,negative,HR-HER2+,""
156,BaselTMA_SP42_156_X15Y1,1,19,FEMALE,0,61,alive,,1c,1. Primary Dx,0,Sp4.2,X15Y1,15,1,tumor,Sp4.2,125,,,,,1998,breast,"invasive ductal breast carcinoma-In situ ductal breast carcinoma, tubular breast carcinoma",0,0,0,positive,negative,negative,none,Letrozol,Sp4.2,breast cancer,174,174,"",1,0,1,,,,TRUE,"","","",435,BaselTMA_SP42_20.8kx6.8ky_6500x1500_15_20179015_125_156_X15Y1_175_a0_full.tiff,739,864,638496,27891,PR-ER+,positive,HR+HER2-,Sensitive
156,BaselTMA_SP42_156_X16Y1,1,19,FEMALE,0,61,alive,,1c,1. Primary Dx,0,Sp4.2,X16Y1,16,1,non-tumor,Sp4.2,132,,,,,1998,breast,"invasive ductal breast carcinoma-In situ ductal breast carcinoma, tubular breast carcinoma",0,0,0,positive,negative,negative,none,Letrozol,Sp4.2,breast cancer,174,174,"",1,0,1,,,,TRUE,"","","",718,BaselTMA_SP42_20.8kx6.8ky_6500x1500_15_20179015_132_156_X16Y1_248_a0_full.tiff,773,820,633860,52130,PR-ER+,positive,HR+HER2-,Sensitive
51,BaselTMA_SP42_51_X1Y2,1,30,FEMALE,0,79,alive,,2,1. Primary Dx,0,Sp4.2,X1Y2,1,2,tumor,Sp4.2,8,,,,,1999,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,143,143,"",1,0,1,,,,FALSE,i-,"","",1763,BaselTMA_SP42_39.8kx13.885ky_7000x7000_2_20179015_8_51_X1Y2_24_a0_full.tiff,749,765,572985,157525,PR+ER+,positive,HR+HER2-,Sensitive
25,BaselTMA_SP42_25_X3Y2,2,14,FEMALE,0,54,death by primary disease,,1c,1. Primary Dx,1a,Sp4.2,X3Y2,3,2,tumor,Sp4.2,26,,,,,1999,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,negative,negative,none,Chemotherapy - Tamoxifen,Sp4.2,breast cancer,68,102,"",1,0,,,1,1,FALSE,"","","",3874,BaselTMA_SP42_39.8kx13.885ky_7000x7000_2_20179015_26_25_X3Y2_190_a0_full.tiff,754,738,556452,356094,PR-ER+,positive,HR+HER2-,Resistant
25,BaselTMA_SP42_25_X4Y2,2,14,FEMALE,0,54,death by primary disease,,1c,1. Primary Dx,1a,Sp4.2,X4Y2,4,2,non-tumor,Sp4.2,35,,,,,1999,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,negative,negative,none,Chemotherapy - Tamoxifen,Sp4.2,breast cancer,68,102,"",1,0,,,1,1,FALSE,"","","",345,BaselTMA_SP42_39.8kx13.885ky_7000x7000_2_20179015_35_25_X4Y2_287_a0_full.tiff,689,632,435448,27786,PR-ER+,positive,HR+HER2-,Resistant
120,BaselTMA_SP42_120_X5Y2,1,45,FEMALE,0,45,alive,,2,1. Primary Dx,1a,Sp4.2,X5Y2,5,2,tumor,Sp4.2,44,,,,,1999,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,negative,none,Chemotherapy - Tamoxifen,Sp4.2,breast cancer,172,172,"",1,0,,,,,FALSE,"","","",3270,BaselTMA_SP42_32.8kx13.885ky_7000x8000_5_20179015_44_120_X5Y2_27_a0_full.tiff,728,805,586040,286869,PR+ER+,positive,HR+HER2-,""
120,BaselTMA_SP42_120_X6Y2,1,45,FEMALE,0,45,alive,,2,1. Primary Dx,1a,Sp4.2,X6Y2,6,2,non-tumor,Sp4.2,53,,,,,1999,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,negative,none,Chemotherapy - Tamoxifen,Sp4.2,breast cancer,172,172,"",1,0,,,,,FALSE,"","","",828,BaselTMA_SP42_32.8kx13.885ky_7000x8000_5_20179015_53_120_X6Y2_120_a0_full.tiff,735,745,547575,85217,PR+ER+,positive,HR+HER2-,""
29,BaselTMA_SP42_29_X7Y2,3,40,FEMALE,0,91,death,,2,1. Primary Dx,X,Sp4.2,X7Y2,7,2,tumor,Sp4.2,61,,,,,1999,breast,invasive ductal breast carcinoma-,1,0,0,positive,positive,negative,none,none,Sp4.2,breast cancer,11,11,"",1,0,,,,,TRUE,"","","",1066,BaselTMA_SP42_32.8kx13.885ky_7000x8000_5_20179015_61_29_X7Y2_217_a0_full.tiff,388,658,255304,114365,PR+ER+,positive,HR+HER2-,""
240,BaselTMA_SP42_240_X10Y2,2,20,FEMALE,0,42,alive,,1c,1. Primary Dx,2a,Sp4.2,X10Y2,10,2,non-tumor,Sp4.2,85,,,,,1999,breast,invasive ductal breast carcinoma-,0,0,1,positive,negative,negative,none,Chemotherapy - Tamoxifen,Sp4.2,breast cancer,165,165,"",1,0,,,,,FALSE,"","","",640,BaselTMA_SP42_26.8kx12.885ky_7000x7000_6_20179015_85_240_X10Y2_123_a0_full.tiff,768,855,656640,67423,PR-ER+,positive,HR+HER2-,""
240,BaselTMA_SP42_240_X9Y2,2,20,FEMALE,0,42,alive,,1c,1. Primary Dx,2a,Sp4.2,X9Y2,9,2,tumor,Sp4.2,77,,,,,1999,breast,invasive ductal breast carcinoma-,0,0,1,positive,negative,negative,none,Chemotherapy - Tamoxifen,Sp4.2,breast cancer,165,165,"",1,0,,,,,FALSE,"","","",2633,BaselTMA_SP42_26.8kx12.885ky_7000x7000_6_20179015_77_240_X9Y2_30_a0_full.tiff,675,804,542700,237870,PR-ER+,positive,HR+HER2-,""
28,BaselTMA_SP42_28_X11Y2,2,25,FEMALE,0,38,alive,,2,1. Primary Dx,2a,Sp4.2,X11Y2,11,2,tumor,Sp4.2,93,,,,,1999,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,positive,none,Chemotherapy - Tamoxifen,Sp4.2,breast cancer,167,167,"",1,0,,,,,FALSE,"","","",2977,BaselTMA_SP42_26.8kx12.885ky_7000x7000_6_20179015_93_28_X11Y2_220_a0_full.tiff,728,847,616616,316617,PR+ER+,positive,HR+HER2+,""
28,BaselTMA_SP42_28_X12Y2,2,25,FEMALE,0,38,alive,,2,1. Primary Dx,2a,Sp4.2,X12Y2,12,2,non-tumor,Sp4.2,101,,,,,1999,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,positive,none,Chemotherapy - Tamoxifen,Sp4.2,breast cancer,167,167,"",1,0,,,,,FALSE,"","","",2425,BaselTMA_SP42_26.8kx12.885ky_7000x7000_6_20179015_101_28_X12Y2_316_a0_full.tiff,725,850,616250,245800,PR+ER+,positive,HR+HER2+,""
253,BaselTMA_SP42_253_X13Y2,2,28,FEMALE,0,48,alive,,2,1. Primary Dx,1a,Sp4.2,X13Y2,13,2,tumor,Sp4.2,109,,,,,2004,breast,"invasive ductal breast carcinoma-In situ ductal breast carcinoma, malignant phylloidal tumor",0,1,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,112,112,"",1,0,1,,,,TRUE,"","","",3370,BaselTMA_SP42_19.8kx12.535ky_7000x6500_7_20179015_109_253_X13Y2_33_a0_full.tiff,719,771,554349,321008,PR+ER+,positive,HR+HER2-,Sensitive
253,BaselTMA_SP42_253_X14Y2,2,28,FEMALE,0,48,alive,,2,1. Primary Dx,1a,Sp4.2,X14Y2,14,2,non-tumor,Sp4.2,117,,,,,2004,breast,"invasive ductal breast carcinoma-In situ ductal breast carcinoma, malignant phylloidal tumor",0,1,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,112,112,"",1,0,1,,,,TRUE,"","","",1341,BaselTMA_SP42_19.8kx12.535ky_7000x6500_7_20179015_117_253_X14Y2_126_a0_full.tiff,728,755,549640,129142,PR+ER+,positive,HR+HER2-,Sensitive
251,BaselTMA_SP42_251_X15Y2,3,15,FEMALE,0,63,alive,,1c,1. Primary Dx,1a,Sp4.2,X15Y2,15,2,tumor,Sp4.2,124,,,,,2001,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,negative,negative,positive,none,Chemotherapy,Sp4.2,breast cancer,139,139,"",,0,,,,,TRUE,"","","",2289,BaselTMA_SP42_19.8kx12.535ky_7000x6500_7_20179015_124_251_X15Y2_199_a0_full.tiff,671,871,584441,130819,PR-ER-,negative,HR-HER2+,""
251,BaselTMA_SP42_251_X16Y2,3,15,FEMALE,0,63,alive,,1c,1. Primary Dx,1a,Sp4.2,X16Y2,16,2,non-tumor,Sp4.2,131,,,,,2001,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,negative,negative,positive,none,Chemotherapy,Sp4.2,breast cancer,139,139,"",,0,,,,,TRUE,"","","",442,BaselTMA_SP42_19.8kx12.535ky_7000x6500_7_20179015_131_251_X16Y2_272_a0_full.tiff,803,601,482603,44276,PR-ER-,negative,HR-HER2+,""
217,BaselTMA_SP42_217_X1Y3,2,45,FEMALE,0,57,alive,,2,1. Primary Dx,0,Sp4.2,X1Y3,1,3,tumor,Sp4.2,7,,,,,2001,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,negative,none,Letrozol,Sp4.2,breast cancer,145,145,"",1,0,1,,,,FALSE,"","","",3893,BaselTMA_SP42_39.8kx13.885ky_7000x7000_2_20179015_7_217_X1Y3_47_a0_full.tiff,848,778,659744,348904,PR+ER+,positive,HR+HER2-,Sensitive
217,BaselTMA_SP42_217_X2Y3,2,45,FEMALE,0,57,alive,,2,1. Primary Dx,0,Sp4.2,X2Y3,2,3,non-tumor,Sp4.2,16,,,,,2001,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,negative,none,Letrozol,Sp4.2,breast cancer,145,145,"",1,0,1,,,,FALSE,"","","",2085,BaselTMA_SP42_39.8kx13.885ky_7000x7000_2_20179015_16_217_X2Y3_117_a0_full.tiff,762,797,607314,188714,PR+ER+,positive,HR+HER2-,Sensitive
80,BaselTMA_SP42_80_X3Y3,2,14,FEMALE,0,54,death,,1c,1. Primary Dx,0,Sp4.2,X3Y3,3,3,tumor,Sp4.2,25,,,,,2002,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,76,76,"",1,0,1,,,,FALSE,i+,"","",4311,BaselTMA_SP42_39.8kx13.885ky_7000x7000_2_20179015_25_80_X3Y3_214_a0_full.tiff,796,851,677396,427203,PR+ER+,positive,HR+HER2-,Sensitive
80,BaselTMA_SP42_80_X4Y3,2,14,FEMALE,0,54,death,,1c,1. Primary Dx,0,Sp4.2,X4Y3,4,3,non-tumor,Sp4.2,34,,,,,2002,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,76,76,"",1,0,1,,,,FALSE,i+,"","",177,BaselTMA_SP42_39.8kx13.885ky_7000x7000_2_20179015_34_80_X4Y3_311_a0_full.tiff,728,777,565656,16915,PR+ER+,positive,HR+HER2-,Sensitive
70,BaselTMA_SP42_70_X5Y3,3,18,FEMALE,0,58,alive,,1c,1. Primary Dx,0,Sp4.2,X5Y3,5,3,tumor,Sp4.2,43,,,,,2004,breast,invasive ductal breast carcinoma-,0,0,0,positive,negative,negative,none,Tamoxifen,Sp4.2,breast cancer,97,97,"",1,0,1,,,,FALSE,i-,sn,"",3103,BaselTMA_SP42_32.8kx13.885ky_7000x8000_5_20179015_43_70_X5Y3_50_a0_full.tiff,761,756,575316,330009,PR-ER+,positive,HR+HER2-,Sensitive
70,BaselTMA_SP42_70_X6Y3,3,18,FEMALE,0,58,alive,,1c,1. Primary Dx,0,Sp4.2,X6Y3,6,3,non-tumor,Sp4.2,52,,,,,2004,breast,invasive ductal breast carcinoma-,0,0,0,positive,negative,negative,none,Tamoxifen,Sp4.2,breast cancer,97,97,"",1,0,1,,,,FALSE,i-,sn,"",197,BaselTMA_SP42_32.8kx13.885ky_7000x8000_5_20179015_52_70_X6Y3_145_a0_full.tiff,805,687,553035,16942,PR-ER+,positive,HR+HER2-,Sensitive
30,BaselTMA_SP42_30_X8Y3,3,19,FEMALE,0,41,alive,,1c,1. Primary Dx,0,Sp4.2,X8Y3,8,3,non-tumor,Sp4.2,68,,,,,2004,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,positive,none,Chemotherapy - Immune therapy - Tamoxifen,Sp4.2,breast cancer,82,82,"",1,0,,,,,FALSE,i-,sn,"",414,BaselTMA_SP42_32.8kx13.885ky_7000x8000_5_20179015_68_30_X8Y3_290_a0_full.tiff,668,754,503672,53098,PR+ER+,positive,HR+HER2+,""
96,BaselTMA_SP42_96_X9Y3,3,25,FEMALE,0,69,alive,,2,1. Primary Dx,2a,Sp4.2,X9Y3,9,3,tumor,Sp4.2,76,,,,,1997,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,negative,negative,none,Hormone therapy,Sp4.2,breast cancer,181,181,"",1,0,1,,,,FALSE,"","","",1272,BaselTMA_SP42_26.8kx12.885ky_7000x7000_6_20179015_76_96_X9Y3_53_a0_full.tiff,708,711,503388,133375,PR-ER+,positive,HR+HER2-,Sensitive
10,BaselTMA_SP42_10_X1Y5,1,21,FEMALE,0,79,death,,2,1. Primary Dx,3a,Sp4.2,X1Y5,1,5,tumor,Sp4.2,5,,,,,2004,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,66,66,"",1,0,1,,,,TRUE,"","","",2509,BaselTMA_SP42_39.025kx22410ky_7000x8500_8_20179015_5_10_X1Y5_12_a0_full.tiff,713,773,551149,270928,PR+ER+,positive,HR+HER2-,Sensitive
35,BaselTMA_SP42_35_X16Y4,2,17,FEMALE,0,62,alive,,1c,1. Primary Dx,0,Sp4.2,X16Y4,16,4,tumor,Sp4.2,129,,,,,1997,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,185,185,"",1,0,1,,,,FALSE,"","","",1797,BaselTMA_SP42_19.8kx12.535ky_7000x6500_7_20179015_129_35_X16Y4_319_a0_full.tiff,708,860,608880,140242,PR+ER+,positive,HR+HER2-,Sensitive
138,BaselTMA_SP42_138_X3Y5,2,30,FEMALE,0,65,death by primary disease,,2,1. Primary Dx,1mi,Sp4.2,X3Y5,3,5,tumor,Sp4.2,23,,,,,1998,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,28,77,"",1,0,,1,,,FALSE,"","","",3806,BaselTMA_SP42_39.025kx22410ky_7000x8500_8_20179015_23_138_X3Y5_251_a0_full.tiff,668,850,567800,336383,PR+ER+,positive,HR+HER2-,Refractory
264,BaselTMA_SP42_264_X14Y5,2,23,FEMALE,0,82,death,,2,1. Primary Dx,1mi,Sp4.2,X14Y5,14,5,tumor,Sp4.2,114,,,,,1998,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,113,113,"",1,0,1,,,,FALSE,"","","",2418,BaselTMA_SP42_19.78kx19.035ky_6500x7000_13_20179015_114_264_X14Y5_138_a0_full.tiff,696,819,570024,245377,PR+ER+,positive,HR+HER2-,Sensitive
160,BaselTMA_SP42_160_X13Y5,2,14,FEMALE,0,60,alive,,1c,1. Primary Dx,0,Sp4.2,X13Y5,13,5,tumor,Sp4.2,106,,,,,1998,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,178,178,"",1,0,1,,,,FALSE,"","","",3084,BaselTMA_SP42_19.78kx19.035ky_6500x7000_13_20179015_106_160_X13Y5_21_a0_full.tiff,674,805,542570,303802,PR+ER+,positive,HR+HER2-,Sensitive
54,BaselTMA_SP42_54_X12Y5,2,35,FEMALE,0,85,death,,2,1. Primary Dx,X,Sp4.2,X12Y5,12,5,tumor,Sp4.2,98,,,,,1998,breast,invasive ductal breast carcinoma-,0,0,0,positive,negative,negative,none,Tamoxifen,Sp4.2,breast cancer,7,7,"",1,0,,,,,FALSE,"","","",3007,BaselTMA_SP42_25.78kx19.535ky_7000x7000_12_20179015_98_54_X12Y5_305_a0_full.tiff,729,798,581742,318679,PR-ER+,positive,HR+HER2-,""
96,BaselTMA_SP42_96_X10Y3,3,25,FEMALE,0,69,alive,,2,1. Primary Dx,2a,Sp4.2,X10Y3,10,3,non-tumor,Sp4.2,84,,,,,1997,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,negative,negative,none,Hormone therapy,Sp4.2,breast cancer,181,181,"",1,0,1,,,,FALSE,"","","",725,BaselTMA_SP42_26.8kx12.885ky_7000x7000_6_20179015_84_96_X10Y3_148_a0_full.tiff,812,647,525364,80478,PR-ER+,positive,HR+HER2-,Sensitive
98,BaselTMA_SP42_98_X11Y5,1,22,FEMALE,0,74,death by primary disease,,2,1. Primary Dx,1a,Sp4.2,X11Y5,11,5,tumor,Sp4.2,90,,,,,1997,breast,invasive ductal breast carcinoma-,0,0,0,positive,negative,negative,none,Tamoxifen,Sp4.2,breast cancer,99,99,"",1,0,,,1,,FALSE,"","","",2576,BaselTMA_SP42_25.78kx19.535ky_7000x7000_12_20179015_90_98_X11Y5_208_a0_full.tiff,715,822,587730,325061,PR-ER+,positive,HR+HER2-,Resistant
91,BaselTMA_SP42_91_X11Y3,2,22,FEMALE,0,81,alive,,2,1. Primary Dx,1a,Sp4.2,X11Y3,11,3,tumor,Sp4.2,92,,,,,1997,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,195,195,"",1,0,1,,,,FALSE,"","","",4136,BaselTMA_SP42_26.8kx12.885ky_7000x7000_6_20179015_92_91_X11Y3_245_a0_full.tiff,693,944,654192,387131,PR+ER+,positive,HR+HER2-,Sensitive
91,BaselTMA_SP42_91_X12Y3,2,22,FEMALE,0,81,alive,,2,1. Primary Dx,1a,Sp4.2,X12Y3,12,3,non-tumor,Sp4.2,100,,,,,1997,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,195,195,"",1,0,1,,,,FALSE,"","","",659,BaselTMA_SP42_26.8kx12.885ky_7000x7000_6_20179015_100_91_X12Y3_337_a0_full.tiff,576,700,403200,50089,PR+ER+,positive,HR+HER2-,Sensitive
161,BaselTMA_SP42_161_X13Y3,2,22,FEMALE,0,79,death,,2,1. Primary Dx,X,Sp4.2,X13Y3,13,3,tumor,Sp4.2,108,,,,,1997,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,52,52,"",1,0,,,,,TRUE,"","","",4003,BaselTMA_SP42_19.8kx12.535ky_7000x6500_7_20179015_108_161_X13Y3_56_a0_full.tiff,807,763,615741,356857,PR+ER+,positive,HR+HER2-,""
188,BaselTMA_SP42_188_X10Y5,3,35,FEMALE,0,52,death by primary disease,,2,1. Primary Dx,0,Sp4.2,X10Y5,10,5,tumor,Sp4.2,82,,,,,1997,breast,"invasive ductal breast carcinoma-In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,44,44,"",1,0,,,1,,FALSE,"","","",1667,BaselTMA_SP42_25.78kx19.535ky_7000x7000_12_20179015_82_188_X10Y5_110_a0_full.tiff,826,624,515424,161983,PR+ER+,positive,HR+HER2-,Resistant
74,BaselTMA_SP42_74_X15Y3,3,21,FEMALE,0,44,alive,,2,1. Primary Dx,0,Sp4.2,X15Y3,15,3,tumor,Sp4.2,123,,,,,2005,breast,"invasive ductal breast carcinoma-In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,72,72,"",1,0,1,,,,FALSE,i-,sl,"",2701,BaselTMA_SP42_19.8kx12.535ky_7000x6500_7_20179015_123_74_X15Y3_223_a0_full.tiff,751,392,294392,231312,PR+ER+,positive,HR+HER2-,Sensitive
74,BaselTMA_SP42_74_X16Y3,3,21,FEMALE,0,44,alive,,2,1. Primary Dx,0,Sp4.2,X16Y3,16,3,non-tumor,Sp4.2,130,,,,,2005,breast,"invasive ductal breast carcinoma-In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,72,72,"",1,0,1,,,,FALSE,i-,sl,"",260,BaselTMA_SP42_19.8kx12.535ky_7000x6500_7_20179015_130_74_X16Y3_296_a0_full.tiff,765,752,575280,28487,PR+ER+,positive,HR+HER2-,Sensitive
190,BaselTMA_SP42_190_X9Y5,2,19,FEMALE,0,73,death by primary disease,,1c,1. Primary Dx,0,Sp4.2,X9Y5,9,5,tumor,Sp4.2,74,,,,,2005,breast,invasive ductal breast carcinoma-,0,0,0,positive,negative,positive,none,Anastrazol,Sp4.2,breast cancer,24,59,"",1,0,,1,,,FALSE,i-,sn,"",1736,BaselTMA_SP42_25.78kx19.535ky_7000x7000_12_20179015_74_190_X9Y5_18_a0_full.tiff,685,804,550740,172802,PR-ER+,positive,HR+HER2+,Refractory
192,BaselTMA_SP42_192_X8Y5,3,80,FEMALE,0,69,alive,,4,1. Primary Dx,0,Sp4.2,X8Y5,8,5,tumor,Sp4.2,66,,,,,2005,breast,invasive ductal breast carcinoma-,0,0,0,negative,negative,positive,none,Chemotherapy,Sp4.2,breast cancer,93,93,"",,0,,,,,FALSE,"","","",2897,BaselTMA_SP42_32.435kx20.41ky_7000x7000_11_20179015_66_192_X8Y5_302_a0_full.tiff,692,803,555676,373394,PR-ER-,negative,HR-HER2+,""
185,BaselTMA_SP42_185_X7Y5,3,43,FEMALE,0,63,death by primary disease,,2,1. Primary Dx,3a,Sp4.2,X7Y5,7,5,tumor,Sp4.2,58,,,,,2005,breast,"invasive ductal breast carcinoma-In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,1,positive,positive,positive,none,Anastrazol,Sp4.2,breast cancer,3,22,"",1,0,,1,,,TRUE,"","","",2456,BaselTMA_SP42_32.435kx20.41ky_7000x7000_11_20179015_58_185_X7Y5_205_a0_full.tiff,706,740,522440,306956,PR+ER+,positive,HR+HER2+,Refractory
145,BaselTMA_SP42_145_X1Y4,3,22,FEMALE,0,52,alive,,2,1. Primary Dx,x,Sp4.2,X1Y4,1,4,tumor,Sp4.2,6,,,,,2005,breast,invasive ductal breast carcinoma-,0,0,0,negative,negative,negative,none,Chemotherapy,Sp4.2,breast cancer,98,98,"",,1,,,,,TRUE,"","","",3367,BaselTMA_SP42_39.8kx13.885ky_7000x7000_2_20179015_6_145_X1Y4_68_a0_full.tiff,675,821,554175,330726,PR-ER-,negative,TripleNeg,""
145,BaselTMA_SP42_145_X2Y4_141,3,22,FEMALE,0,52,alive,,2,1. Primary Dx,x,Sp4.2,X2Y4,2,4,non-tumor,Sp4.2,15,,,,,2005,breast,invasive ductal breast carcinoma-,0,0,0,negative,negative,negative,none,Chemotherapy,Sp4.2,breast cancer,98,98,"",,1,,,,,TRUE,"","","",55,BaselTMA_SP42_39.8kx13.885ky_7000x7000_2_20179015_15_145_X2Y4_141_a0_full.tiff,324,316,102384,6084,PR-ER-,negative,TripleNeg,""
145,BaselTMA_SP42_145_X2Y4_142,3,22,FEMALE,0,52,alive,,2,1. Primary Dx,x,Sp4.2,X2Y4,2,4,non-tumor,Sp4.2,15,,,,,2005,breast,invasive ductal breast carcinoma-,0,0,0,negative,negative,negative,none,Chemotherapy,Sp4.2,breast cancer,98,98,"",,1,,,,,TRUE,"","","",25,BaselTMA_SP42_39.8kx13.885ky_7000x7000_2_20179015_15_145_X2Y4_142_a0_full.tiff,228,293,66804,2266,PR-ER-,negative,TripleNeg,""
181,BaselTMA_SP42_181_X6Y5,2,16,FEMALE,0,59,alive,,1c,1. Primary Dx,0,Sp4.2,X6Y5,6,5,tumor,Sp4.2,50,,,,,2005,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,negative,none,Anastrazol,Sp4.2,breast cancer,71,71,"",1,0,1,,,,FALSE,i-,"","",2081,BaselTMA_SP42_32.435kx20.41ky_7000x7000_11_20179015_50_181_X6Y5_107_a0_full.tiff,585,876,512460,189469,PR+ER+,positive,HR+HER2-,Sensitive
16,BaselTMA_SP42_16_X3Y4,1,12,FEMALE,0,67,alive,,1c,1. Primary Dx,0,Sp4.2,X3Y4,3,4,tumor,Sp4.2,24,,,,,2005,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,89,89,"",1,0,1,,,,FALSE,"","","",533,BaselTMA_SP42_39.8kx13.885ky_7000x7000_2_20179015_24_16_X3Y4_239_a0_full.tiff,565,251,141815,51147,PR+ER+,positive,HR+HER2-,Sensitive
16,BaselTMA_SP42_16_X4Y4,1,12,FEMALE,0,67,alive,,1c,1. Primary Dx,0,Sp4.2,X4Y4,4,4,non-tumor,Sp4.2,33,,,,,2005,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,89,89,"",1,0,1,,,,FALSE,"","","",226,BaselTMA_SP42_39.8kx13.885ky_7000x7000_2_20179015_33_16_X4Y4_334_a0_full.tiff,779,912,710448,23614,PR+ER+,positive,HR+HER2-,Sensitive
189,BaselTMA_SP42_189_X5Y5,3,21,FEMALE,0,53,death by primary disease,,2,1. Primary Dx,0,Sp4.2,X5Y5,5,5,tumor,Sp4.2,41,,,,,2005,breast,invasive ductal breast carcinoma-,0,1,0,negative,negative,negative,none,Chemotherapy,Sp4.2,breast cancer,13,20,"",,1,,,,,FALSE,"","","",3491,BaselTMA_SP42_32.435kx20.41ky_7000x7000_11_20179015_41_189_X5Y5_15_a0_full.tiff,708,810,573480,345905,PR-ER-,negative,TripleNeg,""
210,BaselTMA_SP42_210_X4Y5,2,25,FEMALE,0,75,alive,,2,1. Primary Dx,0,Sp4.2,X4Y5,4,5,tumor,Sp4.2,32,,,,,2005,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,negative,negative,none,Tamoxifen,Sp4.2,breast cancer,70,70,"",1,0,1,,,,TRUE,i-,sl,"",2544,BaselTMA_SP42_39.025kx22410ky_7000x8500_8_20179015_32_210_X4Y5_352_a0_full.tiff,721,795,573195,263371,PR-ER+,positive,HR+HER2-,Sensitive
275,BaselTMA_SP42_275_X5Y4,3,26,FEMALE,0,79,alive,,2,1. Primary Dx,0sl,Sp4.2,X5Y4,5,4,tumor,Sp4.2,42,,,,,2005,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,positive,none,Anastrazol,Sp4.2,breast cancer,69,69,"",1,0,1,,,,FALSE,i-,sl,"",1828,BaselTMA_SP42_32.8kx13.885ky_7000x8000_5_20179015_42_275_X5Y4_71_a0_full.tiff,762,768,585216,195540,PR+ER+,positive,HR+HER2+,Sensitive
275,BaselTMA_SP42_275_X6Y4,3,26,FEMALE,0,79,alive,,2,1. Primary Dx,0sl,Sp4.2,X6Y4,6,4,non-tumor,Sp4.2,51,,,,,2005,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,positive,none,Anastrazol,Sp4.2,breast cancer,69,69,"",1,0,1,,,,FALSE,i-,sl,"",55,BaselTMA_SP42_32.8kx13.885ky_7000x8000_5_20179015_51_275_X6Y4_169_a0_full.tiff,239,618,147702,4934,PR+ER+,positive,HR+HER2+,Sensitive
154,BaselTMA_SP42_154_X7Y4,2,45,FEMALE,0,79,alive,,4,1. Primary Dx,0,Sp4.2,X7Y4,7,4,tumor,Sp4.2,59,,,,,2005,breast,invasive ductal breast carcinoma-Lymphangiosis carcinomatosa,0,1,0,positive,negative,negative,none,Anastrazol,Sp4.2,breast cancer,72,72,"",1,0,1,,,,FALSE,"","","",1307,BaselTMA_SP42_32.8kx13.885ky_7000x8000_5_20179015_59_154_X7Y4_242_a0_full.tiff,634,643,407662,136338,PR-ER+,positive,HR+HER2-,Sensitive
154,BaselTMA_SP42_154_X8Y4,2,45,FEMALE,0,79,alive,,4,1. Primary Dx,0,Sp4.2,X8Y4,8,4,non-tumor,Sp4.2,67,,,,,2005,breast,invasive ductal breast carcinoma-Lymphangiosis carcinomatosa,0,1,0,positive,negative,negative,none,Anastrazol,Sp4.2,breast cancer,72,72,"",1,0,1,,,,FALSE,"","","",659,BaselTMA_SP42_32.8kx13.885ky_7000x8000_5_20179015_67_154_X8Y4_313_a0_full.tiff,720,702,505440,77726,PR-ER+,positive,HR+HER2-,Sensitive
89,BaselTMA_SP42_89_X4Y6,3,14,FEMALE,0,37,alive,,1c,1. Primary Dx,1a,Sp4.2,X4Y6,4,6,tumor,Sp4.2,31,,,,,2005,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,1,negative,negative,negative,none,Chemotherapy,Sp4.2,breast cancer,95,95,"",,1,,,,,TRUE,"",sn,"",3064,BaselTMA_SP42_39.025kx22410ky_7000x8500_8_20179015_31_89_X4Y6_361_a0_full.tiff,692,784,542528,275131,PR-ER-,negative,TripleNeg,""
183,BaselTMA_SP42_183_X3Y6,1,14,FEMALE,0,84,alive,,1c,1. Primary Dx,0sl,Sp4.2,X3Y6,3,6,tumor,Sp4.2,22,,,,,2005,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,93,93,"",1,0,1,,,,FALSE,i-,sl,"",2333,BaselTMA_SP42_39.025kx22410ky_7000x8500_8_20179015_22_183_X3Y6_275_a0_full.tiff,691,843,582513,214110,PR+ER+,positive,HR+HER2-,Sensitive
56,BaselTMA_SP42_56_X2Y6,2,17,FEMALE,0,57,alive,,1c,1. Primary Dx,0,Sp4.2,X2Y6,2,6,tumor,Sp4.2,13,,,,,2005,breast,"invasive ductal breast carcinoma-invasive lobular breast carcinoma, In situ ductal breast carcinoma",0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,90,90,"",1,0,1,,,,FALSE,i-,"","",3144,BaselTMA_SP42_39.025kx22410ky_7000x8500_8_20179015_13_56_X2Y6_154_a0_full.tiff,665,857,569905,333438,PR+ER+,positive,HR+HER2-,Sensitive
130,BaselTMA_SP42_130_X1Y6,1,12,FEMALE,0,62,alive,,1c,1. Primary Dx,0,Sp4.2,X1Y6,1,6,tumor,Sp4.2,4,,,,,2005,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,86,86,"",1,0,1,,,,FALSE,i-,"","",2416,BaselTMA_SP42_39.025kx22410ky_7000x8500_8_20179015_4_130_X1Y6_35_a0_full.tiff,703,847,595441,247652,PR+ER+,positive,HR+HER2-,Sensitive
136,BaselTMA_SP42_136_X10Y4,3,16,FEMALE,0,55,alive,,1c,1. Primary Dx,0,Sp4.2,X10Y4,10,4,non-tumor,Sp4.2,83,,,,,2005,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,negative,negative,none,Anastrazol,Sp4.2,breast cancer,97,97,"",1,0,1,,,,FALSE,i-,sn,"",979,BaselTMA_SP42_26.8kx12.885ky_7000x7000_6_20179015_83_136_X10Y4_172_a0_full.tiff,714,881,629034,116030,PR-ER+,positive,HR+HER2-,Sensitive
136,BaselTMA_SP42_136_X9Y4,3,16,FEMALE,0,55,alive,,1c,1. Primary Dx,0,Sp4.2,X9Y4,9,4,tumor,Sp4.2,75,,,,,2005,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,negative,negative,none,Anastrazol,Sp4.2,breast cancer,97,97,"",1,0,1,,,,FALSE,i-,sn,"",3181,BaselTMA_SP42_26.8kx12.885ky_7000x7000_6_20179015_78_136_X9Y4_74_a0_full.tiff,709,758,537422,356172,PR-ER+,positive,HR+HER2-,Sensitive
175,BaselTMA_SP42_175_X15Y5_235,3,38,FEMALE,0,56,death by primary disease,,2,1. Primary Dx,3a,Sp4.2,X15Y5,15,5,tumor,Sp4.2,121,,,,,2005,breast,invasive ductal breast carcinoma-Lymphangiosis carcinomatosa,0,1,0,negative,negative,negative,none,Chemotherapy,Sp4.2,breast cancer,16,21,"",,1,,,,,FALSE,"","","",2330,BaselTMA_SP42_19.78kx19.035ky_6500x7000_13_20179015_121_175_X15Y5_235_a0_full.tiff,776,372,288672,200261,PR-ER-,negative,TripleNeg,""
175,BaselTMA_SP42_175_X15Y5_236,3,38,FEMALE,0,56,death by primary disease,,2,1. Primary Dx,3a,Sp4.2,X15Y5,15,5,tumor,Sp4.2,121,,,,,2005,breast,invasive ductal breast carcinoma-Lymphangiosis carcinomatosa,0,1,0,negative,negative,negative,none,Chemotherapy,Sp4.2,breast cancer,16,21,"",,1,,,,,FALSE,"","","",669,BaselTMA_SP42_19.78kx19.035ky_6500x7000_13_20179015_121_175_X15Y5_236_a0_full.tiff,256,351,89856,64623,PR-ER-,negative,TripleNeg,""
76,BaselTMA_SP42_76_X13Y6,2,30,FEMALE,0,78,alive,,4,1. Primary Dx,3a,Sp4.2,X13Y6,13,6,tumor,Sp4.2,105,,,,,2006,breast,invasive ductal breast carcinoma-Lymphangiosis carcinomatosa,0,1,1,positive,positive,negative,none,Anastrazol,Sp4.2,breast cancer,83,83,"",1,0,1,,,,FALSE,"","","",2476,BaselTMA_SP42_19.78kx19.035ky_6500x7000_13_20179015_105_76_X13Y6_44_a0_full.tiff,774,760,588240,266395,PR+ER+,positive,HR+HER2-,Sensitive
158,BaselTMA_SP42_158_X12Y6,2,15,FEMALE,0,80,alive,,1c,1. Primary Dx,0sn,Sp4.2,X12Y6,12,6,tumor,Sp4.2,97,,,,,2006,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,67,67,"",1,0,1,,,,TRUE,i-,"","",1242,BaselTMA_SP42_25.78kx19.535ky_7000x7000_12_20179015_97_158_X12Y6_328_a0_full.tiff,489,768,375552,110654,PR+ER+,positive,HR+HER2-,Sensitive
261,BaselTMA_SP42_261_X11Y6,2,27,FEMALE,0,73,alive,,2,1. Primary Dx,0,Sp4.2,X11Y6,11,6,tumor,Sp4.2,89,,,,,2006,breast,invasive ductal breast carcinoma-,0,0,0,positive,negative,negative,none,Tamoxifen,Sp4.2,breast cancer,80,80,"",1,0,1,,,,FALSE,i-,sn,"",3449,BaselTMA_SP42_25.78kx19.535ky_7000x7000_12_20179015_89_261_X11Y6_232_a0_full.tiff,723,831,600813,376905,PR-ER+,positive,HR+HER2-,Sensitive
109,BaselTMA_SP42_109_X10Y6,1,15,FEMALE,0,79,alive,,1c,1. Primary Dx,1a,Sp4.2,X10Y6,10,6,tumor,Sp4.2,81,,,,,2006,breast,"invasive ductal breast carcinoma-In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,78,78,"",1,0,1,,,,FALSE,i+,sn,mic,2615,BaselTMA_SP42_25.78kx19.535ky_7000x7000_12_20179015_81_109_X10Y6_135_a0_full.tiff,724,813,588612,252391,PR+ER+,positive,HR+HER2-,Sensitive
174,BaselTMA_SP42_174_X9Y6,2,9,FEMALE,0,70,alive,,1b,1. Primary Dx,0,Sp4.2,X9Y6,9,6,tumor,Sp4.2,73,,,,,2006,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,85,85,"",1,0,1,,,,FALSE,i-,sn,"",3568,BaselTMA_SP42_25.78kx19.535ky_7000x7000_12_20179015_73_174_X9Y6_41_a0_full.tiff,700,754,527800,394697,PR+ER+,positive,HR+HER2-,Sensitive
123,BaselTMA_SP42_123_X8Y6,3,19,FEMALE,0,32,alive,,1c,1. Primary Dx,0,Sp4.2,X8Y6,8,6,tumor,Sp4.2,65,,,,,2006,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,positive,none,Chemotherapy,Sp4.2,breast cancer,47,47,"",1,0,,,,,TRUE,i-,"","",388,BaselTMA_SP42_32.435kx20.41ky_7000x7000_11_20179015_65_123_X8Y6_325_a0_full.tiff,287,632,181384,38363,PR+ER+,positive,HR+HER2+,""
64,BaselTMA_SP42_64_X13Y4,3,25,FEMALE,0,51,death by primary disease,,2,1. Primary Dx,0,Sp4.2,X13Y4,13,4,tumor,Sp4.2,107,,,,,2006,breast,invasive ductal breast carcinoma-,0,0,0,negative,negative,negative,none,Chemotherapy,Sp4.2,breast cancer,39,50,"",,1,,,,,FALSE,i-,"","",3914,BaselTMA_SP42_19.8kx12.535ky_7000x6500_7_20179015_107_64_X13Y4_77_a0_full.tiff,755,742,560210,450712,PR-ER-,negative,TripleNeg,""
64,BaselTMA_SP42_64_X14Y4,3,25,FEMALE,0,51,death by primary disease,,2,1. Primary Dx,0,Sp4.2,X14Y4,14,4,non-tumor,Sp4.2,115,,,,,2006,breast,invasive ductal breast carcinoma-,0,0,0,negative,negative,negative,none,Chemotherapy,Sp4.2,breast cancer,39,50,"",,1,,,,,FALSE,i-,"","",4843,BaselTMA_SP42_19.8kx12.535ky_7000x6500_7_20179015_115_64_X14Y4_151_a0_full.tiff,747,820,612540,478059,PR-ER-,negative,TripleNeg,""
232,BaselTMA_SP42_232_X7Y6,3,14,FEMALE,0,57,alive,,1c,1. Primary Dx,1,Sp4.2,X7Y6,7,6,tumor,Sp4.2,57,,,,,2006,breast,mixed ductal lobular breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,positive,none,Chemotherapy - Immune therapy - Anastrozol,Sp4.2,breast cancer,54,89,"",,0,,,1,,FALSE,"","","",2485,BaselTMA_SP42_32.435kx20.41ky_7000x7000_11_20179015_57_232_X7Y6_229_a0_full.tiff,675,781,527175,254867,PR+ER+,positive,HR+HER2+,Resistant
27,BaselTMA_SP42_27_X6Y6,3,19,FEMALE,0,54,alive,,1c,1. Primary Dx,0,Sp4.2,X6Y6,6,6,tumor,Sp4.2,49,,,,,2006,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,negative,negative,positive,none,Chemotherapy - Immune therapy,Sp4.2,breast cancer,51,51,"",,0,,,,,FALSE,"","","",2952,BaselTMA_SP42_32.435kx20.41ky_7000x7000_11_20179015_49_27_X6Y6_132_a0_full.tiff,722,810,584820,367715,PR-ER-,negative,HR-HER2+,""
148,BaselTMA_SP42_148_X5Y6,3,22,FEMALE,0,60,alive w metastases,,4b,1. Primary Dx,2a,Sp4.2,X5Y6,5,6,tumor,Sp4.2,40,,,,,2006,breast,"invasive ductal breast carcinoma-In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,1,positive,positive,negative,none,Chemotherapy - Letrozol,Sp4.2,breast cancer,4,66,"",1,0,,1,,,TRUE,"","","",2894,BaselTMA_SP42_32.435kx20.41ky_7000x7000_11_20179015_40_148_X5Y6_38_a0_full.tiff,749,779,583471,267248,PR+ER+,positive,HR+HER2-,Refractory
81,BaselTMA_SP42_81_X11Y4,3,12,FEMALE,0,56,alive,,1c,1. Primary Dx,0,Sp4.2,X11Y4,11,4,tumor,Sp4.2,91,,,,,2006,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,negative,negative,negative,none,none,Sp4.2,breast cancer,89,89,"",,1,,,,,FALSE,i-,sn,"",3244,BaselTMA_SP42_26.8kx12.885ky_7000x7000_6_20179015_91_81_X11Y4_269_a0_full.tiff,706,819,578214,349290,PR-ER-,negative,TripleNeg,""
81,BaselTMA_SP42_81_X12Y4,3,12,FEMALE,0,56,alive,,1c,1. Primary Dx,0,Sp4.2,X12Y4,12,4,non-tumor,Sp4.2,99,,,,,2006,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,negative,negative,negative,none,none,Sp4.2,breast cancer,89,89,"",,1,,,,,FALSE,i-,sn,"",781,BaselTMA_SP42_26.8kx12.885ky_7000x7000_6_20179015_99_81_X12Y4_349_a0_full.tiff,749,858,642642,86595,PR-ER-,negative,TripleNeg,""
279,BaselTMA_SP42_279_X14Y6,2,13,FEMALE,0,42,alive,,1c,1. Primary Dx,0,Sp4.2,X14Y6,14,6,tumor,Sp4.2,113,,,,,2006,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,80,80,"",1,0,1,,,,FALSE,"",sn,"",1578,BaselTMA_SP42_19.78kx19.035ky_6500x7000_13_20179015_113_279_X14Y6_163_a0_full.tiff,730,775,565750,158735,PR+ER+,positive,HR+HER2-,Sensitive
152,BaselTMA_SP42_152_X15Y6,2,28,FEMALE,0,74,alive,,2,1. Primary Dx,0,Sp4.2,X15Y6,15,6,tumor,Sp4.2,120,,,,,2006,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,negative,negative,positive,none,Chemotherapy - Immune therapy,Sp4.2,breast cancer,81,81,"",,0,,,,,FALSE,i-,sn,"",2591,BaselTMA_SP42_19.78kx19.035ky_6500x7000_13_20179015_120_152_X15Y6_260_a0_full.tiff,755,818,617590,328541,PR-ER-,negative,HR-HER2+,""
146,BaselTMA_SP42_146_X16Y6,2,15,FEMALE,0,61,alive,,1c,1. Primary Dx,0,Sp4.2,X16Y6,16,6,tumor,Sp4.2,127,,,,,2006,breast,mixed ductal lobular breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Anastrazol,Sp4.2,breast cancer,72,72,"",,0,1,,,,TRUE,i-,"","",69,BaselTMA_SP42_19.78kx19.035ky_6500x7000_13_20179015_127_146_X16Y6_308_a0_full.tiff,596,816,486336,6463,PR+ER+,positive,HR+HER2-,Sensitive
229,BaselTMA_SP42_229_X1Y7,3,17,FEMALE,0,35,alive,,1c,1. Primary Dx,0,Sp4.2,X1Y7,1,7,tumor,Sp4.2,3,,,,,2006,breast,invasive ductal breast carcinoma-medullary features,0,0,0,negative,negative,negative,none,Chemotherapy,Sp4.2,breast cancer,74,74,"",,1,,,,,FALSE,i-,sn,"",3217,BaselTMA_SP42_39.025kx22410ky_7000x8500_8_20179015_3_229_X1Y7_59_a0_full.tiff,730,862,629260,385901,PR-ER-,negative,TripleNeg,""
171,BaselTMA_SP42_171_X2Y7,2,34,FEMALE,0,88,alive,,2,1. Primary Dx,1a,Sp4.2,X2Y7,2,7,tumor,Sp4.2,12,,,,,2006,breast,"invasive ductal breast carcinoma-In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,0,positive,positive,positive,none,Tamoxifen,Sp4.2,breast cancer,62,62,"",1,0,1,,,,TRUE,"","","",3906,BaselTMA_SP42_39.025kx22410ky_7000x8500_8_20179015_12_171_X2Y7_178_a0_full.tiff,705,784,552720,344859,PR+ER+,positive,HR+HER2+,Sensitive
176,BaselTMA_SP42_176_X3Y7,3,125,FEMALE,0,50,death by primary disease,,4b,1. Primary Dx,1a,Sp4.2,X3Y7,3,7,tumor,Sp4.2,21,,,,,2006,breast,invasive ductal breast carcinoma-Lymphangiosis carcinomatosa,1,1,0,negative,negative,negative,none,none,Sp4.2,breast cancer,7,10,"",,1,,,,,FALSE,"","","",4783,BaselTMA_SP42_39.025kx22410ky_7000x8500_8_20179015_21_176_X3Y7_299_a0_full.tiff,811,832,674752,418381,PR-ER-,negative,TripleNeg,""
99,BaselTMA_SP42_99_X5Y7,3,13,FEMALE,0,69,alive,,1c,1. Primary Dx,0,Sp4.2,X5Y7,5,7,tumor,Sp4.2,39,,,,,2007,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,positive,none,Immune therapy - Anastrozol,Sp4.2,breast cancer,80,80,"",1,0,,,,,TRUE,i-,"","",1970,BaselTMA_SP42_32.435kx20.41ky_7000x7000_11_20179015_39_99_X5Y7_62_a0_full.tiff,770,753,579810,174640,PR+ER+,positive,HR+HER2+,""
258,BaselTMA_SP42_258_X4Y7,2,16,FEMALE,0,68,alive,,1c,1. Primary Dx,0,Sp4.2,X4Y7,4,7,tumor,Sp4.2,30,,,,,2006,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Anastrazol,Sp4.2,breast cancer,80,80,"",1,0,1,,,,FALSE,i-,sn,"",1935,BaselTMA_SP42_39.025kx22410ky_7000x8500_8_20179015_30_258_X4Y7_364_a0_full.tiff,646,859,554914,201377,PR+ER+,positive,HR+HER2-,Sensitive
273,BaselTMA_SP42_273_X6Y7,1,12,FEMALE,0,46,alive,,1c,1. Primary Dx,0,Sp4.2,X6Y7,6,7,tumor,Sp4.2,48,,,,,2007,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Anastrazol,Sp4.2,breast cancer,77,77,"",1,0,1,,,,TRUE,i-,sn,"",2915,BaselTMA_SP42_32.435kx20.41ky_7000x7000_11_20179015_48_273_X6Y7_157_a0_full.tiff,733,842,617186,237196,PR+ER+,positive,HR+HER2-,Sensitive
285,BaselTMA_SP42_285_X7Y7,2,16,FEMALE,0,73,alive,,1c,1. Primary Dx,0,Sp4.2,X7Y7,7,7,tumor,Sp4.2,56,,,,,2007,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,67,67,"",1,0,1,,,,FALSE,i-,sn,"",3549,BaselTMA_SP42_32.435kx20.41ky_7000x7000_11_20179015_56_285_X7Y7_254_a0_full.tiff,755,778,587390,399795,PR+ER+,positive,HR+HER2-,Sensitive
5,BaselTMA_SP42_5_X8Y7,2,19,FEMALE,0,49,alive,,1c,1. Primary Dx,0,Sp4.2,X8Y7,8,7,tumor,Sp4.2,64,,,,,2007,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,79,79,"",1,0,1,,,,FALSE,i-,sn,"",2428,BaselTMA_SP42_32.435kx20.41ky_7000x7000_11_20179015_64_5_X8Y7_343_a0_full.tiff,719,772,555068,206768,PR+ER+,positive,HR+HER2-,Sensitive
223,BaselTMA_SP42_223_X9Y7,1,14,FEMALE,0,50,alive,,1c,1. Primary Dx,0,Sp4.2,X9Y7,9,7,tumor,Sp4.2,72,,,,,2007,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,75,75,"",1,0,1,,,,FALSE,i-,sn,"",2570,BaselTMA_SP42_25.78kx19.535ky_7000x7000_12_20179015_72_223_X9Y7_65_a0_full.tiff,762,795,605790,263779,PR+ER+,positive,HR+HER2-,Sensitive
46,BaselTMA_SP42_46_X10Y7,3,51,FEMALE,0,85,alive,,3,1. Primary Dx,0,Sp4.2,X10Y7,10,7,tumor,Sp4.2,80,,,,,2007,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,negative,negative,positive,none,Immune therapy,Sp4.2,breast cancer,74,74,"",,0,,,,,FALSE,i-,sn,"",2909,BaselTMA_SP42_25.78kx19.535ky_7000x7000_12_20179015_80_46_X10Y7_160_a0_full.tiff,807,721,581847,332132,PR-ER-,negative,HR-HER2+,""
236,BaselTMA_SP42_236_X11Y7,2,30,FEMALE,0,83,death by primary disease,,2,1. Primary Dx,0,Sp4.2,X11Y7,11,7,tumor,Sp4.2,88,,,,,2007,breast,invasive ductal breast carcinoma-Lymphangiosis carcinomatosa,0,1,0,negative,negative,negative,none,none,Sp4.2,breast cancer,9,23,"",,1,,,,,TRUE,i-,sn,"",2749,BaselTMA_SP42_25.78kx19.535ky_7000x7000_12_20179015_88_236_X11Y7_257_a0_full.tiff,866,903,781998,307661,PR-ER-,negative,TripleNeg,""
73,BaselTMA_SP42_73_X12Y7,2,16,FEMALE,0,41,alive,,1c,1. Primary Dx,0,Sp4.2,X12Y7,12,7,tumor,Sp4.2,96,,,,,2007,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,68,68,"",1,0,1,,,,FALSE,i-,sn,"",2930,BaselTMA_SP42_25.78kx19.535ky_7000x7000_12_20179015_96_73_X12Y7_346_a0_full.tiff,744,770,572880,273724,PR+ER+,positive,HR+HER2-,Sensitive
178,BaselTMA_SP42_178_X13Y7,3,11,FEMALE,0,47,alive,,1c,1. Primary Dx,0,Sp4.2,X13Y7,13,7,tumor,Sp4.2,104,,,,,2007,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,positive,none,Chemotherapy - Immune therapy - Tamoxifen,Sp4.2,breast cancer,71,71,"",1,0,,,,,FALSE,i-,sn,"",1988,BaselTMA_SP42_19.78kx19.035ky_6500x7000_13_20179015_104_178_X13Y7_89_a0_full.tiff,736,770,566720,266810,PR+ER+,positive,HR+HER2+,""
151,BaselTMA_SP42_151_X14Y7,3,10,FEMALE,0,78,alive,,1b,1. Primary Dx,0,Sp4.2,X14Y7,14,7,tumor,Sp4.2,112,,,,,2007,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,negative,negative,positive,none,Immune therapy,Sp4.2,breast cancer,70,70,"",,0,,,,,FALSE,i-,"","",4016,BaselTMA_SP42_19.78kx19.035ky_6500x7000_13_20179015_112_151_X14Y7_187_a0_full.tiff,669,817,546573,461631,PR-ER-,negative,HR-HER2+,""
208,BaselTMA_SP42_208_X15Y7,2,14,FEMALE,0,47,alive,,1c,1. Primary Dx,0,Sp4.2,X15Y7,15,7,tumor,Sp4.2,119,,,,,2007,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Exemestan,Sp4.2,breast cancer,73,73,"",1,0,1,,,,FALSE,"","","",1857,BaselTMA_SP42_19.78kx19.035ky_6500x7000_13_20179015_119_208_X15Y7_284_a0_full.tiff,706,682,481492,181595,PR+ER+,positive,HR+HER2-,Sensitive
182,BaselTMA_SP42_182_X1Y8,3,30,FEMALE,0,63,alive,,2,1. Primary Dx,3,Sp4.2,X1Y8,1,8,tumor,Sp4.2,2,,,,,2007,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.2,breast cancer,33,66,"",1,0,,1,,,TRUE,"","","",2769,BaselTMA_SP42_39.025kx22410ky_7000x8500_8_20179015_2_182_X1Y8_80_a0_full.tiff,682,771,525822,278767,PR+ER+,positive,HR+HER2-,Refractory
127,BaselTMA_SP42_127_X2Y8,2,32,FEMALE,0,54,alive,,2,1. Primary Dx,0,Sp4.2,X2Y8,2,8,tumor,Sp4.2,11,,,,,2007,breast,invasive ductal breast carcinoma-,0,0,0,negative,negative,positive,none,Immune therapy,Sp4.2,breast cancer,64,64,"",,0,,,,,FALSE,i-,sn,"",6866,BaselTMA_SP42_39.025kx22410ky_7000x8500_8_20179015_11_127_X2Y8_202_a0_full.tiff,751,869,652619,586411,PR-ER-,negative,HR-HER2+,""
169,BaselTMA_SP42_169_X3Y8,1,15,FEMALE,0,84,alive,,1c,1. Primary Dx,0,Sp4.2,X3Y8,3,8,tumor,Sp4.2,20,,,,,2007,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,negative,none,Anastrazol,Sp4.2,breast cancer,58,58,"",1,0,1,,,,FALSE,i-,sn,"",3463,BaselTMA_SP42_39.025kx22410ky_7000x8500_8_20179015_20_169_X3Y8_322_a0_full.tiff,780,817,637260,317735,PR+ER+,positive,HR+HER2-,Sensitive
184,BaselTMA_SP42_184_X6Y8,3,26,FEMALE,0,58,alive,,2,1. Primary Dx,0,Sp4.2,X6Y8,6,8,tumor,Sp4.2,47,,,,,2008,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,negative,negative,positive,none,Immune therapy,Sp4.2,breast cancer,57,57,"",,0,,,,,FALSE,i-,sn,"",4390,BaselTMA_SP42_32.435kx20.41ky_7000x7000_11_20179015_47_184_X6Y8_181_a0_full.tiff,797,803,639991,401737,PR-ER-,negative,HR-HER2+,""
198,BaselTMA_SP42_198_X7Y8,1,20,FEMALE,0,85,alive,,1c,1. Primary Dx,1,Sp4.2,X7Y8,7,8,tumor,Sp4.2,55,,,,,2008,breast,invasive ductal breast carcinoma-Lymphangiosis carcinomatosa,0,1,0,negative,negative,positive,none,Immune therapy,Sp4.2,breast cancer,59,59,"",,0,,,,,FALSE,"",sn,mic,2641,BaselTMA_SP42_32.435kx20.41ky_7000x7000_11_20179015_55_198_X7Y8_278_a0_full.tiff,772,757,584404,348680,PR-ER-,negative,HR-HER2+,""
71,BaselTMA_SP42_71_X8Y8,1,17,FEMALE,0,65,alive,,1c,1. Primary Dx,0,Sp4.2,X8Y8,8,8,tumor,Sp4.2,63,,,,,2008,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,negative,negative,positive,none,Immune therapy,Sp4.2,breast cancer,27,27,"",,0,,,,,FALSE,i-,sn,"",2006,BaselTMA_SP42_32.435kx20.41ky_7000x7000_11_20179015_63_71_X8Y8_355_a0_full.tiff,687,844,579828,212757,PR-ER-,negative,HR-HER2+,""
164,BaselTMA_SP42_164_X9Y8,3,15,FEMALE,0,71,alive,,1c,1. Primary Dx,0,Sp4.2,X9Y8,9,8,tumor,Sp4.2,71,,,,,2008,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,negative,negative,positive,none,Chemotherapy - Immune therapy,Sp4.2,breast cancer,33,33,"",,0,,,,,TRUE,i-,sn,"",1764,BaselTMA_SP42_25.78kx19.535ky_7000x7000_12_20179015_71_164_X9Y8_86_a0_full.tiff,781,876,684156,199967,PR-ER-,negative,HR-HER2+,""
262,BaselTMA_SP42_262_X10Y8,3,16,FEMALE,0,60,alive,,1c,1. Primary Dx,0,Sp4.2,X10Y8,10,8,tumor,Sp4.2,79,,,,,2008,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,positive,positive,positive,none,Chemotherapy - Immune therapy - Anastrozol,Sp4.2,breast cancer,57,57,"",1,0,,,,,FALSE,"",sn,"",228,BaselTMA_SP42_25.78kx19.535ky_7000x7000_12_20179015_79_262_X10Y8_184_a0_full.tiff,755,689,520195,23491,PR+ER+,positive,HR+HER2+,""
121,BaselTMA_SP42_121_X11Y8,3,75,FEMALE,0,42,alive,,3,1. Primary Dx,3a,Sp4.2,X11Y8,11,8,tumor,Sp4.2,87,,,,,2008,breast,"invasive ductal breast carcinoma-In situ ductal breast carcinoma, in situ lobular breast carcinoma",0,0,0,negative,negative,positive,none,Chemotherapy - Immune therapy,Sp4.2,breast cancer,63,63,"",,0,,,,,FALSE,"","","",2390,BaselTMA_SP42_25.78kx19.535ky_7000x7000_12_20179015_87_121_X11Y8_281_a0_full.tiff,664,924,613536,221334,PR-ER-,negative,HR-HER2+,""
12,BaselTMA_SP42_12_X12Y8,3,18,FEMALE,0,50,alive,,1c,1. Primary Dx,1,Sp4.2,X12Y8,12,8,tumor,Sp4.2,95,,,,,2008,breast,"invasive ductal breast carcinoma-In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,0,negative,negative,positive,none,Chemotherapy - Immune therapy,Sp4.2,breast cancer,59,59,"",,0,,,,,FALSE,i+,"","",983,BaselTMA_SP42_25.78kx19.535ky_7000x7000_12_20179015_95_12_X12Y8_358_a0_full.tiff,448,645,288960,94866,PR-ER-,negative,HR-HER2+,""
179,BaselTMA_SP42_179_X13Y8,3,36,FEMALE,0,59,alive,,2,1. Primary Dx,0,Sp4.2,X13Y8,13,8,tumor,Sp4.2,103,,,,,2008,breast,invasive ductal breast carcinoma-,0,0,0,negative,negative,negative,none,Chemotherapy,Sp4.2,breast cancer,54,54,"",,1,,,,,FALSE,i-,sn,"",5199,BaselTMA_SP42_19.78kx19.035ky_6500x7000_13_20179015_103_179_X13Y8_114_a0_full.tiff,747,818,611046,512136,PR-ER-,negative,TripleNeg,""
167,BaselTMA_SP42_167_X14Y8,3,50,FEMALE,0,82,alive,,2,1. Primary Dx,0,Sp4.2,X14Y8,14,8,tumor,Sp4.2,111,,,,,2008,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,negative,negative,negative,none,none,Sp4.2,breast cancer,36,36,"",,1,,,,,FALSE,"",sn,"",377,BaselTMA_SP42_19.78kx19.035ky_6500x7000_13_20179015_111_167_X14Y8_211_a0_full.tiff,692,800,553600,19565,PR-ER-,negative,TripleNeg,""
163,BaselTMA_SP42_163_X1Y9,3,36,FEMALE,0,42,alive,,2a,1. Primary Dx,1a,Sp4.2,X1Y9,1,9,tumor,Sp4.2,1,,,,,2008,breast,invasive ductal breast carcinoma-In situ ductal breast carcinoma,0,0,0,negative,negative,negative,none,Chemotherapy,Sp4.2,breast cancer,58,58,"",,1,,,,,FALSE,"","","",2741,BaselTMA_SP42_39.025kx22410ky_7000x8500_8_20179015_1_163_X1Y9_104_a0_full.tiff,769,831,639039,240298,PR-ER-,negative,TripleNeg,""
82,BaselTMA_SP42_82_X2Y9,3,22,FEMALE,0,41,alive,,2,1. Primary Dx,1a,Sp4.2,X2Y9,2,9,tumor,Sp4.2,10,,,,,2008,breast,invasive ductal breast carcinoma-,0,1,1,negative,negative,positive,none,Chemotherapy - Immune therapy,Sp4.2,breast cancer,58,58,"",,0,,,,,FALSE,"","","",5032,BaselTMA_SP42_39.025kx22410ky_7000x8500_8_20179015_10_82_X2Y9_226_a0_full.tiff,840,868,729120,425522,PR-ER-,negative,HR-HER2+,""
59,BaselTMA_SP42_59_X3Y9,3,41,FEMALE,0,28,alive,,2,1. Primary Dx,0,Sp4.2,X3Y9,3,9,tumor,Sp4.2,19,,,,,2008,breast,invasive ductal breast carcinoma-Lymphangiosis carcinomatosa,0,0,0,negative,negative,negative,none,Chemotherapy,Sp4.2,breast cancer,53,53,"",,1,,,,,FALSE,i-,sn,"",4513,BaselTMA_SP42_39.025kx22410ky_7000x8500_8_20179015_19_59_X3Y9_340_a0_full.tiff,856,782,669392,457114,PR-ER-,negative,TripleNeg,""
155,BaselTMA_SP42_155_X4Y9,3,28,FEMALE,0,66,alive,,2,1. Primary Dx,3b,Sp4.2,X4Y9,4,9,tumor,Sp4.2,28,,,,,2008,breast,invasive ductal breast carcinoma-Lymphangiosis carcinomatosa,0,1,0,negative,negative,negative,none,Chemotherapy,Sp4.2,breast cancer,25,25,"",,1,,,,,FALSE,"","","",4590,BaselTMA_SP42_39.025kx22410ky_7000x8500_8_20179015_28_155_X4Y9_370_a0_full.tiff,773,854,660142,383675,PR-ER-,negative,TripleNeg,""
162,BaselTMA_SP42_162_X16Y7,3,28,FEMALE,0,38,alive,,2,1. Primary Dx,1,Sp4.2,X16Y7,16,7,tumor,Sp4.2,126,,,,,1992,breast,invasive ductal breast carcinoma-,0,0,0,positive,positive,positive,none,Tamoxifen,Sp4.2,breast cancer,141,141,"",1,0,1,,,,FALSE,"","","",3164,BaselTMA_SP42_19.78kx19.035ky_6500x7000_13_20179015_126_162_X16Y7_331_a0_full.tiff,631,811,511741,275674,PR+ER+,positive,HR+HER2+,Sensitive
87,BaselTMA_SP43_87_X15Y4,3,45,FEMALE,0,81,death by primary disease,,2,3. Primary Dx,2,Sp4.3,x15y4,15,4,tumor,Sp4.3,61,90,0,10,0,1997,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",1,1,0,negative,negative,positive,none,none,Sp4.3,breast cancer,11,13,"",,0,,,,,FALSE,"","","",1953,BaselTMA_SP43_10.3kx13.7ky_6500x8000_6_20170928_61_87_X15Y4_259_a0_full.tiff,795,772,613740,253685,PR-ER-,negative,HR-HER2+,""
142,BaselTMA_SP43_142_X5Y1,3,60,FEMALE,0,85,death,,4b,4. Primary Dx,x,Sp4.3,x5y1,5,1,tumor,Sp4.3,3,75,0,20,5,2005,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,0,positive,negative,positive,none,Anastrazol,Sp4.3,breast cancer,12,29,"",1,0,,1,,,FALSE,"","","",2570,BaselTMA_SP43_22.8kx15ky_7000x8000_4_20170928_3_142_X5Y1_6_a0_full.tiff,715,759,542685,275663,PR-ER+,positive,HR+HER2+,Refractory
142,BaselTMA_SP43_142_X6Y1,3,60,FEMALE,0,85,death,,4b,4. Primary Dx,x,Sp4.3,x6y1,6,1,non-tumor,Sp4.3,4,0,5,95,0,2005,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,0,positive,negative,positive,none,Anastrazol,Sp4.3,breast cancer,12,29,"",1,0,,1,,,FALSE,"","","",493,BaselTMA_SP43_22.8kx15ky_7000x8000_4_20170928_4_142_X6Y1_93_a0_full.tiff,767,732,561444,55705,PR-ER+,positive,HR+HER2+,Refractory
1,BaselTMA_SP43_1_X1Y8,2,35,FEMALE,1,83,death by primary disease,,2,5. Primary Dx,3,Sp4.3,x1y8,1,8,tumor,Sp4.3,111,85,0,15,0,2007,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,,,positive,positive,negative,none,Hormone therapy,Sp4.3,breast cancer,0,33,"",1,0,,1,,,FALSE,"","","",3010,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_111_1_X1Y8_45_a0_full.tiff,642,866,555972,308787,PR+ER+,positive,HR+HER2-,Refractory
128,BaselTMA_SP43_128_X16Y7,2,70,FEMALE,1,71,death by primary disease,,4b,6. Primary Dx,1,Sp4.3,x16y7,16,7,tumor,Sp4.3,110,80,0,10,10,2007,breast,invasive ductal breast carcinoma - Lymphangiosis carcinomatosa,1,1,,positive,positive,negative,none,Letrozol,Sp4.3,breast cancer,0,44,"",1,0,,1,,,FALSE,"","","",5106,BaselTMA_SP43_9.9kx19.3ky_6000x5500_11_20170928_110_128_X16Y7_331_a0_full.tiff,793,809,641537,472554,PR+ER+,positive,HR+HER2-,Refractory
17,BaselTMA_SP43_17_X11Y4,2,30,FEMALE,0,77,alive,,2,7. Primary Dx,1,Sp4.3,x11y4,11,4,tumor,Sp4.3,57,85,0,15,0,2007,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,,positive,negative,negative,none,Chemotherapy - Anastrazol,Sp4.3,breast cancer,71,71,"",1,0,,,,,FALSE,"","","",4063,BaselTMA_SP43_16.3kx14.5ky_7000x8000_5_20170928_57_17_X11Y4_256_a0_full.tiff,798,780,622440,436171,PR-ER+,positive,HR+HER2-,""
17,BaselTMA_SP43_17_X12Y4,2,30,FEMALE,0,77,alive,,2,7. Primary Dx,1,Sp4.3,x12y4,12,4,non-tumor,Sp4.3,58,0,40,60,0,2007,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,,positive,negative,negative,none,Chemotherapy - Anastrazol,Sp4.3,breast cancer,71,71,"",1,0,,,,,FALSE,"","","",537,BaselTMA_SP43_16.3kx14.5ky_7000x8000_5_20170928_58_17_X12Y4_358_a0_full.tiff,700,836,585200,53238,PR-ER+,positive,HR+HER2-,""
102,BaselTMA_SP43_102_X1Y4,3,21,FEMALE,0,59,death by primary disease,,2,8. Primary Dx,0,Sp4.3,x1y4,1,4,tumor,Sp4.3,47,90,0,10,0,2007,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Chemotherapy - Tamoxifen,Sp4.3,breast cancer,15,38,"",1,0,,1,,,FALSE,"","","",5165,BaselTMA_SP43_29.3kx15.5ky_7000x8000_3_20170928_47_102_X1Y4_51_a0_full.tiff,770,800,616000,431294,PR+ER+,positive,HR+HER2-,Refractory
102,BaselTMA_SP43_102_X2Y4,3,21,FEMALE,0,59,death by primary disease,,2,8. Primary Dx,0,Sp4.3,x2y4,2,4,non-tumor,Sp4.3,48,0,20,80,0,2007,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Chemotherapy - Tamoxifen,Sp4.3,breast cancer,15,38,"",1,0,,1,,,FALSE,"","","",476,BaselTMA_SP43_29.3kx15.5ky_7000x8000_3_20170928_48_102_X2Y4_147_a0_full.tiff,669,893,597417,58170,PR+ER+,positive,HR+HER2-,Refractory
173,BaselTMA_SP43_173_X2Y8,2,11,FEMALE,0,73,alive,,1,9. Primary Dx,1,Sp4.3,x2y8,2,8,tumor,Sp4.3,112,95,0,5,0,2007,breast,invasive ductal breast carcinoma - Lymphangiosis carcinomatosa,0,1,1,positive,positive,negative,none,Anastrazol,Sp4.3,breast cancer,53,53,"",1,0,,,,,FALSE,"","","",5809,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_112_173_X2Y8_123_a0_full.tiff,816,750,612000,503304,PR+ER+,positive,HR+HER2-,""
79,BaselTMA_SP43_79_X7Y4,2,17,FEMALE,0,35,alive,,1,10. Primary Dx,0,Sp4.3,x7y4,7,4,tumor,Sp4.3,53,70,0,30,0,2007,breast,invasive ductal breast carcinoma -,0,0,0,positive,negative,negative,none,Chemotherapy - Tamoxifen,Sp4.3,breast cancer,65,65,"",1,0,,,,,FALSE,"","","",3669,BaselTMA_SP43_22.8kx15ky_7000x8000_4_20170928_53_79_X7Y4_253_a0_full.tiff,784,812,636608,385288,PR-ER+,positive,HR+HER2-,""
79,BaselTMA_SP43_79_X8Y4,2,17,FEMALE,0,35,alive,,1,10. Primary Dx,0,Sp4.3,x8y4,8,4,non-tumor,Sp4.3,54,0,90,10,0,2007,breast,invasive ductal breast carcinoma -,0,0,0,positive,negative,negative,none,Chemotherapy - Tamoxifen,Sp4.3,breast cancer,65,65,"",1,0,,,,,FALSE,"","","",4085,BaselTMA_SP43_22.8kx15ky_7000x8000_4_20170928_54_79_X8Y4_355_a0_full.tiff,786,790,620940,438746,PR-ER+,positive,HR+HER2-,""
271,BaselTMA_SP43_271_X11Y8,3,27,FEMALE,0,70,alive,,2,11. Primary Dx,0,Sp4.3,x11y8,11,8,tumor,Sp4.3,121,80,0,20,0,2007,breast,"invasive ductal breast carcinoma - papillary breast carcinoma, In situ ductal breast carcinoma",0,,,positive,negative,negative,none,Chemotherapy - Tamoxifen,Sp4.3,breast cancer,71,71,"",1,0,,,,,FALSE,"","","",2368,BaselTMA_SP43_15.9kx19.3ky_10000x5500_10_20170928_121_271_X11Y8_328_a0_full.tiff,746,761,567706,268176,PR-ER+,positive,HR+HER2-,""
131,BaselTMA_SP43_131_X13Y4,1,18,FEMALE,0,68,alive,,1c,12. Primary Dx,0,Sp4.3,x13y4,13,4,tumor,Sp4.3,59,70,0,30,0,2007,breast,mixed ductal lobular breast carcinoma - In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,75,75,"",,0,1,,,,FALSE,"","","",1767,BaselTMA_SP43_10.3kx13.7ky_6500x8000_6_20170928_59_131_X13Y4_60_a0_full.tiff,808,857,692456,161176,PR+ER+,positive,HR+HER2-,Sensitive
143,BaselTMA_SP43_143_X1Y2,3,13,FEMALE,0,63,alive,,1c,13. Primary Dx,0,Sp4.3,x1y2,1,2,tumor,Sp4.3,15,70,0,15,15,2007,breast,mixed ductal lobular breast carcinoma - In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,70,70,"",,0,1,,,,FALSE,"","","",113,BaselTMA_SP43_29.3kx15.5ky_7000x8000_3_20170928_15_143_X1Y2_18_a0_full.tiff,748,787,588676,14935,PR+ER+,positive,HR+HER2-,Sensitive
143,BaselTMA_SP43_143_X2Y2,3,13,FEMALE,0,63,alive,,1c,13. Primary Dx,0,Sp4.3,x2y2,2,2,non-tumor,Sp4.3,16,0,50,50,0,2007,breast,mixed ductal lobular breast carcinoma - In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,70,70,"",,0,1,,,,FALSE,"","","",1062,BaselTMA_SP43_29.3kx15.5ky_7000x8000_3_20170928_16_143_X2Y2_111_a0_full.tiff,804,783,629532,77566,PR+ER+,positive,HR+HER2-,Sensitive
233,BaselTMA_SP43_233_X13Y7,1,14,FEMALE,0,69,alive,,1c,14. Primary Dx,1,Sp4.3,x13y7,13,7,tumor,Sp4.3,107,80,0,15,5,2007,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,1,,,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,61,61,"",,0,1,,,,FALSE,"","","",2229,BaselTMA_SP43_9.9kx19.3ky_6000x5500_11_20170928_107_233_X13Y7_108_a0_full.tiff,720,623,448560,229196,PR+ER+,positive,HR+HER2-,Sensitive
243,BaselTMA_SP43_243_X13Y3,1,19,FEMALE,0,40,alive,,1c,15. Primary Dx,0,Sp4.3,x13y3,13,3,tumor,Sp4.3,43,80,0,10,10,2008,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,58,58,"",1,0,1,,,,FALSE,"","","",2001,BaselTMA_SP43_10.3kx13.7ky_6500x8000_6_20170928_43_243_X13Y3_42_a0_full.tiff,825,632,521400,206575,PR+ER+,positive,HR+HER2-,Sensitive
243,BaselTMA_SP43_243_X14Y3,1,19,FEMALE,0,40,alive,,1c,15. Primary Dx,0,Sp4.3,x14y3,14,3,non-tumor,Sp4.3,44,0,50,50,0,2008,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,58,58,"",1,0,1,,,,FALSE,"","","",810,BaselTMA_SP43_10.3kx13.7ky_6500x8000_6_20170928_44_243_X14Y3_138_a0_full.tiff,744,755,561720,87372,PR+ER+,positive,HR+HER2-,Sensitive
278,BaselTMA_SP43_278_X3Y2,2,15,FEMALE,0,76,alive,,1c,16. Primary Dx,0,Sp4.3,x3y2,3,2,tumor,Sp4.3,17,80,0,20,0,2008,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,65,65,"",1,0,1,,,,FALSE,"","","",3435,BaselTMA_SP43_29.3kx15.5ky_7000x8000_3_20170928_17_278_X3Y2_207_a0_full.tiff,757,732,554124,364909,PR+ER+,positive,HR+HER2-,Sensitive
278,BaselTMA_SP43_278_X4Y2,2,15,FEMALE,0,76,alive,,1c,16. Primary Dx,0,Sp4.3,x4y2,4,2,non-tumor,Sp4.3,18,0,20,80,0,2008,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,65,65,"",1,0,1,,,,FALSE,"","","",1108,BaselTMA_SP43_29.3kx15.5ky_7000x8000_3_20170928_18_278_X4Y2_313_a0_full.tiff,729,976,711504,153093,PR+ER+,positive,HR+HER2-,Sensitive
132,BaselTMA_SP43_132_X13Y1,2,28,FEMALE,0,67,alive,,2,17. Primary Dx,0,Sp4.3,x13y1,13,1,tumor,Sp4.3,11,80,0,10,10,2008,breast,invasive ductal breast carcinoma -,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,68,68,"",1,0,1,,,,FALSE,"","","",4263,BaselTMA_SP43_10.3kx13.7ky_6500x8000_6_20170928_13_132_X13Y1_12_a0_full.tiff,744,761,566184,394629,PR+ER+,positive,HR+HER2-,Sensitive
132,BaselTMA_SP43_132_X14Y1,2,28,FEMALE,0,67,alive,,2,17. Primary Dx,0,Sp4.3,x14y1,14,1,non-tumor,Sp4.3,12,0,10,70,20,2008,breast,invasive ductal breast carcinoma -,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,68,68,"",1,0,1,,,,FALSE,"","","",898,BaselTMA_SP43_10.3kx13.7ky_6500x8000_6_20170928_12_132_X14Y1_99_a0_full.tiff,742,775,575050,90751,PR+ER+,positive,HR+HER2-,Sensitive
34,BaselTMA_SP43_34_X12Y5,3,25,FEMALE,0,75,alive,,4b,18. Primary Dx,2,Sp4.3,x12y5,12,5,tumor,Sp4.3,74,75,0,20,5,2005,breast,invasive ductal breast carcinoma - Lymphangiosis carcinomatosa,0,1,0,positive,positive,negative,none,Anastrazol,Sp4.3,breast cancer,96,96,"",1,0,1,,,,FALSE,"","","",2552,BaselTMA_SP43_16.3kx14.5ky_7000x8000_5_20170928_74_34_X12Y5_376_a0_full.tiff,737,748,551276,267683,PR+ER+,positive,HR+HER2-,Sensitive
144,BaselTMA_SP43_144_X15Y1,2,12,FEMALE,0,50,alive,,1c,19. Primary Dx,0,Sp4.3,x15y1,15,1,tumor,Sp4.3,13,25,0,25,50,2008,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,61,61,"",1,0,1,,,,FALSE,"","","",6273,BaselTMA_SP43_10.3kx13.7ky_6500x8000_6_20170928_13_144_X15Y1_195_a0_full.tiff,883,856,755848,523890,PR+ER+,positive,HR+HER2-,Sensitive
144,BaselTMA_SP43_144_X16Y1,2,12,FEMALE,0,50,alive,,1c,19. Primary Dx,0,Sp4.3,x16y1,16,1,non-tumor,Sp4.3,14,0,50,40,10,2008,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,61,61,"",1,0,1,,,,FALSE,"","","",1727,BaselTMA_SP43_10.3kx13.7ky_6500x8000_6_20170928_14_144_X16Y1_301_a0_full.tiff,814,855,695970,158131,PR+ER+,positive,HR+HER2-,Sensitive
124,BaselTMA_SP43_124_X10Y8,2,13,FEMALE,0,67,alive,,1c,20. Primary Dx,0,Sp4.3,x10y8,10,8,tumor,Sp4.3,120,60,0,20,20,2008,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,,0,0,negative,negative,positive,none,Chemotherapy - Immune therapy,Sp4.3,breast cancer,57,57,"",,0,,,,,FALSE,"","","",281,BaselTMA_SP43_15.9kx19.3ky_10000x5500_10_20170928_120_124_X10Y8_265_a0_full.tiff,664,890,590960,30754,PR-ER-,negative,HR-HER2+,""
180,BaselTMA_SP43_180_X5Y2,2,17,FEMALE,0,39,alive,,1c,21. Primary Dx,0,Sp4.3,x5y2,5,2,tumor,Sp4.3,19,60,0,10,30,2008,breast,invasive ductal breast carcinoma - Lymphangiosis carcinomatosa,0,1,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,65,65,"",1,0,1,,,,FALSE,"","","",2872,BaselTMA_SP43_22.8kx15ky_7000x8000_4_20170928_19_180_X5Y2_21_a0_full.tiff,760,798,606480,262951,PR+ER+,positive,HR+HER2-,Sensitive
180,BaselTMA_SP43_180_X6Y2,2,17,FEMALE,0,39,alive,,1c,21. Primary Dx,0,Sp4.3,x6y2,6,2,non-tumor,Sp4.3,20,0,40,60,0,2008,breast,invasive ductal breast carcinoma - Lymphangiosis carcinomatosa,0,1,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,65,65,"",1,0,1,,,,FALSE,"","","",112,BaselTMA_SP43_22.8kx15ky_7000x8000_4_20170928_20_180_X6Y2_114_a0_full.tiff,721,757,545797,11416,PR+ER+,positive,HR+HER2-,Sensitive
222,BaselTMA_SP43_222_X7Y2,2,10,FEMALE,0,76,alive,,1b,22. Primary Dx,0,Sp4.3,x7y2,7,2,tumor,Sp4.3,21,90,0,10,0,2008,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Anastrazol,Sp4.3,breast cancer,58,58,"",1,0,1,,,,FALSE,"","","",3193,BaselTMA_SP43_22.8kx15ky_7000x8000_4_20170928_21_222_X7Y2_210_a0_full.tiff,789,723,570447,323245,PR+ER+,positive,HR+HER2-,Sensitive
222,BaselTMA_SP43_222_X8Y2,2,10,FEMALE,0,76,alive,,1b,22. Primary Dx,0,Sp4.3,x8y2,8,2,non-tumor,Sp4.3,22,0,50,50,0,2008,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Anastrazol,Sp4.3,breast cancer,58,58,"",1,0,1,,,,FALSE,"","","",118,BaselTMA_SP43_22.8kx15ky_7000x8000_4_20170928_22_222_X8Y2_316_a0_full.tiff,684,741,506844,9987,PR+ER+,positive,HR+HER2-,Sensitive
4,BaselTMA_SP43_4_X15Y3,1,11,FEMALE,0,49,alive,,1c,23. Primary Dx,0,Sp4.3,x15y3,15,3,tumor,Sp4.3,45,80,0,20,0,2008,breast,invasive ductal breast carcinoma -,1,0,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,63,63,"",,0,1,,,,FALSE,"","","",3150,BaselTMA_SP43_10.3kx13.7ky_6500x8000_6_20170928_45_4_X15Y3_238_a0_full.tiff,784,849,665616,285638,PR+ER+,positive,HR+HER2-,Sensitive
4,BaselTMA_SP43_4_X16Y3,1,11,FEMALE,0,49,alive,,1c,23. Primary Dx,0,Sp4.3,x16y3,16,3,non-tumor,Sp4.3,46,0,30,70,0,2008,breast,invasive ductal breast carcinoma -,1,0,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,63,63,"",,0,1,,,,FALSE,"","","",149,BaselTMA_SP43_10.3kx13.7ky_6500x8000_6_20170928_46_4_X16Y3_343_a0_full.tiff,727,824,599048,16964,PR+ER+,positive,HR+HER2-,Sensitive
260,BaselTMA_SP43_260_X10Y4,2,18,FEMALE,0,59,alive,,1c,24. Primary Dx,1,Sp4.3,x10y4,10,4,tumor,Sp4.3,55,80,0,20,0,2008,breast,"mixed ductal lobular breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",,1,0,positive,positive,negative,none,Chemotherapy - Anastrazol,Sp4.3,breast cancer,59,59,"",,0,,,,,FALSE,"","","",2906,BaselTMA_SP43_16.3kx14.5ky_7000x8000_5_20170928_55_260_X10Y4_153_a0_full.tiff,820,791,648620,341888,PR+ER+,positive,HR+HER2-,""
260,BaselTMA_SP43_260_X9Y4,2,18,FEMALE,0,59,alive,,1c,24. Primary Dx,1,Sp4.3,x9y4,9,4,non-tumor,Sp4.3,56,0,30,70,0,2008,breast,"mixed ductal lobular breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",,1,0,positive,positive,negative,none,Chemotherapy - Anastrazol,Sp4.3,breast cancer,59,59,"",,0,,,,,FALSE,"","","",2594,BaselTMA_SP43_16.3kx14.5ky_7000x8000_5_20170928_56_260_X9Y4_57_a0_full.tiff,706,791,558446,365729,PR+ER+,positive,HR+HER2-,""
118,BaselTMA_SP43_118_X13Y5,2,14,FEMALE,0,50,alive,,1c,25. Primary Dx,0,Sp4.3,x13y5,13,5,tumor,Sp4.3,75,50,0,10,40,2008,breast,invasive ductal breast carcinoma -,1,0,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,53,53,"",1,0,,,,,FALSE,"","","",3510,BaselTMA_SP43_10.3kx13.7ky_6500x8000_6_20170928_75_118_X13Y5_81_a0_full.tiff,805,801,644805,336591,PR+ER+,positive,HR+HER2-,""
119,BaselTMA_SP43_119_X9Y8,3,45,FEMALE,0,39,alive,,2,26. Primary Dx,3,Sp4.3,x9y8,9,8,tumor,Sp4.3,119,90,0,10,0,2008,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",,1,0,positive,positive,negative,none,Chemotherapy - Letrozol,Sp4.3,breast cancer,61,61,"",1,0,,,,,FALSE,"","","",1654,BaselTMA_SP43_15.9kx19.3ky_10000x5500_10_20170928_119_119_X9Y8_201_a0_full.tiff,803,701,562903,176903,PR+ER+,positive,HR+HER2-,""
248,BaselTMA_SP43_248_X8Y8,2,33,FEMALE,0,62,alive,,2,27. Primary Dx,1,Sp4.3,x8y8,8,8,tumor,Sp4.3,118,60,0,30,10,2008,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,0,positive,positive,negative,none,Chemotherapy - Letrozol,Sp4.3,breast cancer,56,56,"",1,0,,,,,FALSE,"","","",830,BaselTMA_SP43_15.9kx19.3ky_10000x5500_10_20170928_118_248_X8Y8_144_a0_full.tiff,725,821,595225,104178,PR+ER+,positive,HR+HER2-,""
201,BaselTMA_SP43_201_X14Y5,1,10,FEMALE,0,83,alive,,1b,28. Primary Dx,0,Sp4.3,x14y5,14,5,tumor,Sp4.3,76,70,0,15,15,2008,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,,0,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,54,54,"",1,0,,,,,FALSE,"","","",3076,BaselTMA_SP43_10.3kx13.7ky_6500x8000_6_20170928_76_201_X14Y5_174_a0_full.tiff,812,800,649600,318437,PR+ER+,positive,HR+HER2-,""
266,BaselTMA_SP43_266_X7Y8,2,25,FEMALE,0,48,alive,,2,29. Primary Dx,0,Sp4.3,x7y8,7,8,tumor,Sp4.3,117,75,0,25,0,2008,breast,invasive ductal breast carcinoma -,0,0,0,positive,positive,negative,none,Chemotherapy - Anastrazol,Sp4.3,breast cancer,59,59,"",1,0,,,,,FALSE,"","","",3999,BaselTMA_SP43_15.9kx19.3ky_10000x5500_10_20170928_117_266_X7Y8_87_a0_full.tiff,739,908,671012,367402,PR+ER+,positive,HR+HER2-,""
122,BaselTMA_SP43_122_X12Y8,3,35,FEMALE,0,49,alive,,2,30. Primary Dx,2,Sp4.3,x12y8,12,8,tumor,Sp4.3,122,70,0,20,10,2008,breast,"mixed ductal lobular breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",1,1,1,positive,positive,negative,none,Chemotherapy - Letrozol,Sp4.3,breast cancer,58,58,"",,0,,,,,FALSE,"","","",3465,BaselTMA_SP43_15.9kx19.3ky_10000x5500_10_20170928_122_122_X12Y8_385_a0_full.tiff,794,771,612174,390896,PR+ER+,positive,HR+HER2-,""
67,BaselTMA_SP43_67_X14Y7,3,32,FEMALE,0,67,alive,,2,31. Primary Dx,0,Sp4.3,x14y7,14,7,tumor,Sp4.3,108,80,0,20,0,2002,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",1,1,0,negative,negative,negative,none,Chemotherapy,Sp4.3,breast cancer,8,8,"CEA values more elevated by last consultation; liver metastases could not be clearly defined, possibly myom im Uteri",,1,,,,,FALSE,"","","",3356,BaselTMA_SP43_9.9kx19.3ky_6000x5500_11_20170928_108_67_X14Y7_226_a0_full.tiff,748,753,563244,358926,PR-ER-,negative,TripleNeg,""
49,BaselTMA_SP43_49_X1Y5,2,25,FEMALE,0,46,alive,,2,32. Primary Dx,1,Sp4.3,x1y5,1,5,tumor,Sp4.3,63,70,0,10,20,2004,breast,"mixed ductal lobular breast carcinoma - in situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,0,positive,positive,positive,none,Tamoxifen,Sp4.3,breast cancer,107,107,"",,0,1,,,,FALSE,"","","",4240,BaselTMA_SP43_29.3kx15.5ky_7000x8000_3_20170928_63_49_X1Y5_72_a0_full.tiff,748,782,584936,437955,PR+ER+,positive,HR+HER2+,Sensitive
244,BaselTMA_SP43_244_X3Y1,2,23,FEMALE,0,46,alive,,2,33. Primary Dx,0,Sp4.3,x3y1,3,1,tumor,Sp4.3,1,70,0,25,5,2004,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,0,positive,positive,positive,none,Chemotherapy,Sp4.3,breast cancer,110,110,"",1,0,,,,,FALSE,"","","",2997,BaselTMA_SP43_29.3kx15.5ky_7000x8000_3_20170928_1_244_X3Y1_186_a0_full.tiff,757,768,581376,330119,PR+ER+,positive,HR+HER2+,""
244,BaselTMA_SP43_244_X4Y1,2,23,FEMALE,0,46,alive,,2,33. Primary Dx,0,Sp4.3,x4y1,4,1,non-tumor,Sp4.3,2,0,40,60,0,2004,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,0,positive,positive,positive,none,Chemotherapy,Sp4.3,breast cancer,110,110,"",1,0,,,,,FALSE,"","","",113,BaselTMA_SP43_29.3kx15.5ky_7000x8000_3_20170928_2_244_X4Y1_292_a0_full.tiff,691,784,541744,13276,PR+ER+,positive,HR+HER2+,""
75,BaselTMA_SP43_75_X2Y5,1,8,FEMALE,0,57,alive,,1b,34. Primary Dx,x,Sp4.3,x2y5,2,5,tumor,Sp4.3,64,10,0,60,30,2004,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,1,,,positive,positive,positive,none,"",Sp4.3,breast cancer,35,35,"",1,0,,,,,FALSE,"","","",2777,BaselTMA_SP43_29.3kx15.5ky_7000x8000_3_20170928_64_75_X2Y5_165_a0_full.tiff,745,738,549810,301580,PR+ER+,positive,HR+HER2+,""
47,BaselTMA_SP43_47_X16Y4,3,22,FEMALE,0,48,alive,,2,35. Primary Dx,1,Sp4.3,x16y4,16,4,tumor,Sp4.3,62,75,0,25,0,2004,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",1,1,0,negative,negative,positive,none,"",Sp4.3,breast cancer,4,4,"",,0,,,,,FALSE,"","","",2683,BaselTMA_SP43_10.3kx13.7ky_6500x8000_6_20170928_62_47_X16Y4_361_a0_full.tiff,733,820,601060,283968,PR-ER-,negative,HR-HER2+,""
21,BaselTMA_SP43_21_X3Y5,3,15,FEMALE,0,56,alive,,1c,36. Primary Dx,0,Sp4.3,x3y5,3,5,tumor,Sp4.3,65,60,0,20,20,2005,breast,mixed ductal lobular breast carcinoma - In situ ductal breast carcinoma,0,0,0,negative,negative,negative,none,Chemotherapy - Tamoxifen,Sp4.3,breast cancer,90,90,"",,1,,,,,FALSE,"","","",1793,BaselTMA_SP43_29.3kx15.5ky_7000x8000_3_20170928_65_21_X3Y5_271_a0_full.tiff,632,500,316000,193118,PR-ER-,negative,TripleNeg,""
23,BaselTMA_SP43_23_X15Y7,3,22,FEMALE,0,84,alive,,2,37. Primary Dx,0,Sp4.3,x15y7,15,7,tumor,Sp4.3,109,70,0,20,10,2006,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,0,negative,negative,negative,none,"",Sp4.3,breast cancer,1,1,"",,1,,,,,FALSE,"","","",2612,BaselTMA_SP43_9.9kx19.3ky_6000x5500_11_20170928_109_23_X15Y7_289_a0_full.tiff,644,667,429548,325531,PR-ER-,negative,TripleNeg,""
272,BaselTMA_SP43_272_X11Y3,2,7,FEMALE,0,70,alive,,1b,38. Primary Dx,0,Sp4.3,x11y3,11,3,tumor,Sp4.3,41,70,0,30,0,2006,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,1,negative,negative,negative,neoadjuvant Chemo,"",Sp4.3,breast cancer,1,1,"",,1,,,,,FALSE,"","","",1826,BaselTMA_SP43_16.3kx14.5ky_7000x8000_5_20170928_41_272_X11Y3_235_a0_full.tiff,791,743,587713,200437,PR-ER-,negative,TripleNeg,""
272,BaselTMA_SP43_272_X12Y3,2,7,FEMALE,0,70,alive,,1b,38. Primary Dx,0,Sp4.3,x12y3,12,3,non-tumor,Sp4.3,42,0,20,80,0,2006,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,1,negative,negative,negative,neoadjuvant Chemo,"",Sp4.3,breast cancer,1,1,"",,1,,,,,FALSE,"","","",698,BaselTMA_SP43_16.3kx14.5ky_7000x8000_5_20170928_42_272_X12Y3_340_a0_full.tiff,790,677,534830,69596,PR-ER-,negative,TripleNeg,""
137,BaselTMA_SP43_137_X10Y3,3,100,FEMALE,0,59,alive,,3,39. Primary Dx,0,Sp4.3,x10y3,10,3,tumor,Sp4.3,39,80,0,20,0,2007,breast,invasive ductal breast carcinoma - Lymphangiosis carcinomatosa,0,1,1,negative,negative,negative,none,"",Sp4.3,breast cancer,1,1,"",,1,,,,,FALSE,"","","",290,BaselTMA_SP43_16.3kx14.5ky_7000x8000_5_20170928_39_137_X10Y3_135_a0_full.tiff,779,734,571786,35234,PR-ER-,negative,TripleNeg,""
137,BaselTMA_SP43_137_X9Y3,3,100,FEMALE,0,59,alive,,3,39. Primary Dx,0,Sp4.3,x9y3,9,3,non-tumor,Sp4.3,40,0,50,50,0,2007,breast,invasive ductal breast carcinoma - Lymphangiosis carcinomatosa,0,1,1,negative,negative,negative,none,"",Sp4.3,breast cancer,1,1,"",,1,,,,,FALSE,"","","",4382,BaselTMA_SP43_16.3kx14.5ky_7000x8000_5_20170928_40_137_X9Y3_39_a0_full.tiff,678,816,553248,371634,PR-ER-,negative,TripleNeg,""
200,BaselTMA_SP43_200_X9Y6,3,19,FEMALE,0,54,alive,,1,40. Primary Dx,0,Sp4.3,x9y6,9,6,tumor,Sp4.3,87,85,0,15,0,1995,breast,invasive ductal breast carcinoma -,0,,,positive,positive,negative,none,"",Sp4.3,breast cancer,147,149,"",1,0,,,,,FALSE,"","","",2334,BaselTMA_SP43_15.9kx19.3ky_10000x5500_10_20170928_87_200_X9Y6_162_a0_full.tiff,815,680,554200,301781,PR+ER+,positive,HR+HER2-,""
111,BaselTMA_SP43_111_X8Y6,3,18,FEMALE,0,61,alive,,1c,41. Primary Dx,2,Sp4.3,x8y6,8,6,tumor,Sp4.3,86,50,0,25,25,2008,breast,invasive ductal breast carcinoma -,0,0,0,negative,negative,negative,none,"",Sp4.3,breast cancer,0,0,"",,1,,,,,FALSE,"","","",5066,BaselTMA_SP43_15.9kx19.3ky_10000x5500_10_20170928_86_111_X8Y6_105_a0_full.tiff,735,814,598290,395524,PR-ER-,negative,TripleNeg,""
90,BaselTMA_SP43_90_X7Y6,3,17,FEMALE,0,70,alive,,1c,42. Primary Dx,1,Sp4.3,x7y6,7,6,tumor,Sp4.3,85,40,0,40,20,2008,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",1,1,0,negative,negative,negative,none,"",Sp4.3,breast cancer,1,1,"",,1,,,,,FALSE,"","","",3197,BaselTMA_SP43_15.9kx19.3ky_10000x5500_10_20170928_85_90_X7Y6_48_a0_full.tiff,744,770,572880,274303,PR-ER-,negative,TripleNeg,""
147,BaselTMA_SP43_147_X6Y6,3,34,FEMALE,0,79,alive,,4b,43. Primary Dx,1,Sp4.3,x6y6,6,6,tumor,Sp4.3,84,60,0,30,10,2008,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,1,negative,negative,negative,none,"",Sp4.3,breast cancer,1,1,"",,1,,,,,FALSE,"","","",329,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_84_147_X6Y6_364_a0_full.tiff,657,844,554508,36970,PR-ER-,negative,TripleNeg,""
172,BaselTMA_SP43_172_X10Y2,3,20,FEMALE,0,75,alive,,1c,44. Primary Dx,2,Sp4.3,x10y2,10,2,non-tumor,Sp4.3,24,0,60,30,10,2008,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,0,negative,negative,negative,none,"",Sp4.3,breast cancer,1,1,"",,1,,,,,FALSE,"","","",213,BaselTMA_SP43_16.3kx14.5ky_7000x8000_5_20170928_24_172_X10Y2_117_a0_full.tiff,737,730,538010,24798,PR-ER-,negative,TripleNeg,""
172,BaselTMA_SP43_172_X9Y2,3,20,FEMALE,0,75,alive,,1c,44. Primary Dx,2,Sp4.3,x9y2,9,2,tumor,Sp4.3,23,80,0,15,5,2008,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,0,negative,negative,negative,none,"",Sp4.3,breast cancer,1,1,"",,1,,,,,FALSE,"","","",3059,BaselTMA_SP43_16.3kx14.5ky_7000x8000_5_20170928_23_172_X9Y2_24_a0_full.tiff,745,756,563220,348658,PR-ER-,negative,TripleNeg,""
242,BaselTMA_SP43_242_X5Y6,2,24,FEMALE,0,59,alive w metastases,,2,45. Primary Dx,0,Sp4.3,x5y6,5,6,tumor,Sp4.3,83,85,0,10,5,2001,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,1,positive,positive,negative,none,Chemotherapy - Hormone therapy,Sp4.3,breast cancer,73,88,"",1,0,,,1,,FALSE,"","","",3116,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_83_242_X5Y6_304_a0_full.tiff,698,824,575152,361890,PR+ER+,positive,HR+HER2-,Resistant
32,BaselTMA_SP43_32_X4Y6,2,19,FEMALE,0,73,alive,,1c,46. Primary Dx,1,Sp4.3,x4y6,4,6,tumor,Sp4.3,82,90,0,5,5,2001,breast,invasive ductal breast carcinoma - Lymphangiosis carcinomatosa,0,1,,positive,negative,negative,none,Hormone therapy,Sp4.3,breast cancer,41,75,"",1,0,,,1,,FALSE,"","","",3923,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_82_32_X4Y6_219_a0_full.tiff,737,754,555698,368216,PR-ER+,positive,HR+HER2-,Resistant
205,BaselTMA_SP43_205_X3Y6,2,40,FEMALE,0,83,alive w metastases,,2,47. Primary Dx,0,Sp4.3,x3y6,3,6,tumor,Sp4.3,81,80,0,15,5,2001,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",1,1,,positive,negative,negative,none,Hormone therapy,Sp4.3,breast cancer,34,38,"",1,0,,1,,,FALSE,"","","",2407,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_81_205_X3Y6_159_a0_full.tiff,742,754,559468,243662,PR-ER+,positive,HR+HER2-,Refractory
246,BaselTMA_SP43_246_X2Y6,1,55,FEMALE,0,50,alive w metastases,,4,48. Primary Dx,1,Sp4.3,x2y6,2,6,tumor,Sp4.3,80,70,0,30,0,2000,breast,invasive mucinous breast carcinoma -,0,,,positive,positive,negative,none,Chemotherapy - Hormone therapy,Sp4.3,breast cancer,47,74,"",,0,,,1,,FALSE,"","","",1779,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_80_246_X2Y6_84_a0_full.tiff,814,1032,840048,143952,PR+ER+,positive,HR+HER2-,Resistant
207,BaselTMA_SP43_207_X1Y6,2,15,FEMALE,0,32,alive w metastases,,1,49. Primary Dx,1,Sp4.3,x1y6,1,6,tumor,Sp4.3,79,80,0,15,5,2000,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,,,positive,positive,negative,none,Chemotherapy - Hormone therapy,Sp4.3,breast cancer,77,77,"",,0,,,1,,FALSE,"","","",3225,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_79_207_X1Y6_15_a0_full.tiff,770,785,604450,325836,PR+ER+,positive,HR+HER2-,Resistant
26,BaselTMA_SP43_26_X16Y5,2,25,FEMALE,0,58,alive,,2,50. Primary Dx,x,Sp4.3,x16y5,16,5,tumor,Sp4.3,78,70,0,20,10,1998,breast,"mixed ductal lobular breast carcinoma - In situ ductal breast carcinoma, in situ lobular breast carcinoma",1,0,,positive,positive,positive,none,Hormone therapy,Sp4.3,breast cancer,33,182,"",,0,,1,,,FALSE,"","","",1664,BaselTMA_SP43_10.3kx13.7ky_6500x8000_6_20170928_78_26_X16Y5_379_a0_full.tiff,793,780,618540,190371,PR+ER+,positive,HR+HER2+,Refractory
93,BaselTMA_SP43_93_X15Y5,3,50,FEMALE,0,80,death,,2,51. Primary Dx,2,Sp4.3,x15y5,15,5,tumor,Sp4.3,77,70,0,10,20,1997,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,,positive,"",negative,none,Hormone therapy,Sp4.3,breast cancer,11,12,"",1,0,,1,,,FALSE,"","","",5287,BaselTMA_SP43_10.3kx13.7ky_6500x8000_6_20170928_77_93_X15Y5_280_a0_full.tiff,737,808,595496,455160,"","","",Refractory
97,BaselTMA_SP43_97_X16Y6,3,15,FEMALE,0,81,alive w metastases,,1,52. Primary Dx,0,Sp4.3,x16y6,16,6,tumor,Sp4.3,94,85,0,15,0,1996,breast,invasive ductal breast carcinoma -,0,0,0,positive,positive,negative,none,Hormone therapy,Sp4.3,breast cancer,15,107,"",1,0,,1,,,FALSE,"","","",3653,BaselTMA_SP43_9.9kx19.3ky_6000x5500_11_20170928_94_97_X16Y6_310_a0_full.tiff,767,828,635076,411353,PR+ER+,positive,HR+HER2-,Refractory
66,BaselTMA_SP43_66_X15Y6,2,25,FEMALE,0,70,death by primary disease,,2,53. Primary Dx,2,Sp4.3,x15y6,15,6,tumor,Sp4.3,93,80,0,10,10,1996,breast,mixed ductal lobular breast carcinoma - Lymphangiosis carcinomatosa,0,1,1,positive,negative,negative,none,Hormone therapy,Sp4.3,breast cancer,14,32,"",,0,,1,,,FALSE,"","","",1763,BaselTMA_SP43_9.9kx19.3ky_6000x5500_11_20170928_93_66_X15Y6_268_a0_full.tiff,722,768,554496,147913,PR-ER+,positive,HR+HER2-,Refractory
65,BaselTMA_SP43_65_X14Y6,3,18,FEMALE,0,52,alive w metastases,,1,54. Primary Dx,0,Sp4.3,x14y6,14,6,tumor,Sp4.3,92,90,0,10,0,1996,breast,invasive ductal breast carcinoma -,0,,,positive,positive,negative,none,Hormone therapy,Sp4.3,breast cancer,130,130,"",1,0,,,1,,FALSE,"","","",109,BaselTMA_SP43_9.9kx19.3ky_6000x5500_11_20170928_92_65_X14Y6_204_a0_full.tiff,786,761,598146,8834,PR+ER+,positive,HR+HER2-,Resistant
3,BaselTMA_SP43_3_X13Y6,3,75,FEMALE,0,63,death by primary disease,,3,55. Primary Dx,0,Sp4.3,x13y6,13,6,tumor,Sp4.3,91,75,0,20,5,1996,breast,invasive lobular breast carcinoma - Lymphangiosis carcinomatosa,1,1,,positive,positive,negative,none,Chemotherapy - Hormone therapy,Sp4.3,breast cancer,23,23,"",,0,,1,,,FALSE,"","","",1614,BaselTMA_SP43_9.9kx19.3ky_6000x5500_11_20170928_91_3_X13Y6_69_a0_full.tiff,699,731,510969,158931,PR+ER+,positive,HR+HER2-,Refractory
235,BaselTMA_SP43_235_X11Y2,2,20,FEMALE,0,41,death by primary disease,,2,56. Primary Dx,1,Sp4.3,x11y2,11,2,tumor,Sp4.3,25,60,0,30,10,1996,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",1,1,,negative,positive,negative,none,Chemotherapy - Hormone therapy,Sp4.3,breast cancer,33,191,"",,0,,1,,,FALSE,"","","",3519,BaselTMA_SP43_16.3kx14.5ky_7000x8000_5_20170928_25_235_X11Y2_213_a0_full.tiff,811,725,587975,356310,PR+ER-,positive,HR+HER2-,Refractory
235,BaselTMA_SP43_235_X12Y2,2,20,FEMALE,0,41,death by primary disease,,2,56. Primary Dx,1,Sp4.3,x12y2,12,2,non-tumor,Sp4.3,26,0,80,20,0,1996,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",1,1,,negative,positive,negative,none,Chemotherapy - Hormone therapy,Sp4.3,breast cancer,33,191,"",,0,,1,,,FALSE,"","","",2053,BaselTMA_SP43_16.3kx14.5ky_7000x8000_5_20170928_26_235_X12Y2_319_a0_full.tiff,723,654,472842,186073,PR+ER-,positive,HR+HER2-,Refractory
22,BaselTMA_SP43_22_X12Y6,2,25,FEMALE,0,79,death by primary disease,,1,57. Primary Dx,1,Sp4.3,x12y6,12,6,tumor,Sp4.3,90,70,0,20,10,1996,breast,invasive ductal breast carcinoma -,0,,,positive,"",negative,none,Hormone therapy,Sp4.3,breast cancer,23,33,"",,0,,1,,,FALSE,"","","",3311,BaselTMA_SP43_15.9kx19.3ky_10000x5500_10_20170928_90_22_X12Y6_349_a0_full.tiff,770,754,580580,404877,"","","",Refractory
140,BaselTMA_SP43_140_X10Y7,2,40,FEMALE,0,65,alive w metastases,,2,61. Primary Dx,0,Sp4.3,x10y7,10,7,tumor,Sp4.3,104,60,0,30,10,1997,breast,invasive lobular breast carcinoma -,0,,,positive,negative,positive,none,Hormone therapy,Sp4.3,breast cancer,49,88,"",,0,,,1,,FALSE,"","","",1865,BaselTMA_SP43_15.9kx19.3ky_10000x5500_10_20170928_104_140_X10Y7_244_a0_full.tiff,708,702,497016,227780,PR-ER+,positive,HR+HER2+,Resistant
195,BaselTMA_SP43_195_X11Y6,3,24,FEMALE,0,47,death by primary disease,,2,58. Primary Dx,x,Sp4.3,x11y6,11,6,tumor,Sp4.3,89,50,0,20,30,1996,breast,invasive ductal breast carcinoma -,0,0,0,positive,"",negative,none,Hormone therapy,Sp4.3,breast cancer,12,56,"",,0,,1,,,FALSE,"","","",2369,BaselTMA_SP43_15.9kx19.3ky_10000x5500_10_20170928_89_195_X11Y6_286_a0_full.tiff,771,730,562830,250820,"","","",Refractory
149,BaselTMA_SP43_149_X10Y6_222,3,24,FEMALE,0,63,death by primary disease,,2,59. Primary Dx,0,Sp4.3,x10y6,10,6,tumor,Sp4.3,88,70,0,30,0,1995,breast,mixed ductal lobular breast carcinoma -,1,0,0,positive,positive,negative,none,Hormone therapy,Sp4.3,breast cancer,24,38,"",,0,,1,,,FALSE,"","","",553,BaselTMA_SP43_15.9kx19.3ky_10000x5500_10_20170928_88_149_X10Y6_222_a0_full.tiff,546,303,165438,50491,PR+ER+,positive,HR+HER2-,Refractory
149,BaselTMA_SP43_149_X10Y6_223,3,24,FEMALE,0,63,death by primary disease,,2,59. Primary Dx,0,Sp4.3,x10y6,10,6,tumor,Sp4.3,88,70,0,30,0,1995,breast,mixed ductal lobular breast carcinoma -,1,0,0,positive,positive,negative,none,Hormone therapy,Sp4.3,breast cancer,24,38,"",,0,,1,,,FALSE,"","","",484,BaselTMA_SP43_15.9kx19.3ky_10000x5500_10_20170928_88_149_X10Y6_223_a0_full.tiff,292,438,127896,43500,PR+ER+,positive,HR+HER2-,Refractory
194,BaselTMA_SP43_194_X11Y7,2,19,FEMALE,0,73,alive,,1c,60. Primary Dx,1,Sp4.3,x11y7,11,7,tumor,Sp4.3,105,80,0,20,0,2004,breast,invasive lobular breast carcinoma -,1,,,positive,positive,negative,none,Tamoxifen - Femara,Sp4.3,breast cancer,36,105,"",,0,,,1,,FALSE,"","","",953,BaselTMA_SP43_15.9kx19.3ky_10000x5500_10_20170928_105_194_X11Y7_307_a0_full.tiff,728,703,511784,100027,PR+ER+,positive,HR+HER2-,Resistant
252,BaselTMA_SP43_252_X6Y7,1,20,FEMALE,0,56,alive w metastases,,1,62. Primary Dx,1,Sp4.3,x6y7,6,7,tumor,Sp4.3,100,80,0,10,10,1995,breast,invasive lobular breast carcinoma - invasive tubular breast carcinoma,0,0,0,positive,positive,negative,none,Hormone therapy,Sp4.3,breast cancer,33,123,"",,0,,1,,,FALSE,"","","",2713,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_100_252_X6Y7_382_a0_full.tiff,758,746,565468,250170,PR+ER+,positive,HR+HER2-,Refractory
125,BaselTMA_SP43_125_X5Y7,3,13,FEMALE,0,79,death by primary disease,,1c,63. Primary Dx,0,Sp4.3,x5y7,5,7,tumor,Sp4.3,99,75,0,25,0,1995,breast,invasive lobular breast carcinoma - In situ lobular breast carcinoma,1,,,positive,positive,negative,none,Hormone therapy,Sp4.3,breast cancer,15,17,"",,0,,1,,,FALSE,"","","",1967,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_99_125_X5Y7_325_a0_full.tiff,834,758,632172,211645,PR+ER+,positive,HR+HER2-,Refractory
107,BaselTMA_SP43_107_X4Y7,3,21,FEMALE,0,85,alive,,2,64. Primary Dx,0,Sp4.3,x4y7,4,7,tumor,Sp4.3,98,75,0,25,0,1995,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,,,negative,negative,negative,none,Hormone therapy,Sp4.3,breast cancer,23,44,"",,1,,,,,FALSE,"","","",2839,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_98_107_X4Y7_241_a0_full.tiff,783,767,600561,366744,PR-ER-,negative,TripleNeg,""
193,BaselTMA_SP43_193_X9Y7,2,30,FEMALE,0,59,alive w metastases,,2,66. Primary Dx,2,Sp4.3,x9y7,9,7,tumor,Sp4.3,103,80,0,15,5,2010,breast,invasive lobular breast carcinoma -,0,,,positive,positive,negative,none,Chemotherapy - Hormone therapy,Sp4.3,breast cancer,22,33,"",,0,,1,,,FALSE,"","","",3661,BaselTMA_SP43_15.9kx19.3ky_10000x5500_10_20170928_103_193_X9Y7_180_a0_full.tiff,778,756,588168,388471,PR+ER+,positive,HR+HER2-,Refractory
213,BaselTMA_SP43_213_X7Y7,3,17,FEMALE,0,60,alive,,1c,67. Primary Dx,3,Sp4.3,x7y7,7,7,tumor,Sp4.3,101,50,0,20,30,2004,breast,"invasive ductal breast carcinoma - in situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,,positive,negative,positive,none,Chemotherapy,Sp4.3,breast cancer,41,41,"",,0,,,,,FALSE,"","","",1678,BaselTMA_SP43_15.9kx19.3ky_10000x5500_10_20170928_101_213_X7Y7_66_a0_full.tiff,690,774,534060,193294,PR-ER+,positive,HR+HER2+,""
281,BaselTMA_SP43_281_X8Y7,3,21,FEMALE,0,78,death by primary disease,,2,68. Primary Dx,0,Sp4.3,x8y7,8,7,tumor,Sp4.3,102,75,0,15,10,2008,breast,mixed ductal lobular breast carcinoma - In situ ductal breast carcinoma,0,,,positive,positive,negative,none,Anastrazol,Sp4.3,breast cancer,23,41,"",,0,,1,,,FALSE,"","","",2226,BaselTMA_SP43_15.9kx19.3ky_10000x5500_10_20170928_102_281_X8Y7_126_a0_full.tiff,735,857,629895,279127,PR+ER+,positive,HR+HER2-,Refractory
221,BaselTMA_SP43_221_X2Y7,3,25,FEMALE,0,57,alive w metastases,,2,69. Primary Dx,x,Sp4.3,x2y7,2,7,tumor,Sp4.3,96,60,0,30,10,1992,breast,invasive ductal breast carcinoma -,0,,0,positive,positive,negative,none,Chemotherapy - Hormone therapy,Sp4.3,breast cancer,40,171,"",1,0,,,1,,FALSE,"","","",1450,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_96_221_X2Y7_102_a0_full.tiff,733,695,509435,136872,PR+ER+,positive,HR+HER2-,Resistant
139,BaselTMA_SP43_139_X1Y7,3,40,FEMALE,0,40,death by primary disease,,2,70. Primary Dx,2,Sp4.3,x1y7,1,7,tumor,Sp4.3,95,90,0,10,0,1999,breast,mixed ductal lobular breast carcinoma - Lymphangiosis carcinomatosa,0,1,,positive,"",negative,none,Chemotherapy - Tamoxifen,Sp4.3,breast cancer,81,84,"",,0,,,1,,FALSE,"","","",2332,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_95_139_X1Y7_30_a0_full.tiff,727,759,551793,218570,"","","",Resistant
95,BaselTMA_SP43_95_X13Y2,2,25,FEMALE,0,57,alive w metastases,,2,71. Primary Dx,1,Sp4.3,x13y2,13,2,tumor,Sp4.3,27,80,0,20,0,2000,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,,,positive,positive,negative,none,Chemotherapy - Tamoxifen,Sp4.3,breast cancer,146,152,"",1,0,,,1,,FALSE,"","","",2717,BaselTMA_SP43_10.3kx13.7ky_6500x8000_6_20170928_27_95_X13Y2_27_a0_full.tiff,736,779,573344,289037,PR+ER+,positive,HR+HER2-,Resistant
95,BaselTMA_SP43_95_X14Y2,2,25,FEMALE,0,57,alive w metastases,,2,71. Primary Dx,1,Sp4.3,x14y2,14,2,non-tumor,Sp4.3,28,0,30,70,0,2000,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,,,positive,positive,negative,none,Chemotherapy - Tamoxifen,Sp4.3,breast cancer,146,152,"",1,0,,,1,,FALSE,"","","",390,BaselTMA_SP43_10.3kx13.7ky_6500x8000_6_20170928_28_95_X14Y2_120_a0_full.tiff,715,699,499785,36811,PR+ER+,positive,HR+HER2-,Resistant
19,BaselTMA_SP43_19_X15Y2,3,20,FEMALE,0,47,alive,,1,72. Primary Dx,1,Sp4.3,x15y2,15,2,tumor,Sp4.3,29,80,0,20,0,1994,breast,"invasive ductal breast carcinoma - invasive tubular breast carcinoma, in situ ductal breast carcinoma",0,0,0,positive,positive,negative,none,Hormone therapy,Sp4.3,breast cancer,195,195,"",1,0,1,,,,FALSE,"","","",3562,BaselTMA_SP43_10.3kx13.7ky_6500x8000_6_20170928_29_19_X15Y2_216_a0_full.tiff,777,771,599067,315067,PR+ER+,positive,HR+HER2-,Sensitive
19,BaselTMA_SP43_19_X16Y2,3,20,FEMALE,0,47,alive,,1,72. Primary Dx,1,Sp4.3,x16y2,16,2,non-tumor,Sp4.3,30,0,50,50,0,1994,breast,"invasive ductal breast carcinoma - invasive tubular breast carcinoma, in situ ductal breast carcinoma",0,0,0,positive,positive,negative,none,Hormone therapy,Sp4.3,breast cancer,195,195,"",1,0,1,,,,FALSE,"","","",280,BaselTMA_SP43_10.3kx13.7ky_6500x8000_6_20170928_30_19_X16Y2_322_a0_full.tiff,767,801,614367,30486,PR+ER+,positive,HR+HER2-,Sensitive
250,BaselTMA_SP43_250_X1Y3,2,40,FEMALE,0,56,alive,,2,73. Primary Dx,1,Sp4.3,x1y3,1,3,tumor,Sp4.3,31,80,0,15,5,1997,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,157,200,"",1,0,,,1,,FALSE,"","","",2510,BaselTMA_SP43_29.3kx15.5ky_7000x8000_3_20170928_31_250_X1Y3_33_a0_full.tiff,686,826,566636,310846,PR+ER+,positive,HR+HER2-,Resistant
250,BaselTMA_SP43_250_X2Y3,2,40,FEMALE,0,56,alive,,2,73. Primary Dx,1,Sp4.3,x2y3,2,3,non-tumor,Sp4.3,32,0,60,40,0,1997,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,157,200,"",1,0,,,1,,FALSE,"","","",2147,BaselTMA_SP43_29.3kx15.5ky_7000x8000_3_20170928_32_250_X2Y3_129_a0_full.tiff,547,724,396028,175738,PR+ER+,positive,HR+HER2-,Resistant
170,BaselTMA_SP43_170_X3Y3,2,25,FEMALE,0,81,alive w metastases,,2,74. Primary Dx,0,Sp4.3,x3y3,3,3,tumor,Sp4.3,33,70,5,15,10,2009,breast,invasive ductal breast carcinoma -,0,0,0,positive,negative,negative,none,Hormone therapy,Sp4.3,breast cancer,15,15,"",1,0,,,1,,FALSE,"","","",2117,BaselTMA_SP43_29.3kx15.5ky_7000x8000_3_20170928_33_170_X3Y3_229_a0_full.tiff,834,763,636342,303655,PR-ER+,positive,HR+HER2-,Resistant
170,BaselTMA_SP43_170_X4Y3,2,25,FEMALE,0,81,alive w metastases,,2,74. Primary Dx,0,Sp4.3,x4y3,4,3,non-tumor,Sp4.3,34,0,20,80,0,2009,breast,invasive ductal breast carcinoma -,0,0,0,positive,negative,negative,none,Hormone therapy,Sp4.3,breast cancer,15,15,"",1,0,,,1,,FALSE,"","","",595,BaselTMA_SP43_29.3kx15.5ky_7000x8000_3_20170928_34_170_X4Y3_334_a0_full.tiff,699,864,603936,75302,PR-ER+,positive,HR+HER2-,Resistant
150,BaselTMA_SP43_150_X5Y3,3,19,FEMALE,0,69,alive,,1c,75. Primary Dx,1,Sp4.3,x5y3,5,3,tumor,Sp4.3,35,70,0,30,0,2005,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Chemotherapy - Letrozol,Sp4.3,breast cancer,39,103,"",1,0,,,1,,FALSE,"","","",2440,BaselTMA_SP43_22.8kx15ky_7000x8000_4_20170928_35_150_X5Y3_36_a0_full.tiff,530,786,416580,234984,PR+ER+,positive,HR+HER2-,Resistant
150,BaselTMA_SP43_150_X6Y3,3,19,FEMALE,0,69,alive,,1c,75. Primary Dx,1,Sp4.3,x6y3,6,3,non-tumor,Sp4.3,36,0,30,70,0,2005,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Chemotherapy - Letrozol,Sp4.3,breast cancer,39,103,"",1,0,,,1,,FALSE,"","","",218,BaselTMA_SP43_22.8kx15ky_7000x8000_4_20170928_36_150_X6Y3_132_a0_full.tiff,781,715,558415,23214,PR+ER+,positive,HR+HER2-,Resistant
94,BaselTMA_SP43_94_X12Y7,3,50,FEMALE,0,66,alive w metastases,,2,76. Primary Dx,0,Sp4.3,x12y7,12,7,tumor,Sp4.3,106,70,0,30,0,2008,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,1,0,0,positive,negative,negative,none,Tamoxifen,Sp4.3,breast cancer,17,68,"",1,0,,1,,,FALSE,"","","",3089,BaselTMA_SP43_15.9kx19.3ky_10000x5500_10_20170928_106_94_X12Y7_367_a0_full.tiff,810,805,652050,338606,PR-ER+,positive,HR+HER2-,Refractory
241,BaselTMA_SP43_241_X7Y3,3,22,FEMALE,0,85,alive,,4b,77. Primary Dx,2,Sp4.3,x7y3,7,3,tumor,Sp4.3,37,80,0,20,0,2013,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,1,negative,negative,negative,none,"",Sp4.3,breast cancer,3,3,"",,1,,,,,FALSE,"","","",3052,BaselTMA_SP43_22.8kx15ky_7000x8000_4_20170928_37_241_X7Y3_232_a0_full.tiff,859,793,681187,423104,PR-ER-,negative,TripleNeg,""
241,BaselTMA_SP43_241_X8Y3,3,22,FEMALE,0,85,alive,,4b,77. Primary Dx,2,Sp4.3,x8y3,8,3,non-tumor,Sp4.3,38,0,0,100,0,2013,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,1,negative,negative,negative,none,"",Sp4.3,breast cancer,3,3,"",,1,,,,,FALSE,"","","",54,BaselTMA_SP43_22.8kx15ky_7000x8000_4_20170928_38_241_X8Y3_337_a0_full.tiff,717,642,460314,5478,PR-ER-,negative,TripleNeg,""
202,BaselTMA_SP43_202_X9Y5,2,19,FEMALE,1,72,alive w metastases,,1c,78. Primary Dx,3,Sp4.3,x9y5,9,5,tumor,Sp4.3,71,70,0,10,20,2004,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,0,positive,positive,negative,none,Anastrazol,Sp4.3,breast cancer,0,22,"",1,0,,1,,,FALSE,"","","",2978,BaselTMA_SP43_16.3kx14.5ky_7000x8000_5_20170928_71_202_X9Y5_78_a0_full.tiff,762,764,582168,394370,PR+ER+,positive,HR+HER2-,Refractory
209,BaselTMA_SP43_209_X11Y1,3,25,FEMALE,0,73,death by primary disease,,2,79. Primary Dx,1,Sp4.3,x11y1,11,1,tumor,Sp4.3,9,80,0,20,0,2003,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,1,0,0,positive,negative,positive,none,Tamoxifen,Sp4.3,breast cancer,38,74,"",1,0,,,1,,FALSE,"","","",1998,BaselTMA_SP43_16.3kx14.5ky_7000x8000_5_20170928_9_209_X11Y1_192_a0_full.tiff,736,805,592480,250920,PR-ER+,positive,HR+HER2+,Resistant
209,BaselTMA_SP43_209_X12Y1,3,25,FEMALE,0,73,death by primary disease,,2,79. Primary Dx,1,Sp4.3,x12y1,12,1,non-tumor,Sp4.3,10,0,20,80,0,2003,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,1,0,0,positive,negative,positive,none,Tamoxifen,Sp4.3,breast cancer,38,74,"",1,0,,,1,,FALSE,"","","",317,BaselTMA_SP43_16.3kx14.5ky_7000x8000_5_20170928_10_209_X12Y1_298_a0_full.tiff,795,584,464280,30175,PR-ER+,positive,HR+HER2+,Resistant
50,BaselTMA_SP43_50_X7Y1,3,30,FEMALE,0,78,death by primary disease,,2,80. Primary Dx,2,Sp4.3,x7y1,7,1,tumor,Sp4.3,5,90,0,10,0,2000,breast,invasive lobular breast carcinoma - Lymphangiosis carcinomatosa,0,1,0,positive,negative,negative,none,Tamoxifen,Sp4.3,breast cancer,5,15,"",,0,,1,,,FALSE,"","","",2905,BaselTMA_SP43_22.8kx15ky_7000x8000_4_20170928_5_50_X7Y1_189_a0_full.tiff,746,801,597546,369205,PR-ER+,positive,HR+HER2-,Refractory
50,BaselTMA_SP43_50_X8Y1,3,30,FEMALE,0,78,death by primary disease,,2,80. Primary Dx,2,Sp4.3,x8y1,8,1,non-tumor,Sp4.3,6,0,100,0,0,2000,breast,invasive lobular breast carcinoma - Lymphangiosis carcinomatosa,0,1,0,positive,negative,negative,none,Tamoxifen,Sp4.3,breast cancer,5,15,"",,0,,1,,,FALSE,"","","",32,BaselTMA_SP43_22.8kx15ky_7000x8000_4_20170928_6_50_X8Y1_295_a0_full.tiff,737,751,553487,3303,PR-ER+,positive,HR+HER2-,Refractory
157,BaselTMA_SP43_157_X4Y5,3,45,FEMALE,0,63,death by primary disease,,3,81. Primary Dx,2,Sp4.3,x4y5,4,5,tumor,Sp4.3,66,60,0,40,0,2001,breast,"invasive lobular breast carcinoma - In situ lobular breast carcinoma, Lymphangiosis carcinomatosa",1,1,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,21,44,"",,0,,1,,,FALSE,"","","",711,BaselTMA_SP43_29.3kx15.5ky_7000x8000_3_20170928_66_157_X4Y5_370_a0_full.tiff,795,747,593865,80763,PR+ER+,positive,HR+HER2-,Refractory
43,BaselTMA_SP43_43_X5Y5,2,10,FEMALE,0,62,death by primary disease,,3,82. Primary Dx,1,Sp4.3,x5y5,5,5,tumor,Sp4.3,67,50,0,20,30,1999,breast,invasive lobular breast carcinoma - Lymphangiosis carcinomatosa,0,1,0,positive,negative,negative,none,Tamoxifen,Sp4.3,breast cancer,53,55,"",,0,,,1,,FALSE,"","","",2659,BaselTMA_SP43_22.8kx15ky_7000x8000_4_20170928_67_43_X5Y5_75_a0_full.tiff,685,763,522655,219984,PR-ER+,positive,HR+HER2-,Resistant
108,BaselTMA_SP43_108_X13Y8,3,33,FEMALE,0,64,death by primary disease,,2,83. Primary Dx,0,Sp4.3,x13y8,13,8,tumor,Sp4.3,123,80,0,20,0,1998,breast,invasive medullary breast carcinoma - Lymphangiosis carcinomatosa,0,1,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,23,35,"",,0,,1,,,FALSE,"","","",6333,BaselTMA_SP43_9.9kx19.3ky_6000x5500_11_20170928_123_108_X13Y8_183_a0_full.tiff,775,755,585125,559188,PR+ER+,positive,HR+HER2-,Refractory
85,BaselTMA_SP43_85_X10Y1,2,12,FEMALE,0,77,death by primary disease,,4,85. Primary Dx,0,Sp4.3,x10y1,10,1,non-tumor,Sp4.3,8,0,40,60,0,2003,breast,invasive lobular breast carcinoma - In situ ductal breast carcinoma,1,0,0,positive,negative,negative,none,Tamoxifen,Sp4.3,breast cancer,74,75,"",,0,,,1,,FALSE,"","","",404,BaselTMA_SP43_16.3kx14.5ky_7000x8000_5_20170928_8_85_X10Y1_96_a0_full.tiff,714,910,649740,33809,PR-ER+,positive,HR+HER2-,Resistant
85,BaselTMA_SP43_85_X9Y1,2,12,FEMALE,0,77,death by primary disease,,4,85. Primary Dx,0,Sp4.3,x9y1,9,1,tumor,Sp4.3,7,70,0,20,10,2003,breast,invasive lobular breast carcinoma - In situ ductal breast carcinoma,1,0,0,positive,negative,negative,none,Tamoxifen,Sp4.3,breast cancer,74,75,"",,0,,,1,,FALSE,"","","",1855,BaselTMA_SP43_16.3kx14.5ky_7000x8000_5_20170928_7_85_X9Y1_9_a0_full.tiff,764,689,526396,193464,PR-ER+,positive,HR+HER2-,Resistant
199,BaselTMA_SP43_199_X8Y5,3,39,FEMALE,0,48,death by primary disease,,2,86. Primary Dx,1,Sp4.3,x8y5,8,5,tumor,Sp4.3,70,70,0,20,10,1999,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,1,0,0,negative,negative,negative,none,Chemotherapy,Sp4.3,breast cancer,23,28,"",,1,,,,,FALSE,"","","",3082,BaselTMA_SP43_22.8kx15ky_7000x8000_4_20170928_70_199_X8Y5_373_a0_full.tiff,754,807,608478,314870,PR-ER-,negative,TripleNeg,""
230,BaselTMA_SP43_230_X11Y5,3,21,FEMALE,0,71,alive,,2,87. Primary Dx,3,Sp4.3,x11y5,11,5,tumor,Sp4.3,73,60,0,20,20,2010,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,1,negative,negative,negative,none,"",Sp4.3,breast cancer,6,6,"",,1,,,,,FALSE,"","","",2488,BaselTMA_SP43_16.3kx14.5ky_7000x8000_5_20170928_73_230_X11Y5_277_a0_full.tiff,739,748,552772,316190,PR-ER-,negative,TripleNeg,""
168,BaselTMA_SP43_168_X10Y5,3,35,FEMALE,0,86,alive,,2,88. Primary Dx,1,Sp4.3,x10y5,10,5,tumor,Sp4.3,72,80,0,10,10,2010,breast,invasive ductal breast carcinoma - Lymphangiosis carcinomatosa,0,1,1,negative,negative,negative,none,"",Sp4.3,breast cancer,36,36,"",,1,,,,,FALSE,"","","",6940,BaselTMA_SP43_16.3kx14.5ky_7000x8000_5_20170928_72_168_X10Y5_171_a0_full.tiff,814,775,630850,526961,PR-ER-,negative,TripleNeg,""
78,BaselTMA_SP43_78_X3Y9,3,24,FEMALE,0,27,death by primary disease,,2,2. Primary Dx,0,Sp4.3,x3y9,3,9,tumor,Sp4.3,127,50,0,50,0,2003,breast,invasive ductal breast carcinoma - Lymphangiosis carcinomatosa,0,1,0,positive,negative,positive,none,Tamoxifen,Sp4.3,breast cancer,12,61,"",1,0,,1,,,FALSE,"","","",4340,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_113_78_X3Y9_198_a0_full.tiff,767,770,590590,414220,PR-ER+,positive,HR+HER2+,Refractory
115,BaselTMA_SP43_115_X4Y8,2,52,FEMALE,0,37,alive,,3,90. Primary Dx,0,Sp4.3,x4y8,4,8,tumor,Sp4.3,114,60,0,40,0,2009,breast,invasive ductal breast carcinoma -,0,0,0,negative,negative,negative,none,Chemotherapy,Sp4.3,breast cancer,54,54,"",,1,,,,,FALSE,"","","",4946,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_114_115_X4Y8_262_a0_full.tiff,782,803,627946,392277,PR-ER-,negative,TripleNeg,""
131,BaselTMA_SP43_131_X14Y4,1,18,FEMALE,0,68,alive,,1c,12. Primary Dx,0,Sp4.3,x14y4,14,4,non-tumor,Sp4.3,60,0,30,70,0,2007,breast,mixed ductal lobular breast carcinoma - In situ ductal breast carcinoma,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,75,75,"",,0,1,,,,FALSE,"","","",894,BaselTMA_SP43_10.3kx13.7ky_6500x8000_6_20170928_50_131_X14Y4_156_a0_full.tiff,756,721,545076,92025,PR+ER+,positive,HR+HER2-,Sensitive
116,BaselTMA_SP43_116_X3Y4,3,24,FEMALE,0,49,alive,,2,91. Primary Dx,0,Sp4.3,x3y4,3,4,tumor,Sp4.3,49,60,0,20,20,2009,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,0,negative,negative,negative,none,Chemotherapy,Sp4.3,breast cancer,46,46,"",,1,,,,,FALSE,"","","",6080,BaselTMA_SP43_29.3kx15.5ky_7000x8000_3_20170928_49_116_X3Y4_250_a0_full.tiff,792,802,635184,534851,PR-ER-,negative,TripleNeg,""
116,BaselTMA_SP43_116_X4Y4,3,24,FEMALE,0,49,alive,,2,91. Primary Dx,0,Sp4.3,x4y4,4,4,non-tumor,Sp4.3,50,0,80,20,0,2009,breast,invasive ductal breast carcinoma - In situ ductal breast carcinoma,0,0,0,negative,negative,negative,none,Chemotherapy,Sp4.3,breast cancer,46,46,"",,1,,,,,FALSE,"","","",3024,BaselTMA_SP43_29.3kx15.5ky_7000x8000_3_20170928_50_116_X4Y4_352_a0_full.tiff,821,805,660905,259631,PR-ER-,negative,TripleNeg,""
103,BaselTMA_SP43_103_X5Y4,3,30,FEMALE,0,60,alive,,2,93. Primary Dx,0,Sp4.3,x5y4,5,4,tumor,Sp4.3,51,70,0,20,10,2012,breast,invasive ductal breast carcinoma -,0,0,0,negative,negative,negative,none,Chemotherapy,Sp4.3,breast cancer,12,12,"",,1,,,,,FALSE,"","","",4195,BaselTMA_SP43_22.8kx15ky_7000x8000_4_20170928_51_103_X5Y4_54_a0_full.tiff,764,818,624952,467875,PR-ER-,negative,TripleNeg,""
103,BaselTMA_SP43_103_X6Y4,3,30,FEMALE,0,60,alive,,2,93. Primary Dx,0,Sp4.3,x6y4,6,4,non-tumor,Sp4.3,52,0,10,90,0,2012,breast,invasive ductal breast carcinoma -,0,0,0,negative,negative,negative,none,Chemotherapy,Sp4.3,breast cancer,12,12,"",,1,,,,,FALSE,"","","",187,BaselTMA_SP43_22.8kx15ky_7000x8000_4_20170928_52_103_X6Y4_150_a0_full.tiff,835,726,606210,20629,PR-ER-,negative,TripleNeg,""
77,BaselTMA_SP43_77_X3Y8,3,31,FEMALE,0,85,alive,,2,89. Primary Dx,1,Sp4.3,x3y8,3,8,tumor,Sp4.3,113,90,0,5,5,2009,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,0,negative,negative,negative,none,"",Sp4.3,breast cancer,33,33,"",,1,,,,,FALSE,"","","",2215,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_116_77_X3Y8_177_a0_full.tiff,727,784,569968,225281,PR-ER-,negative,TripleNeg,""
270,BaselTMA_SP43_270_X6Y8,3,13,FEMALE,0,58,alive,,1c,94. Primary Dx,0,Sp4.3,x6y8,6,8,tumor,Sp4.3,116,70,0,10,20,2011,breast,invasive ductal breast carcinoma -,0,0,0,negative,negative,negative,none,Chemotherapy,Sp4.3,breast cancer,23,23,"",,1,,,,,FALSE,"","","",4311,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_116_270_X6Y8_388_a0_full.tiff,858,829,711282,547119,PR-ER-,negative,TripleNeg,""
110,BaselTMA_SP43_110_X14Y8,3,75,FEMALE,1,90,death,,4b,95. Primary Dx,3,Sp4.3,x14y8,14,8,tumor,Sp4.3,124,90,0,10,0,2002,breast,invasive ductal breast carcinoma - Lymphangiosis carcinomatosa,0,1,0,negative,negative,negative,none,"",Sp4.3,breast cancer,0,13,"",,1,,,,,FALSE,"","","",1143,BaselTMA_SP43_9.9kx19.3ky_6000x5500_11_20170928_124_110_X14Y8_247_a0_full.tiff,754,737,555698,150546,PR-ER-,negative,TripleNeg,""
15,BaselTMA_SP43_15_X1Y9,3,25,FEMALE,0,63,alive,,2,96. Primary Dx,1,Sp4.3,x1y9,1,9,tumor,Sp4.3,125,80,0,15,5,2003,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,0,negative,negative,negative,none,Chemotherapy,Sp4.3,breast cancer,87,87,"",,1,,,,,FALSE,"","","",4399,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_125_15_X1Y9_63_a0_full.tiff,714,771,550494,444209,PR-ER-,negative,TripleNeg,""
225,BaselTMA_SP43_225_X2Y9,2,50,FEMALE,1,42,alive w metastases,,4,97. Primary Dx,1,Sp4.3,x2y9,2,9,tumor,Sp4.3,126,80,0,20,0,2003,breast,"invasive lobular breast carcinoma - In situ lobular breast carcinoma, Lymphangiosis carcinomatosa",1,1,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,9,18,"",,0,,1,,,FALSE,"","","",2906,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_126_225_X2Y9_141_a0_full.tiff,748,741,554268,331408,PR+ER+,positive,HR+HER2-,Refractory
226,BaselTMA_SP43_226_X6Y9,3,35,FEMALE,0,70,alive,,2,98. Primary Dx,2,Sp4.3,x6y9,6,9,tumor,Sp4.3,130,80,0,20,0,2001,breast,"mixed ductal lobular breast carcinoma - In situ ductal breast carcinoma, Morbus Paget",0,0,0,positive,negative,negative,none,Tamoxifen,Sp4.3,breast cancer,143,143,"",,0,1,,,,FALSE,"","","",5291,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_130_226_X6Y9_391_a0_full.tiff,698,827,577246,462336,PR-ER+,positive,HR+HER2-,Sensitive
245,BaselTMA_SP43_245_X6Y5,2,15,FEMALE,0,57,alive w metastases,,1c,99. Primary Dx,x,Sp4.3,x6y5,6,5,tumor,Sp4.3,68,80,0,10,10,2004,breast,invasive lobular breast carcinoma -,0,0,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,94,94,"",,0,,,1,,FALSE,"","","",4641,BaselTMA_SP43_22.8kx15ky_7000x8000_4_20170928_68_245_X6Y5_168_a0_full.tiff,749,732,548268,449533,PR+ER+,positive,HR+HER2-,Resistant
269,BaselTMA_SP43_269_X5Y9,2,22,FEMALE,0,57,alive,,2,100. Primary Dx,0,Sp4.3,x5y9,5,9,tumor,Sp4.3,129,60,0,30,10,2001,breast,"invasive ductal breast carcinoma - In situ ductal breast carcinoma, Lymphangiosis carcinomatosa",0,1,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,150,150,"",1,0,1,,,,FALSE,"","","",3949,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_129_269_X5Y9_346_a0_full.tiff,772,772,595984,371534,PR+ER+,positive,HR+HER2-,Sensitive
197,BaselTMA_SP43_197_X4Y9,1,18,FEMALE,0,64,alive,,1c,1. Primary Dx,0,Sp4.3,x4y9,4,9,tumor,Sp4.3,128,50,0,50,0,2003,breast,invasive lobular breast carcinoma - tubular lobular subtype,,0,0,positive,positive,negative,none,Tamoxifen,Sp4.3,breast cancer,95,95,"",,0,1,,,,FALSE,"","","",850,BaselTMA_SP43_25.8kx22ky_10500x6500_8_20170928_128_197_X4Y9_283_a0_full.tiff,731,414,302634,76532,PR+ER+,positive,HR+HER2-,Sensitive
